Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Suspect Hepatitis C (HCV) Clinical Research Samples
Discovery Life Sciences provides the highest quality Suspect Hepatitis C (HCV) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Suspect Hepatitis C (HCV) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 603 of 603 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Consent Status Date | Current Medications | Diagnosis | Symptoms | Western Blot | Abbott Architect | Risk Categories | Vaccinated for Hepatitis A | Vaccinated for Hepatitis B | Vaccinated for Influenza within 60 days prior to phlebotomy | Subject Taking Vitamin B7 (Biotin) | Is Subject Taking a Multivitamin Supplement | Additional Medications |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBP0000-BU900106672060613DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 4.00 | $150.00 | 34 Y | Female | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0000-A0900107210070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 69 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hypokalemia, Unspecified protein-calorie malnutrition, Hypotension of hemodialysis | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Colchicine, Metoprolol, Zantac | U/A | Yes Date of Vaccination: 3/19/2019 | No | No | ||||||||||||||||
| BBS0000-A0900107211070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 61 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Hypocalcemia, Hypotension of hemodialysis, Constipation, Fever, Other disorders of calcium metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Peritonitis, Diabetes mellitus type 2, Hypercalcemia, Hypokalemia, Hypoxemia, Other disorders of phosphorus metabolism, Hypertensi | Liquacel, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, Levetiracetam, Ammonium lactate, Lexapro, Bentyl, Metoprolol, Celebrex, Midodrine, Chlorzoxazone, Colace, Omeprazole, Dialyvite, Dicyclomine, Albuterol, Diprolene, Doxepin, Polycarbophil, EMLA, Pregabalin, Fioricet, Protonix, Flomax, Renvela, Flovent, Spiriva, Gabapentin, Ultram, Lactulose, Zocor | U/A | Yes Date of Vaccination: 2/14/2007 | No | No | ||||||||||||||||
| BBS0000-A0900107219070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 57 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypercalcemia, Other fluid overload, Vomiting | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Promethazine, Allopurinol, Cinacalcet, Amlodipine, Fosrenol, Atorvastatin, Furosemide, Cardura, Minoxidil, Carvedilol, Terazosin | U/A | Yes Date of Vaccination: 10/12/2016 | No | No | ||||||||||||||||
| BBS0000-A0900107220070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 39 Y | Female | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of calcium metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypercalcemia, Hypocalcemia, Other fluid overload, Bacteremia, Calcinosis cutis, Cough, Hypoglycemia, Local infection due to central venous catheter, Nausea, Strepotococcus group B, Diabetes mellitus ty | Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Apixiban, Clonazepam, Dilaudid, Glucagon, Plavix, Insulin Lantus, Primidone, Atorvastatin, Protonix, Lopressor, Requip, Melatonin, Senna | No | Yes Date of Vaccination: 4/12/2012 | No | No | ||||||||||||||||
| BBS0000-A0900107221070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 63 Y | Female | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypokalemia, Fluid overload, Shortness of breath, Headache | Epogen, Liquacel, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Acyclovir cream, Aspirin, Carvedilol, Colace, EMLA, Fentanyl, Flexeril, Hydralazine, Lidocaine, Losartan, PhosLo, Minoxidil, Synthroid, Nephro-Vite, Valtrex, Nepro, Voltaren, Zyrtec | No | Yes Date of Vaccination: 6/16/2016 | No | No | ||||||||||||||||
| BBS0000-A0900107222070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 61 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Fluid overload, Shortness of breath | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Calcium acetate, Minoxidil, Carvedilol, Norvasc | U/A | Yes Date of Vaccination: 11/18/2017 | No | No | ||||||||||||||||
| BBS0000-A0900107229082919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 34 Y | Female | <-70C | 29-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease on dialysis, Lupus, Asthma | Epoetin alfa, Metoclopramide, Ondansetron, Pantoprazole | Yes U/A | Yes U/A | No | No | |||||||||||||||||
| BBS0000-A0900107232082719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 44 Y | Male | <-70C | 27-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 164 U/L | ALT: 141 U/L | ALP: 626 U/L | $150.00 | Unknown | Biliary obstruction status post biliary drain and stent placement, Cholecystectomy | Acyclovir, Docusate sodium, Hydrocodone-acetaminophen, Polyethylene glycol, Senna | No | No | No | No | |||||||||||||||||
| BBS0000-A0900107234091019DD | Suspect Hepatitis C (HCV) | USA | 7.00 | $150.00 | 47 Y | Female | <-70C | 10-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Ascites, Elevated liver enzymes | ALP: 257 U/L | 9-Sep-19 | $150.00 | Unknown | Diabetes mellitus, Cirrhosis, End stage renal disease on hemodialysis, Hypertension, Pulmonary embolism | Albuterol, Hydrocodone-acetaminophen, Insulin glargine, Lidocaine, Metoprolol tartrate, Apixaban | No | No | No | Yes | |||||||||||||||||
| BBS0000-A0900107235090319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 46 Y | Male | <-70C | 03-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Kidney transplant 2009 which failed | Acetaminophen, Amlodipine, Calcium acetate, Diclofenac sodium, Nicotine | No | No | No | No | |||||||||||||||||
| BBS0000-A0900107304070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 59 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, End stage renal disease, Fluid overload, Iron deficiency anemia, Renal osteodystrophy, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance | Hectoral, Liquacel, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, Aspirin, Atorvastatin, Pioglitazone, Colace, Renvela, Midodrine, Toprol XL | U/A | Yes Date of Vaccination: 5/18/2019 | No | No | ||||||||||||||||
| BBS0000-A0900107317070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 72 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Hyperkalemia, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Aspirin, Bumetanide, Carvedilol, Fish oil, Furosemide, Hydralazine, Isosorbide mononitrate, Vitamin D3, Acetaminophen, Diphenhydramine, Nitroglycerin, Loperamide, Ondansetron, Promethazine, Losartan, Renvela, Vitamin B complex | U/A | Yes Date of Vaccination: 19-Feb-2019 | No | Yes | ||||||||||||||||
| BBS0000-A0900107318070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 67 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Anemia, Chronic kidney disease stage 4, Dependence on renal dialysis, Hypoxemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Unspecified protein-calorie malnutrition, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Shortness of breath | Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Losartan, Atorvastatin, Nifedipine, Budesonide, PhosLo, Bumetanide, Sevelamer, Ipratropium inhaler | No | Yes Date of Vaccination: 16-Oct-2018 | No | No | ||||||||||||||||
| BBS0000-A0900107319070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 68 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, Atorvastatin, Flonase, Paricalcitol, Folic acid, Tamsulosin, Lorazepam, Torsemide, NovoLog insulin, Warfarin, Insulin degludec | No | No | No | No | ||||||||||||||||
| BBS0000-A0900107320070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 65 Y | Female | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Anorexia, Hypercalcemia, Hypocalcemia | Epogen, Hectorol, Liquacel, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Acetaminophen, Amlodipine, Vitamin C, Aspirin, Plavix, Atorvastatin, Protonix, Carvedilol, Tums, Cinacalcet, Vitamin B complex | No | No | No | No | ||||||||||||||||
| BBS0000-A0900107321070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 62 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Chills | Hectoral, Liquacel, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Ondansetron, Calcium acetate, Furosemide, Coumadin | U/A | Yes Date of Vaccination: 2/19/2018 | No | No | ||||||||||||||||
| BBS0000-A0900107835070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 63 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Cardiomegaly, Disorders of phosphorus metabolism, Hypercalcemia, Hypertension, Iron deficiency anemia, Obesity, Pure hypercholestrolemia, Renal osteodystrophy, Vitamin D deficiency, Secondary hyperparathyroidism | Amlodipine, Aspirin, Dialyvite, Renvela, Sensipar | No | No | No | No | ||||||||||||||||
| BBS0000-A0900108389072919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 75 Y | <-70C | 29-Jul-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Fever, Hypocalcemia, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 2, Dependence on renal dialysis, Hyperkalemia, Hypokalemia, Long term current use of anticoagulants, Unspecified protein-calorie malnutrition | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atovaquone, Hydroxyzine, Cetirizine, Ketoconazole, Clindamycin, Levothyroxine, Cyanocobalamin, Cyclosporine, Midodrine, Desonide, Ergocalciferol, Rena-Vite, Fludrocortisone, Renvela, Fluticasone, Tums, Gabapentin, Ursodeoxycholic acid, Hydrocortisone, Warfarin | No | No | No | No | |||||||||||||||||
| BBS0000-A0900108389101119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 42 Y | <-70C | 11-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Unspecified protein-calorie malnutrition, Iron deficiency anemia, Secondary Hyperparathyroidism of renal origin | Epogen, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Isosorbide, Metoprolol, PhosLo, Iron sucrose, Levofloxacin, Tylenol | No | yes 11-Oct-19 | No | No | ||||||||||||||||||
| BBS0000-A0900109655082719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 60 Y | Male | <-70C | 27-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 38 U/L | ALP: 299 U/L | $150.00 | Unknown | Hypertension, Atrial fibrillation, Congestive heart failure, Venous stasis, Pneumonia | Bumetanide, Carvedilol, Metolazone, Potassium chloride, Rivaroxaban, Vitamin A & D ointment | No | No | No | No | |||||||||||||||||
| BBS0000-A0900109699070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 69 Y | Female | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Alcohol abuse, Cardiomegaly, Fluid overload, Hyperkalemia, Idiopathic gout, Localized edema, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Heart failure, Nicotine dependence, Hypertensive chronic kidney disease with stage 5 chronic kidney disease | Epogen, Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Furosemide, Atrovent, Metoprolol, Cinacalcet, Rena-Vite, Cozaar, Renvela | U/A | Yes Date of Vaccination: 11/18/2017 | No | No | ||||||||||||||||
| BBS0000-A0900109700070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 72 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypocalcemia, Hyperkalemia | Epogen, Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Hydralazine, Amlodipine, Insulin lantus, Aspirin, Plavix, Atorvastatin, Renvela, Clonidine, Tobramycin, Enalapril | U/A | Yes Date of Vaccination: 1/16/2018 | No | No | ||||||||||||||||
| BBS0000-A0900109701070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 64 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Hypokalemia, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Calcium acetate, Niacin, Clonazepam, Garlique, Oxycodone, Glipizide, Rosuvastatin, Insulin lispro, Sertraline, Insulin lantus, Sildenafil, Metoprolol | U/A | Yes 24-Nov-18 | No | No | ||||||||||||||||
| BBS0000-A0900109702070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 62 Y | Female | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Anemia, Chronic kidney disease stage 4, End stage renal disease, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition | Engerix, Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Allopurinol, NovoLog, Clopidogrel, EMLA, Guaifenesin, Albuterol sulfate, Hydralazine, Renvela, Lamictal, Senna, Insulin lantus, Sertraline, Levothyroxine, Triamcinolone, Lipitor, MiraLax | U/A | Yes Date of Vaccination: 4/16/2019 | No | No | ||||||||||||||||
| BBS0000-A0900109703070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 92 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, End stage renal disease, Hyperkalemia, Other disorders of phosphorus metabolism, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Diabetes mellitus type 2, Hypertensive chronic kidney disease with stage 5 chronic kidney disease, Old myocardial infarction, Heart failure, Shortness of breath, Obstructive sleep apnea, Ather | Epogen, Hectorol, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Metoprolol, Clopidogrel, Norvasc, Docusate, Omeprazole, Gabapentin, Voltaren gel, Humalog, PhosLo | U/A | Yes Date of Vaccination: 10/21/2016 | No | No | ||||||||||||||||
| BBS0000-A0900109704070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 72 Y | Female | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Hypokalemia, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Furosemide, Losartan, Biotin, Metoprolol, PhosLo, Protonix | U/A | Yes Date of Vaccination: 8/19/2017 | No | Yes | ||||||||||||||||
| BBS0000-A0900109816070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 55 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, Fluid overload, End stage renal disease, Hypokalemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Shortness of breath | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Budesonide, Insulin humalog, Lac-Hydrin, Atorvastatin, Bumetanide, Hydralazine, Insulin lantus, Bupropion, Losartan, Calcium acetate, Metoprolol, Doxazosin, Nystatin, Duloxetine, Oxycodone, DuoNeb, Oxycontin, Famotidine, Ticagrelor, Ferrous gluconate, Furosemide | U/A | Yes Date of Vaccination: 6/17/2019 | No | No | ||||||||||||||||
| BBS0000-A0900109817070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 68 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance, Unspecified protein-calorie malnutrition, Hypocalcemia, Hypercalcemia | Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Acetaminophen, Metoprolol, Melatonin, Cinacalcet, Aspirin, Pantoprazole, Doxazosin, Pravastatin, Glipizide, Trazodone, Loratadine | U/A | Yes Date of Vaccination: 2/19/2019 | No | No | ||||||||||||||||
| BBS0000-A0900109818070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 60 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 1, Anemia in chronic kidney disease, Cellutiis of right finger, Fluid overload, End stage renal disease, Hyperkalemia, Hypercalcemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Other disorders of electrolyte and fluid balance | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Alprazolam, Losartan, Amlodipine, Lumigan, Aspirin, Metoprolol, Atorvastatin, Biotin, Dorzolamide, Oxycodone, Insulin humalog, Pantoprazole, Insulin lantus, Renvela, Lidocaine | U/A | Yes Date of Vaccination: 7/14/2017 | No | No | ||||||||||||||||
| BBS0000-A0900109819070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 59 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Other fluid overload | Engerix, Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Carvedilol, PhosLo, Pravastatin, Losartan, Prednisone, Sevelamer, Triphrocaps | U/A | Yes Date of Vaccination: 5/20/2019 | No | No | ||||||||||||||||
| BBS0000-A0900109820070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 38 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Anemia in chronic kidney disease, End stage renal disease, Other disorders of electrolyte and fluid balance, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition | Epogen, Hectorol, Heparin, Liquacel, Venofer, Acetaminophen, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Methylphenidate, Atorvastatin, Metronidazole, Bupropion, Ondansetron, Dicyclomine, Dolutegravir, Doxycycline, Pantoprazole, Emtriva, Sevelamer, Flonase, Tenofovir, Loratadine | U/A | U/A | No | No | ||||||||||||||||
| BBS0000-A0900109821070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 62 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Chills, End stage renal disease, Anemia in chronic kidney disease, Hypercalcemia, Iron deficiency anemia, Bacteremia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Other disorders of electrolyte and fluid balance, Fever, Hyperkalemia, Unspecified protein-calorie malnutrition, Methicillin susceptible Staphylococcus aureus infection as the cause of diseases classified elsewhere, Other disorders of phosphorus metabolism | Epogen, Hectorol, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Insulin lantus, Atorvastatin, Midodrine, Carvedilol, Pantoprazole, Clopidogrel, Renvela | No | Yes Date of Vaccination: 9/15/2016 | No | No | ||||||||||||||||
| BBS0000-A0900109887062419DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 17.00 | $150.00 | 66 Y | Female | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Autoimmune hepatitis, Venous stasis dermatitis, Hypokalemia, Normocytic anemia, Hypertension, Thrombocytopenia, Rheumatoid arthritis | Enalapril, Folic acid, Furosemide, Hydrocortisone ointment, Protonix, Prednisone, Spironolactone, Thiamine | No | No | No | No | |||||||||||||||||
| BBS0000-A0900109888090419DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 54 Y | Female | <-70C | 04-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Former user of IV drugs | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Congestive heart failure, Diabetes mellitus, GERD, End stage renal disease on hemodialysis | Carvedilol, Clonidine, Docusate sodium, Furosemide, Hydralazine, Oxcarbazepine, Sevelamer hydrochloride | No | Yes 19-Aug-19 | No | No | |||||||||||||||||
| BBS0000-A0900109889082919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 46 Y | Male | <-70C | 29-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 96 U/L | ALP: 166 U/L | $150.00 | Unknown | Liver cirrhosis 2nd stage due to alcohol abuse | Chlordiazepoxide, Fluoxetine, Folic acid, Gabapentin, Hydrocodone-acetaminophen, Mirtazapine, Nicotine, Ondansetron, Thiamine | Unknown | U/A | Yes | Unknown | |||||||||||||||||
| BBS0000-A0900109890090519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 2.00 | $150.00 | 59 Y | Female | <-70C | 05-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 135 U/L | $150.00 | Unknown | Heart artery stent, Hypertension | Aspirin, Clopidogrel bisulfate, Hydrocodone-acetaminophen | Yes U/A | Yes U/A | No | No | |||||||||||||||||
| BBS0000-A0900109891082919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 5.00 | $150.00 | 57 Y | Male | <-70C | 29-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 181 U/L | ALT: 83 U/L | $150.00 | Unknown | Congestive heart failure, Atrial flutter, Alcohol abuse | Aspirin, Atorvastatin, Benazepril, Carvedilol, furosemide, Magnesium chloride, Potassium chloride, Spironolactone, Warfarin | Yes U/A | U/A | No | Yes | |||||||||||||||||
| BBS0000-A0900109909070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 52 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Acute kidney failure, Chills, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Other disorders of electrolyte and fluid balance | Epogen, Venofer, Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Amlodipine, Niaspan, Aspirin, PhosLo, Crestor, Ranitidine, Ergocalciferol, Senna, Insulin humalog, Synthroid, Insulin lantus, Trileptal, Metoprolol, Vanlafaxine, MiraLax | U/A | Yes Date of Vaccination: 5/20/2019 | No | Yes | ||||||||||||||||
| BBS0000-A0900109910070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 52 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 1, Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition | Acetaminophen, Diphenhydramine, Loperamide, Nitroglycerin, Ondansetron, Promethazine, Aspirin, Medical marijuana, Lactulose, Furosemide, Calcitriol, Vitamin D3, Nortriptyline, Glucagon, Carvedilol, Oxycodone, Omeprazole, Hydralazine, Ciclopirox loprox, Tamsulosin, Insulin novolog, Clonidine, Travatan, Insulin degludec, Zolpidem | U/A | No | No | No | ||||||||||||||||
| BBS0000-A0900109920070319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 59 Y | Male | <-70C | 03-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia, Fever, Morbid obesity, Protein-calorie malnutrition, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Pruritis, Hypercalcemia, Hyperkalemia, Secondary hyperparathyroidism, Iron deficiency anemia, Obstructive sleep apnea, Renal osteodystrophy | Aspirin, Auryxia, Lidocaine cream, Vitamin D3, Vidal, PhosLo, Renvela | No | No | No | No | ||||||||||||||||
| BBS0000-A0900109921080719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 58 Y | Male | <-70C | 07-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992, Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anemia in chronic kidney disease, Chills, End stage renal disease, Infection of amputation stump, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 2, Dependence on renal dialysis, Bacteremia, Fluid overload, Long term current use of anticoagulants, Unspecified protein-calorie malnutrition, Renal osteodystrophy | Hectorol, Liquacel, Venofer, Ascorbic acid, Methocarbamol, Aspirin, Midodrine, Atorvastatin, Carvedilol, Colace, Eliquis, Hydrocodone, Sennoside-docusate sodium, Insulin lispro, Pantoprazole, Insulin aspart, Polyethylene glycol, Isosorbide dinitrate, Renvela, Renvela, Lactulose, Senna | No | No | No | No | |||||||||||||||||
| BBS0000-A0900109922100419DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 16.00 | $150.00 | 63 Y | Female | <-70C | 04-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Gabapentin, Alprazolam, Hydralazine, Ambien, Labetalol, Amiodarone, Lactulose, Amlodipine, Montelukast, Calcium acetate, Norco, Pantoprazole, Ergocalciferol, Prednisone, Escitalopram, Fluticasone | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110004072319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 65 Y | Female | <-70C | 23-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | NASH, Portal hypertension, HCC | Xanax, Prozac, Prevacid, Zofran, Pseudoephedrine, Acetaminophen, Aldactone | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110005081319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 68 Y | Female | <-70C | 13-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | Unknown | Ascites due to alcoholic cirrhosis, Anasarca, Edema, Cellulitis, Preglaucoma, Senile nuclear sclerosis, Diabetes type 2, Atrial fibrillation, Hypertension, Hyperlipidemia | Furosemide, Metoprolol succinate, Spironolactone, Ursodiol, Warfarin | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110006082119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 57 Y | Male | <-70C | 21-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | Unknown | Alcholic cirrhosis, Peptic ulcer disease, Esophageal varices, Anemia | Ferrous sulfate, Furosemide, Omeprazole, Propranolol, Spironolactone | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110007062419DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 69 Y | Male | <-70C | 24-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Non-alcoholic fatty liver disease, Cholecystitis, Ulcerative colitis, Macrocytosis, Elevated TSH, Glaucoma, Sick sinus syndrome, A-fib, Hypertension, Arthritis, Tendonitis, Erectile dysfunction, Seborrheic keratosis, Patent foramen ovale | Allopurinol, Xanax, Norvasc, Eliquis, Alphagan, Vitamin D3, Cosopt, Vitamin D2, Glucosamine, Norco, Hydrocortisone, Xalatan, Magnesium, Purinethol, Mesalamine, Multi-Vitamin Injection, Omega 3, Potassium, Revatio | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110018070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 48 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Bacteremia, Bronchitis, Anemia in chronic kidney disease, Chills, Cough, Acute nasopharyngitis, Disorders of phosphorus metabolism, End stage renal disease, Fever, Hypercalcemia, Hypertension, Fluid overload, Function dyspepsia, Hyperkalemia, Hyperlipidemia, HIV, Iron deficiency anemia, Nausea, Disorders of calcium metabolism, Disorders of electrolyte, Secondary hyperparathyroidism, Vitamin D deficiency, Sepsis, Diabetes type 2, Pruritus, Pneumonia | Acetaminophen, Amlodipine, Coumadin, Hydrocortisone, Dialyvite, Renvela, Juluca, Sensipar | No | No | No | No | ||||||||||||||||
| BBS0000-A0900110018093019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 49 Y | Male | <-70C | 30-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Bicitra, Levothyroxine, Cholecalciferol, Sertraline, Sucroferric oxyhydroxide velphoro | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110019072919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 71 Y | Female | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Hypothyroidism, Chills, Fever, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 2, Dependence on renal dialysis, Long term current use of anticoagulants, Unspecified protein-calorie malnutrition | Epogen, Heparin, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Ondansetron, Allopurinol, Hydrocortisone, Bentyl, Oxycodone, Carvedilol, Pancrelipase, Docusate sodium, Pantoprazole, Folbee Plus, Pravastatin, Fosamax, Prednisone, Fosamax, Gabapentin, Tacrolimus, Humulin insulin, Thiamine, Ipratropium, Torsemide, Lactulose, Acetaminophen, Methocarbamol, Warfarin, Norco, Zinc salts | No | No | No | No | ||||||||||||||
| BBS0000-A0900110019092519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectorol, Parsabiv, Vancomycin, Acetaminophen, Clonidine, Diphenhydramine, Epinephrine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Ipratropium, Ambien, Aspirin, Pantoprazole, Coreg, Epivir, Rena-Vite, Fludrocortisone, Renvela, Kaletra, Stavudine, Norco | No | No | No | No | |||||||||||||||
| BBS0000-A0900110020070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Disorders of phosphorus metabolism, Hypercalcemia, Fluid overload, Hyperkalemia, Hypokalemia, Hyperglycemia, Iron deficiency anemia, Hypercholestrolemia, Renal osteodystrophy, Secondary hyperparathyroidism, Diabetes type 2, Protein-calorie malnutrition | Ferric citrate auryxia, Ergocalciferol, Vitamin D, Aspirin, Amlodipine, Lantus, Lisinopril, Folbee plus, Brilinta, Renvela, Humalog, Trazodone | No | No | No | No | ||||||||||||||
| BBS0000-A0900110020090619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 67 Y | Male | Non-Hispanic | <-70C | 06-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Anorexia, Other disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Lisinopril, Cetirizine, Metoprolol, Minoxidil, Sevelamer, Hydralazine, Sensipar, Isosorbide mononitrate | No | No | No | No | |||||||||||||||
| BBS0000-A0900110021070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine | $150.00 | Unknown | Anemia in chronic kidney disease, Encounter for immunization, Hyperkalemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Diabetes mellitus type 1 without complications and with chronic kidney disease, Dependence on renal dialysis, End stage renal disease, Iron deficiency anemia, Other fluid overload, | Atorvastatin, Omeprazole, Creon, Brilinta, Gabapentin, PhosLo, Midodrine, Ranitidine | No | No | No | No | ||||||||||||||
| BBS0000-A0900110021090619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 55 Y | Male | Non-Hispanic | <-70C | 06-Sep-19 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Renal osteodystrophy (older co-morbidities listed in chart) | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Albuterol, Amlodipine, Lisinopril, Clopidogrel, Sevelamer, Furosemide, Sensipar, Lantus insulin, Simvastatin | No | No | No | No | |||||||||||||||
| BBS0000-A0900110022072919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 42 Y | Male | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anemia in chronic kidney disease, Disorders of phosphorus metabolism, End stage renal disease, Hypercalcemia, Hypocalcemia, Other disorders of calcium metabolism, Fluid overload, Renal osteodystrophy, Unspecified protein-calorie malnutrition, Vitamin D deficiency, Dependence on renal dialysis, Hyperkalemia, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Other disorders of protein-plasma metabolism, Secondary hyperparathyroidism | Acetaminophen, Clonidine, Diphenhydramine, Maalox, Lidociane, Nitroglycerin, Promethazine, Calcitriol, ProAir HFA, Carvedilol, PhosLo, Dialyvite | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110022091719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 16.00 | $150.00 | 46 Y | Male | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectoral, Acetaminophen, Benadryl, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Calcitriol, Sevellamer, Hydralazine, Sensipar, Labetalol, Tenapanor or placebo, Nifedipine | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110139090319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 9.00 | $150.00 | 67 Y | Male | <-70C | 03-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 75 U/L; ALP: 521 | $150.00 | Unknown | Colon cancer metastasized to liver, Status post bowel stent placement | Amlodipine, Chlorpromazine, Ondansetron, Potassium chloride | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110140081419DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 24 Y | Female | <-70C | 14-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes | AST: 34 U/L | $150.00 | Unknown | None | Hydrocodone-acetaminophen | Yes U/A | Yes U/A | No | No | |||||||||||||||||
| BBS0000-A0900110141082219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 56 Y | Male | <-70C | 22-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 115 U/L | ALT: 179 U/L | ALP: 142 U/L | $150.00 | Unknown | Obstructive sleep apnea, Diabetes mellitus, Chronic back pain, Neuropathy | Albuterol HFA, Atorvastatin, Colchicine, Cyclobenzaprine, Diclofenac sodium Duloxetine, Febuxostat, Fenofibrate, Finasteride, Folic acid, Aspart, Insulin lispro, Lantus SoloStar, Liraglutide, Magnesium oxide, Metolazone, Metoprolol tartrate, Naproxen, Polyethylene glycol, Potassium chloride, Pregabalin, Ranitidine, Tamulosin, Trazodone | Yes U/A | Yes 17-Jul-17 | No | No | |||||||||||||||||
| BBS0000-A0900110142081919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 1.00 | $150.00 | 51 Y | Female | <-70C | 19-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 167 U/L | $150.00 | Unknown | End stage renal disease on hemodialysis, Myocardial infarction status post coronary artery bypass graft, Diabetes mellitus, Hypertension, Hypersensitivity lung disease | Acetaminophen, Amlodipine, Atorvastatin, Aspirin, Benazepril, Buspirone, Carvedilol, Cinacalcet, Clonidine, Dextromethorphan-guaifenesin, Epoetin alfa, Gabapentin, Humalog, Hydralazine, Insulin aspart, Isosorbide mononitrate, Lantus SoloStar, Lisinopril, Lorazepam, Mirtazapine, Nitroglycerin, Omeprazole, Oxycodone-acetaminophen, Ranolazine, Sertraline, Sevelamer carbonate, Sevelamer hydrochloride, Trazodone, Ventolin HFA | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110143082019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 76 Y | Female | <-70C | 20-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 35 U/L | ALP: 201 U/L | $150.00 | Unknown | Cirrhosis, Asthma, GERD, Lung cyst, Rheumatoid arthritis | Albuterol HFA, Baricitinib, Calcium carbonate, Cholecalciferol, Fluticasone-vilanterol, Folic acid, Hydroxychloroquine, Omeprazole, Prednisone | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110144082119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 18.00 | $150.00 | 74 Y | Female | <-70C | 21-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L | ALT: 60 U/L | $150.00 | Unknown | Pancreatic cancer on chemo | Aspirin, Clonazepam, Colchicine, Dexamethasone, Diphenoxylate-atropine, Febuxostat, Folic acid, Gabapentin, Hydrocodone-acetaminophen, Lisinopril, Loperamide, Megestrol, Naloxone, Omega 3 acid, Omeprazole, Ondansetron, Prochlorperazine, Rosuvastatin | Yes 17-Mar-2000 | 24-Sep-1999 | Yes 17-Jul-63 | No | No | |||||||||||||||||
| BBS0000-A0900110145081919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 9.00 | $150.00 | 60 Y | Male | <-70C | 19-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | ALT: 52 U/L | $150.00 | Unknown | Congestive heart failure with an ejection fraction of 10%, Status post biventricular ICD, Atrial fibrillation | Aspirin, Atorvastatin, Furosemide, Hydrocodone-acetaminophen, Metoprolol succinate, Sacubitril-valsartan, Warfarin | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110146080519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 9.00 | $150.00 | 77 Y | Male | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Hypercalcemia, Diabetes type 2 with diabetic chronic kidney disease | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Allopurinol, Levaquin, Amlodipine, Levothyroxine, Aspirin, Omeprazole, Atorvastatin, Vitamin D2, Carvedilol, Renvela, Flomax, Sensipar, Imdur, Sertraline | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110159082719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 7.00 | $150.00 | 38 Y | Male | <-70C | 27-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 47 U/L | $150.00 | Unknown | None | None | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110160082119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 44 Y | Male | <-70C | 21-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes AST: 55 U/L | ALT: 60 U/L | ALP: 174 U/L | $150.00 | Unknown | Burn (75% post car accident), Stroke, Bovine aortic valve replacement | Ascorbic acid, Aspirin, Atorvastatin, Ondansetron, Oxycodone-acetaminophen, Pantoprazole, Vitamin B complex, Zinc sulfate, Zolpidem | U/A | Yes 31-Oct-92 | No | No | |||||||||||||||||
| BBS0000-A0900110161081419DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 71 Y | Male | <-70C | 14-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 174 U/L | ALT: 80 U/L | $150.00 | Unknown | Congestive heart failure, Atrial fibrillation | Acetaminophen, Alprazolam, Amlodipine, Aspirin, Citalopram, Diclofenac sodium, Dicyclomine, Docusate sodium, Isosorbide mononitrate, Lactulose, Lisinopril, Metoprolol tartrate, Nitroglycerin, Rosuvastatin, Terazosin, Tramadol | U/A | U/A | No | No | |||||||||||||||||
| BBS0000-A0900110162081519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 53 Y | Female | <-70C | 15-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 191 U/L | $150.00 | Unknown | Hypertension, Diabetes mellitus type 2, End stage renal disease on hemodialysis | Amlodipine, Aspirin, Atorvastatin, Benazepril, Calcium acetate, Cholecalciferol, Ferrous sulfate, Furosemide, Insulin glargine, Insulin lispro, Loperamide, Metoprolol, Multivitamin | Yes U/A | Yes U/A | No | No | |||||||||||||||||
| BBS0000-A0900110163082819DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 47 Y | Male | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Chronic ischemic heart disease, Diabetes type 2, Anemia in chronic kidney disease, Other disorders of plasma-protein metabolism (older co-morbidities listed in chart) | Hectoral, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Maalox, Promethazine, Aspirin, Atorvastatin, Carvedilol, Dialyvite, Fosrenol, PhosLo Kayexalate, Tenapanor, Lactulose | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110164080519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 69 Y | Female | <-70C | 05-Aug-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987; Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Abnormal weight loss, Anemia in chronic kidney disease, Cellulitis of lower limbs, Fever, Cough, Decreased white blood cell count, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Nausea, Other disorders of calcium metabolism, Renal osteodystrophy, Urinary tract infection, Chills, Dependence on renal dialysis, Essential hypertension, Hypercalcemia, Hypokalemia, Restless leg syndrome, | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Epinephrine, Maalox, Nitroglycerin, Promethazine, Albuterol, EMLA, Ambien, Gabapentin, Aspirin, Budesonide, Carvedilol, Singulair, Dialyvite, Spriiva, Elavil, Tramadol | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110196070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 63 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Chills, End stage renal disease, Hyperkalemia, Hyperlipidemia, Iron deficiency anemia, Vitamin D deficiency, Secondary hyperparathyroidism, Diabetes type 2, Protein-calorie malnutrition | Aspirin, Atorvastatin, Candesartan, Carvedilol, Clonidine, Clopidogrel, Ergocalciferol, Hydralazine, Lantus, Nifedipine, Nitroglycerin, Renvela, Sensipar, Tums | No | No | No | No | ||||||||||||||||
| BBS0000-A0900110197093019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 59 Y | Female | <-70C | 30-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus types 1 & 2 (older co-morbidities listed in chart) | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Epinephrine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Alprazolam, Naproxen, Amiodarone, Ondansetron, Amlodipine, Eliquis, Citalopram, Pantoprazole, Sensipar, Cyclobenzaprine, Sevelamer, Diltiazem, Tramadol, Valsartan, Hydralazine | No | No | No | No | |||||||||||||||||
| BBS0000-A0900110198080519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | Y | Male | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Dependence on renal dialysis, Hypercalcemia, Hyperlipidemia, Hyperkalemia, Fever, Iron deficiency anemia, Fluid overload, Renal osteodystrophy, Shortness of breath, Diabetes mellitus type 2, Secondary hyperparathyroidism of renal origin, Other disorders of phosphorus metabolism, Vitamin D deficiency | Epogen, Hectoral, Liquacel, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Ferrous glucontate, Sevelamer, Gabapentin | No | No | Yes | No | |||||||||||||||||
| BBS0000-A0900110199070919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 51 Y | Male | <-70C | 09-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Hyperkalemia, Iron deficiency anemia, Renal osteodystrophy, Diabetes mellitus type 2 without complications and with diabetic chronic kidney disease, Fluid overload, Secondary hyperparathyroidism of renal origin | Labetalol, Nifedipine, Losartan, PhosLo, Minoxidil | No | No | No | No | ||||||||||||||||
| BBS0000-A0900110200082919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 34 Y | Female | <-70C | 29-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes type 2, Thyrotoxicosis, Vitamin D deficiency (older co-morbidities listed in chart) | Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Amlodipine, Cyclobenzaprine, Sevelamer, Losartan, Sensipar | No | No | No | No | |||||||||||||||||
| BBS0000-A0900111704070519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 39 Y | Male | Non-Hispanic | <-70C | 05-Jul-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987; Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Bacteremia, Anemia in chronic kidney disease, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Hypercalcemia, Hyperkalemia, Hypermagnesemia, Polyuria, Tachycardia, Pruritus, Pseudomonas, Vomiting, Renal osteodystrophy, Chills without fever, Hypokalemia, Hypertension, Iron deficiency anemia, Nausea, A-Fib, Secondary hyperparathyroidism, Systemic lupus erythematosus, Protein-calorie malnutrition, Urgency of urination | Auryxia, Aspirin, Carvedilol, Clopidogrel, Hydralazine, Lisinopril, Norco, Lyrica, Tylenol with codeine, Prednisone, Renvela, Spiriva, Tizanidine, Tramadol | No | No | No | No | ||||||||||||||
| BBS0000-A0900111716082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes type 2, Disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | Epogen, Venofer, Acetaminophen, Clonidine, Lidocaine, Promethazine, Nitroglycerin, Apidra, Aspirin, Levemir, Calcium acetate, Nifedipine, Hydralazine, Pantoprazole, Ibuprofen | No | No | No | No | |||||||||||||||
| BBS0000-A0900111721081519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 82 Y | Male | Non-Hispanic | <-70C | 15-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 69 U/L | ALT: 119 U/L | $150.00 | Unknown | Diabetes mellitus, Hypertension, Cataracts, Myocardial infarction post stent placement | Amlodipine, Aspirin, Calcium carbonate, Diclofenac sodium, Docosahexaenoic acid, Fenofibrate, Fluocinolone, Glipizide, Hydrochlorothiazide, Ketoconazole, Latanoprost, Losartan, Metformin, Metoprolol, Nitroglycerin, Ranitidine, Scopolamine, Simvastatin | No | No | No | No | |||||||||||||||
| BBS0000-A0900111722082619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 20 Y | Female | Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes AST: 126 U/L | ALT: 192 U/L | ALP: 304 U/L | $150.00 | Unknown | Liver sarcoma, Cholecystectomy, Strictures and recurrent cholangitis | Duloxetine, Hydroxyzine | Yes U/A | Yes U/A | No | No | |||||||||||||||
| BBS0000-A0900111723070319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 03-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism, Protein-calorie malnutrition | Amlodipine, Lorazepam, Metoprolol, Prezcobix, Triumeq, Pantoprazole, PhosLo | No | No | No | No | ||||||||||||||
| BBS0000-A0900111724070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Bacteremia, Anemia in chronic kidney disease, Disorders of phosphorus metabolism, End stage renal disease, Fever, Hypertension, Fluid overload, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism, Lupus erythematosus, Renal osteodystrophy, Protein-calorie malnutrition | Carvedilol, Gabapentin, Hydroxyzine hydrochloride, Nifedipine, Pantoprazole, Sevelamer, Plaquenil, Zofran, Oxycodone, Promethazine | No | No | No | No | ||||||||||||||
| BBS0000-A0900111725080719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 07-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Chronic kidney disease, Anemia in chronic kidney disease, End stage renal disease, Fluid overload, Cellulitis and abscess in foot, Bacteremia, Fever, Hypercalcemia, Hypocalcemia, Hyperkalemia, Hypokalemia, Iron deficiency anemia, Vitamin D deficiency, Other disorders of electrolyte and fluid balance, Other disorders of phosphorus metabolism, Other disorders of calcium metabolism, Precipitous drop in hematocrit, Rash, Renal osteodystrophy, Secondary hyperparathyroidism, Diabetes mellitus type 2 | Epogen, Hectoral, Venofer, Novasource Renal, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Docusate, Lisinopril, Ergocalciferol, Nifedipine, Ferrous gluconate, Pantoprazole, Hydralazine | No | No | No | No | |||||||||||||||
| BBS0000-A0900111739082119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 31 Y | Female | Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Hypertension, Diabetes mellitus type 1 | Acetaminophen, Acetaminophen-Codeine, Albuterol HFA, Azithromycin, Benazepril, Benzonatate, Calcium acetate, Carvedilol, Docusate sodium, Ferrous sulfate, Fluoxetine, Fluticasone propionate, Furosemide, Glucagon, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Nifedipine, Ondansetron, Promethazine, Sodium bicarbonate | Yes U/A | Yes 30-Jul-98 | No | No | |||||||||||||||
| BBS0000-A0900111740082619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 43 Y | Female | Hispanic | <-70C | 26-Aug-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 58 U/L | ALT: 98 U/L | $150.00 | Unknown | None | Cyclobenzaprine, Metformin | U/A U/A | U/A | No | No | |||||||||||||||
| BBS0000-A0900111741082919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 37 Y | Male | Non-Hispanic | <-70C | 29-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992, Long term hemodialysis patient | Primary Signs and Symptoms | Dark colored urine | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectoral, Parsabiv, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Alprazolam, Minoxidil, Aspirin, Carvedilol, Kayexalate, Nifedipine, Lamictal, Lisinopril, Sevelamer, Methadone, Theragran | No | No | No | No | |||||||||||||||
| BBS0000-A0900111742070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 68 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Fever, Chills, Cough, Disorders of phosphorus metabolism, End stage renal disease, Fluid overload, Hyperkalemia, Iron deficiency anemia, Secondary hyperparathyroidism, Diabetes type 2, Pruritus, Cellulite, Pain in unspecific joint, Obesity, Protein-calorie malnutrion, Renal osteodystrophy | Bisacodyl, Humulin, Clopidogrel bisulfate, Flonase, Gabapentin, Loratadine, Meclizine, Novolin, Eurcerin, Renvela, Ferrous sulfate, Glycolax powder, Senna, Multiplevitamin, Sertraline, Synthroid, Tamoxifen | No | No | No | No | ||||||||||||||
| BBS0000-A0900111743082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 12.00 | $150.00 | 72 Y | Male | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 ,Recipient of clotting factor concentrates produced before 1987; Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Complications of vascular and cardiac devices, Diabetes type 2, Disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | Hectorol, Venofer, Acetaminophen, Clonidine, Lidocaine, Promethazine, Nitroglycerin, Calcium acetate, Eliquis, Midodrine, Gabapentin, Pravastatin, Niacin, Sensipar, Omeprazole, Tramadol | No | No | No | No | |||||||||||||||
| BBS0000-A0900111744091719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 33 Y | Male | Non-Hispanic | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Renal Osteodystrophy, Diabetes mellitus type 2, Secondary hyperparathyroidism of renal origin, Iron deficiency anemia | Epogen, Hectorol, Liquacel, Prevnar, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Hydralazine, Albuterol, Lisinopril, Atorvastatin, Nifedipine, Calcitriol, Sensipar, Carvedilol, Furosemide, Tramadol, Sucroferric oxyhydroxide velphoro | No | No | No | No | |||||||||||||||
| BBS0000-A0900111745082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 66 Y | Female | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Diabetes type 2, Chronic kidney disease (older co-morbidities listed in chart) | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Amiodarone, Metoprolol, Apixiban, Isosorbide mononitrate, Aspirin, Sensipar, Atorvastatin, Ticagrelor | No | No | No | No | |||||||||||||||
| BBS0000-A0900111759080719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 70 Y | Female | Non-Hispanic | <-70C | 07-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Chronic kidney disease, End stage renal disease, Fluid overload, Cellulitis and abscess in upper arm, Bacteremia, Fever, Carbuncle and Furuncle, Chills, Hypercalcemia, Hyperkalemia, Hypokalemia, Hypothyroidism, Liver disease, Iron deficiency anemia, Vitamin D deficiency, Other disorders of electrolyte and fluid balance, Other disorders of phosphorus metabolism, Renal osteodystrophy, Secondary hyperparathyroidism, Diabetes mellitus types 1 and 2, Unspecified protein-calorie malnutrition, Tachy | Epogen, Parsabiv, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Acetaminophen, Rena-Vite, Renvela, Coreg | No | No | No | No | |||||||||||||||
| BBS0000-A0900111760080719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 77 Y | Female | Non-Hispanic | <-70C | 07-Aug-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Abnormal results of liver function studies, Dependence on renal dialysis, Gout, Hyperlipidemia, Iron deficiency anemia, Renal osteodystrophy, Unspecified protein-calorie malnutrition, Anemia in chronic kidney disease, End stage renal disease, Hyperkalemia, Hypothyroidism, Other disorders of plasma-protein metabolism, Secondary hyperparathyroidism | Engerix, Epogen, Hectoral, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Dexilant, Atorvastatin, Febuxostat, Dialyvite, Proair HFA, Isosorbide mononitrate, Uloric, Lactulose, Pantoprazole, Levothyroxine, Sevelamer, Loratadine, Singulair, Metoprolol | No | No | No | No | |||||||||||||||
| BBS0000-A0900111761070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 7.00 | $150.00 | 31 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, Encounter for screening for other viral diseases, Hyperkalemia, Other disorders of electrolyte and fluid balance, Other fluid overload, Secondary hyperparathyroidism of renal origin, Unspecified protein-calorie malnutrition, Dependence on renal dialysis, End stage renal disease, Iron deficiency anemia | Amlodipine, Renvela, Carlsoprodol, Sucralfate, Pantoprazole, Tylenol, Promethazine | No | No | No | No | ||||||||||||||
| BBS0000-A0900111762070919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 3.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Chronic kidney disease, Dependence on renal dialsysis, End stage renal disease, Hyperkalemia, Disorders of phosphorus metabolism, Renal osteodystrophy, Other disorders of electrolyte and fluid balance, Other fluid overload, Hypercalcemia | Amlodipine, Sensipar, Cholecalciferol, Vitamin D3, Tenapanor, Coumadin, Vitamin B Complex, Renvela | No | No | No | No | ||||||||||||||
| BBS0000-A0900111763082819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 66 Y | Male | Non-Hispanic | <-70C | 28-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Carrier or suspected carrier of Methicillin resistant staphylococcus aureus, Endocarditis (older co-morbidities listed in chart) | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Allopurinol, Metoprolol, Amiodarone, Atorvastatin, Psyllium, Ferric citrate auryxia, Sevelamer, Insulin lispro, Spironolactone | No | No | No | No | |||||||||||||||
| BBS0000-A0900111774080519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 6.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Elevated PSA, Unspecified protein-calorie malnutrition, Fluid overload, Hypercalcemia, Hyperkalemia, Other disorders of phosphorus metabolism, Cellulitis of left toe, Renal osteodystrophy, Diabetes mellitus type 2, Hypertensive chronic kidney disease | Hectoral, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Pepcid, Auryxia, Sensipar, Gabapentin, Zolpidem, Kayexalate | No | No | No | No | |||||||||||||||
| BBS0000-A0900111775072919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Other disorders of electrolyte and fluid balance, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Fluid overload, Anorexia, Diarrhea, Hyperkalemia, Unspecified dementia without behavioral disturbance | Epogen, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Minoxidil, Aspirin, Norco, Atorvastatin, Carvedilol, Biotin, Hydralazine, Pantoprazole, Isosorbide mononitrate, Renvela, Lisinopril | No | No | No | No | ||||||||||||||
| BBS0000-A0900111776070119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Acute posthemorrhagic anemia, Fluid overload, Depression disorder, Nausea, Gout, Chronic obstructive pulmonary disease, Hyperkalemia, Hypokalemia, Hypothyroidism, Hypertension, Hyperlipidemia, Iron deficiency anemia, Sleep apnea, Disorders of plasma protein metabolism, Congestive heart failure, Gastrointestinal hemorrhage, Vitamin D deficiency, Disorders of electrolyte, Disorders of phosphorus metabolism, Renal osteodystrophy, Thromboc | Docusate sodium, Senna, Flexeril, Acetaminophen, Amlodipine, Aspirin, Atorvastatin, Benzonatate, Calcium acetate, Citalopram, Folic acid, Levalbuterol, Colcrys colchicine, Levothyroxine, Xopenex, Pantoprazole, PhosLo | No | No | No | No | ||||||||||||||
| BBS0000-A0900111777080519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 73 Y | Female | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Cellulitis and abscess in leg and arm, Bacteremia, Fever, Furuncle, Hypocalcemia, Hyperkalemia, Iron deficiency anemia, Vitamin D deficiency, Other disorders of electrolyte and fluid balance, Other disorders of phosphorus metabolism, Renal osteodystrophy, Thrombocytopenia, Sebaceous cyst, Secondary hyperparathyroidism, Diabetes mellitus type 2, Unspecified protein-calorie malnutrition | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Ergocalciferol, Levetiracetam, Bisacodyl, Nifedipine, Ondansetron, Dialyvite, Pantoprazole, Docusate sodium, Renvela, Furosemide, Sensipar, Gabapentin, Sucroferric oxyhydroxide velphoro, Isosorbide mononitrate | No | No | No | No | |||||||||||||||
| BBS0000-A0900111778072919DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Iron deficiency anemia, Renal osteodystrophy, Diabetes mellitus type 2, Secondary hyperparathyroidism of renal origin, Dependence on renal dialysis, Unspecified protein-calorie malnutrition, Hypercalcemia, Other disorders of phosphorus metabolism | Hectoral, Liquicel, Parsabiv, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Dialyvite, Sidenofil, Metoprolol, Renvela | No | No | No | No | |||||||||||||||
| BBS0000-A0900111779070819DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Anemia in chronic kidney disease, End stage renal disease, Diabetes mellitus type 2 without complications and with diabetic chronic kidney disease, Chronic viral hepatitis B, Diabetes mellitus type 1 with hyperglycemia | Benadryl, Promethazine, Metoprolol, RenaGel, NovoLog insulin, Velphoro | No | No | No | No | ||||||||||||||
| BBS0000-A0900111829090319DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 10.00 | $150.00 | 43 Y | Male | Non-Hispanic | <-70C | 03-Sep-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $150.00 | Unknown | End stage renal disease, Coronary artery disease, Anxiety | Amlodipine, Atorvastatin, Escitalopram oxalate, Hydralazine, Levetiracetam, Lisinopril, Sevelamer carbonate, Sodium chloride | Yes U/A | Yes U/A | No | No | |||||||||||||||
| BBS0000-A0900111845071019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 9.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | NASH, Obstructive sleep apnea, Hyperlipidemia, Glaucoma, Cataracts, Diabetes type 2, Psoriatic arthritis, Psoriasis, Arthritis | Farxiga, Cymbalta, Neurontin, Amaryl, Cozaar, Glucophage, Cosentyx, Zocor | No | No | No | No | |||||||||||||||
| BBS0000-A0900111846082019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 20-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Cirrhois secondary to NASH, Hypothyroidism, Gastroesophageal reflux disease, Depression, Sinusitis, Hypertension, Diabetes, NAFLD, Hepatic enchphalopathy, Osteoarthritis left knee, Squamous cell carcinoma ear | Atarax, Lancets, Claritin-D, Diabetic pen needle, Xifaxan, Insulin aspart, Levothyroxine, Singulair, Zoloft, Hydrocortisone cream | Yes 4-Apr-18 | No | No | No | |||||||||||||||
| BBS0000-A0900111860082719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 27-Aug-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Pancreatitis, Pancreatic mass | Amlodipine, Cholecalciferol, Citalopram, Clopidogrel, Duloxetine, Gabapentin, Losartan, Magnesium oxide, Nicotine oxide, Nortriptyline, Oxycodone, Pancrelipase, Pantoprazole, Senna | No | No | No | No | |||||||||||||||
| BBS0000-BD900111817070519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 16.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 05-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||
| BBS0000-BD900356203112719DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 22.00 | $75.00 | Y | Female | Hispanic | <-70C | 27-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-27 | None | No | No | No | No | Multivitamin; Centrum | |||||||||||||
| BBS0000-BD900356204112119DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 22.00 | $75.00 | Y | Male | Hispanic | <-70C | 21-Nov-19 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Jaundice | $75.00 | Unknown | None | 2019-11-21 | None | U/A | U/A | No | No | No | |||||||||||||
| BBS0000-BD900356205112219DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 24.00 | $75.00 | Y | Male | Hispanic | <-70C | 22-Nov-19 | Subject Risk Information | Current or former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | High blood pressure, Diabetes | 2019-11-22 | Doxazosin, Risperidone, Suboxone | No | No | No | No | No | |||||||||||||
| BBS0000-BD900356206112219DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 20.00 | $75.00 | Y | Male | Hispanic | <-70C | 22-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-22 | None | No | No | No | No | No | |||||||||||||
| BBS0000-BD900356207112719DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 25.00 | $75.00 | Y | Male | Unknown | <-70C | 27-Nov-19 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-27 | Suboxone, Flexeril | No | U/A | No | No | No | |||||||||||||
| BBS0000-BD900356208112119DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 25.00 | $75.00 | Y | Male | Hispanic | <-70C | 21-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-21 | None | U/A | U/A | No | No | No | |||||||||||||
| BBS0000-BD900356209112219DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 27.00 | $75.00 | Y | Male | Hispanic | <-70C | 22-Nov-19 | Subject Risk Information | Current or former user of IV drugs | Primary Signs and Symptoms | Dark colored urine; Jaundice | $75.00 | Unknown | Diabetes | 2019-11-22 | None | U/A | U/A | No | No | No | |||||||||||||
| BBS0000-BD900359204110719DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 5.00 | $75.00 | Y | Female | Hispanic | <-70C | 07-Nov-19 | Subject Risk Information | Current of former user of IV drugs | Primary Signs and Symptoms | Jaundice | $75.00 | Unknown | None | 2019-11-07 | None | No | No | No | No | No | |||||||||||||
| BBS0000-BD900359205110719DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 07-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-07 | None | No | No | No | No | No | |||||||||||||
| BBS0000-BD900359206110719DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Female | Hispanic | <-70C | 07-Nov-19 | Subject Risk Information | Current of former user of IV drugs; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-07 | None | No | No | No | No | No | |||||||||||||
| BBS0000-BD900359207110619DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 5.00 | $75.00 | Y | Male | Hispanic | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-06 | Testosterone, Descovy | U/A | U/A | No | No | Vitamin D, Fish oil | |||||||||||||
| BBS0000-BD900359208110819DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Female | Hispanic | <-70C | 08-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-08 | None | No | U/A | No | No | Omega 3, Centrum | |||||||||||||
| BBS0000-BD900359209110619DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Female | Hispanic | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-06 | None | U/A | U/A | No | No | No | |||||||||||||
| BBS0000-BD900359210110619DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Male | Hispanic | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-06 | None | No | No | Yes | No | No | |||||||||||||
| BBS0000-BD900359211110619DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Female | Hispanic | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | High blood pressure | 2019-11-06 | Doesn't remember name of drug | No | No | No | No | Centrum | |||||||||||||
| BBS0000-BD900359212110619DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 5.00 | $75.00 | Y | Female | Hispanic | <-70C | 06-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | High blood pressure | 2019-11-06 | Valsartan | No | No | No | No | No | |||||||||||||
| BBS0000-BD900359213110719DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Male | Hispanic | <-70C | 07-Nov-19 | Subject Risk Information | Current of former user of IV drugs | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-07 | None | No | No | No | No | No | |||||||||||||
| BBS0000-BD900359537010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BD900359538010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BD900359539112619DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 2.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | None | 2019-11-26 | None | U/A | U/A | No | No | No | |||||||||||||
| BBS0000-BD900359540010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BD900359541010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BD900359542010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BD900359543010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BD900359544010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BD900359545010100DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 5.00 | $75.00 | Y | Unknown | <-70C | 01-Jan-00 | Kits Sent To Site | $75.00 | Unknown | |||||||||||||||||||||||||
| BBS0000-BU900106672060613DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 2.00 | $150.00 | 34 Y | Female | <-70C | 06-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 57 U/L | 31 U/L | 27 U/L ALP | AST | ALT 7.4 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing, piercing) | |||||||||||||||||
| BBS0000-CC900022690100119DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 8.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypercalcemia (older co-morbidities listed in chart) | Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Nicoderm, Citalopram, Pantoprazole, Famotidine, Sevelamer, Felodipine, Sensipar, Ipratropium, Sildenafil, Dayexalate, Tamsulosin, Labetalol, Valsartan, Albuterol | No | No | No | No | |||||||||||||||
| BBS0000-CC900024277100419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 82 Y | Female | Non-Hispanic | <-70C | 04-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Chronic kidney disease, Cutaneous abcess of right foot, (older co-morbidities listed in chart) | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Amlodipine, Fish oil, Ferric citrate, Coreg | No | No | Yes | No | |||||||||||||||
| BBS0000-CC900024278091019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Iron deficiency anemia, Dependence of renal dialysis, Hyperkalemia, Secondary hyperparathyroidism (older co-morbidities listed in chart) | Engerix, Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Losartan, Bumetanide, Metoprolol, Ferrous sulfate, Pantoprazole, Furosemide, Sevelamer, Levothyroxine | No | No | No | No | |||||||||||||||
| BBS0000-CC900024279091019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Hectorol, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Promethazine, Nitroglycerin, Allopurinol, Creon, Aspirin, Atorvastatin, Lantus insulin, Ferric citrate, Carvedilol, Ramipril | No | No | No | No | |||||||||||||||
| BBS0000-CC900024282092519DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Cutaneous abcess of left foot, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Novasource, Hectorol, Parsabiv, Vancomycin, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Labetalol, Renvela, Lisinopril, Temazepam, Nifedipine | No | No | No | No | |||||||||||||||
| BBS0000-CC900024283091719DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 17-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Anorexia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Pepcid, Clopidogrel, Humalog, Renvela, Labetalol, Senna, Levemir, Sensipar, Minoxidil, Telmisartan, Nifedipine | No | No | No | No | |||||||||||||||
| BBS0000-CC900024284092419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 14.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 24-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Systemic lupus erythematosus, Diabetes mellitus type 2 (older co-morbidities listed in chart) | Epogen, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Lantus, Calcitriol, NovoLog, Dialyvite, Plavix, Gabapentin, Tums, Hydrocodone-acetaminophen | No | No | No | No | |||||||||||||||
| BBS0000-CC900024286090619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 11.00 | $150.00 | 67 Y | Female | Non-Hispanic | <-70C | 06-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hypocalcemia (older co-morbidities listed in chart) | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Iron, Carvedilol, Docusate, Polyethylene glycol, Furosemide, Nifedipine, Sevelamer, NovoLog insulin | No | No | No | No | |||||||||||||||
| BBS0000-CC900107988061319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 5.00 | $150.00 | 52 Y | Female | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 82 U/L; ALT: 69 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | Guillain-Barre syndrome, Lyme disease, Multiple sclerosis, Myasthenia gravis, Peripheral arterial disease, Peripheral vascular disease, Raynaud's syndrome | Cyanocobalamin (vitamin B12), Ergocalciferol, Gabapentin, Magnesium hydroxide, Potassium acetate, Pregabalin | No | No | |||||||||||||||||
| BBS0000-CC900111838060419DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 5.00 | $150.00 | 32 Y | Male | Hispanic | <-70C | 04-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | None | Dextran hypomellose, Polymyxin B Sulfate-Trimethoprim drops | No | No | ||||||||||||||||
| BBS0000-CF900099078091219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 21 Y | Male | <-70C | 12-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Dark colored urine, Elevated liver enzymes | AST: 685 U/L | ALT: 235 U/L | 12-Sep-19 | $150.00 | Unknown | Anxiety, Depression, Meningitis | Ibuprofen | Yes U/A | Yes U/A | No | No | ||||||||||||||||
| BBS0000-CF900099079092519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 57 Y | Female | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Small cell lung cancer on chemotherapy | Albuterol, Dexamethasone, Famotidine, Hydrochlorothiazide, Hydrocodone-acetaminophen, Loratidine, Ondansetron, Prochlorperazine, Refresh tears | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099080091919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 74 Y | Male | <-70C | 19-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | Ascites, Elevated liver enzymes | AST: 60 U/L | ALP: 162 U/L | 17-Sep-19 | $150.00 | Unknown | Leukemia in remission, Iron overload syndrome, Pericardial effusion status post pericardia window, Ascites status post paracentesis | Amoxicillin, Fenofibrate, Furosemide, Mirtazapine, Pantoprazole, Polyethylene glycol, Spironolactone | U/A | U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900099081090519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 26 Y | Male | <-70C | 05-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L | ALT: 107 | 4-Sep-19 | $150.00 | Unknown | Anxiety, Degenerative disc disease | Hydrocodone-acetaminophen; Ibuprofen | Yes 19-Jun-19 | Yes U/A | No | No | ||||||||||||||||
| BBS0000-CF900099082091219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 66 Y | Male | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Asthma, Osteoarthritis, Adrenal insufficiency, Hypertension, Chronic kidney disease | Acetaminophen, Acetaminophen-Codeine, Albuterol HFA, Amlodipine, Azelastine, Budesonide, Bupropion, Cephalexin, Desvenlafaxine, Desvenlafaxine succinate, Eszopiclone, Fluticasone sammetro, Gabapentin, Hydrocortisone, Hyqvia, Levothyroxine, Lorazepam, Methocarbamol, Mometasone, Montelukast, Theragran, Naloxone, Omeprazole, Oxycodone, Pimechrolimus cream, Sertraline, Tamsulosin, Tiotropium, Ubidecarenone, Vitamin B complex | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099083092519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 16.00 | $150.00 | 72 Y | Female | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Chronic kidney disease, Diabetes mellitus, Hypertension, GERD | Amlodipine, Aspirin, Calcitriol, Carvedilol, Clopidogrel, Esomeprazole, Ferrous sulfate, Furosemide, Gabapentin, Glipizide, Insulin degludec, Irbesartan, Nitrofurantoin, Pravastatin, Venlafaxine | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099084091219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 44 Y | Female | <-70C | 12-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 50 U/L | 12-Sep-19 | $150.00 | Unknown | None | Ciprofloxacin, Docusate sodium, Metronidazole, Ondansetron | Yes U/A | Yes U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900099948100119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 5.00 | $150.00 | 37 Y | Female | <-70C | 01-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Hysterectomy, Rheumatoid arthritis, Skin cancer, Pulmonary embolism, Recurrent UTI, Care on immunosuppressants | Alprazolam, Oxycodone, Carisoprodol, Prednisione, Cephalexin, Gabapentin, Loratadine, Methotrexate | Yes U/A | No | Yes | No | |||||||||||||||||
| BBS0000-CF900099949101719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 63 Y | Male | <-70C | 17-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Congestive heart failure with an ejection fraction of 10%, Hypertension, Hypersensitivity lung disease, Prio methamphetamine and alcohol use | Acetaminophen, Aspirin, Atorvastatin, Carvedilol, Furosemide, Lisinopril | No | No | No | No | |||||||||||||||||
| BBS0000-CF900099950100719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 4.00 | $150.00 | 62 Y | Male | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | ALP: 253 U/L | 7-Oct-2019 | $150.00 | Unknown | Non-ischemic cardiomyopathy likely secondary to methamphetamine use | Apixaban, Bumetanide, Furosemide | No | No | Yes | No | ||||||||||||||||
| BBS0000-CF900099951100919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 51 Y | Male | <-70C | 09-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 165 U/L | 9-Oct-2019 | $150.00 | Unknown | Hypertension, End stage renal disease, Diabetes mellitus, Congestive heart failure, Chronic kidney disease on hemodialysis, Hypersensitivity lung disease | Alteplase, Amiodarone, Atorvastatin, Balsam Peru castor oil, Calcium, acetate, Cholecalciferol, Clindamycin, Dobutamine, Docusate sodium, Ergocalciferol, Fentanyl, Hydrocodone-acetaminophen, Insulin glargine, Levothyroxine, Midodrine, Novolog, Polyethylene glycol, Rena Vite, Sevelamer carbonate, Vitamin B complex Vitamin C folate, Vitamin A & D ointment, Warfarin | No | No | Yes | No | ||||||||||||||||
| BBS0000-CF900099952091219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 5.00 | $150.00 | 43 Y | Female | <-70C | 12-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Lupus nephritis status post right renal transplant, Heart disease | Furosemide, Mycophenolate, Omeprazole, Prednisone, Tacrolimus | Yes U/A | Yes U/A | No | No | |||||||||||||||||
| BBS0000-CF900099953091919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 17.00 | $150.00 | 67 Y | Female | <-70C | 19-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | COPD with oxygen dependence, Diabetes mellitus, Chronic kidney disease | Acetaminophen, Albuterol, Apixaban, Aspirin, Beclomethasone, Carvedilol, Clonidine, Furosemide, Gabapentin, Hydralazine, Insulin glargine, Insulin lispro, Isosorbide dinitrite, Ondansetron, Pantoprazole, Prazosin, Simvastatin, Tobramycin-dexamethasone | No | No | Yes | No | |||||||||||||||||
| BBS0000-CF900099954091919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 27 Y | Female | <-70C | 19-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 86 U/L | ALT: 79 U/L | 19-Sep-19 | $150.00 | Unknown | None | Gabapentin, Hydrocodone-acetaminophen, Methocarbanol, Senna docusate, Nitrofurantoin | No | No | No | No | ||||||||||||||||
| BBS0000-CF900100813092519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 6.00 | $150.00 | 57 Y | Male | <-70C | 25-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Myocardial infarction, Coronary artery disease | Aspirin, Atorvastatin, Hydrocodone-acetaminophen, Ibuprofen, Lisinopril, Metoprolol succinate, Ondansetron, Sertraline, Spironolactone, Warfarin | No | No | No | Yes | |||||||||||||||||
| BBS0000-CF900100814091219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 7.00 | $150.00 | 65 Y | Female | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus, Hypertension | Atenolol, Insulin lispro | No | No | No | No | |||||||||||||||||
| BBS0000-CF900100815092419DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 11.00 | $150.00 | 65 Y | Male | <-70C | 24-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | NASH, Cirrhosis, Chronic kidney disease stage 4, Hypothyroidism | Albuterol, Aspirin, Atorvastatin, Beclomethasone, Cholecalciferol, Docusate sodium, Fluticasone propionate, Furosemide, Hydrocortisone, Rectal cream and suppository, Lactulose, Levothyroxine, Lidocaine, Olopatadine, Omeprazole, Rifaximin, Simethicone, Spironolactone | U/A | U/A | No | No | |||||||||||||||||
| BBS0000-CF900100816092619DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 34 Y | Female | <-70C | 26-Sep-19 | Subject Risk Information | Current or former user of IV drugs (former) | Primary Signs and Symptoms | Elevated liver enzymes | AST: 139 U/L | ALT: 194 U/L | ALP: 235 U/L | 25-Sep-19 | $150.00 | Unknown | Recurrent deep vein thrombosis due to May-Thurner Syndrome, Recent admission and stent placement by IR | Apixaban, Aspirin, Docusate sodium Hydrocodone-acetaminophen, Naloxone, Oxycodone, Oxycodone-acetaminophen, Polyethylene glycol, Senna, Trazodone | No | No | No | No | ||||||||||||||||
| BBS0000-CF900107230091219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 65 Y | Female | <-70C | 12-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 31 U/L | 12-Sep-19 | $150.00 | Unknown | Hypertension, Rheumatoid arthritis | Amlodipine, Aspirin, Cyclobenzaprine, Diclorenac gel, Etanercept, Ibuprofen, Leflunomide, Loratadine, Losartan, Metoprolol succinate, Prednisone, Pregabalin, Rosuvastatin, Sulfamethoxazole-trimethoprim, Sumatriptan | Yes U/A | Yes U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900107231091019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 66 Y | Female | <-70C | 10-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 (1981) | Primary Signs and Symptoms | Elevated liver enzymes | AST: 57 U/L | 9-Sep-19 | $150.00 | Unknown | Spinal stenosis, Systemic lupus erythematosus | Acyclovir, Albuterol, Ascorbate calcium, B complex vitamins, Blue-green algae, Brimonidine, Cephalexin, Cholecalciferol, Escitalopram oxalate, Fluticasone, Fluticasone-salmeterol, Furosemide, Gabapentin, Grape seed extract, Hydrocodone-acetaminophen, Hydroxychloroquine, Ipratropium, Lidocaine, Multivitamin, Naproxen, Omega 3, Phenazopyrdine, Polyethylene glycol, Selenium, Tramadol, Zinc, Zoledronic, Plaquenil | No | No | No | Yes | ||||||||||||||||
| BBS0000-CF900107233100119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 16.00 | $150.00 | 36 Y | Male | <-70C | 01-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ASP: 505 U/L | 30-Sep-19 | $150.00 | Unknown | Failed kidney transplant; End stage renal disease on hemodialysis | Amlodipine, Apixaban, Carvedilol, Hydralazine, Insulin glargine, Insulin lispro, Levothyroxine, Prednisone, Sevelamer carbonate, Tacrolimus | U/A | U/A | No | Yes | ||||||||||||||||
| BBS0000-CF900107592101519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 9.00 | $150.00 | 68 Y | Male | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 225 U/L | 14-Oct-19 | $150.00 | Unknown | Diabetes mellitus, Hypertension, Coronary artery disease | Glipizide, Insulin glargine | No | No | No | No | ||||||||||||||||
| BBS0000-CF900107989070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 18.00 | $150.00 | 55 Y | Female | <-70C | 01-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Enlarged liver | $150.00 | Unknown | Alcoholic liver disease, Autoimmune hepatitis, Decompensated cirrhosis | Calcium carbonate / Magnesium / Vitamin D3, Cyanocobalamin, Dexlansoprazole, Furosemide, Hydrocodone-acetaminophen, Levothyroxine, Lorazepam, Ondansetron, Propranolol, Rifaximin, Spironolactone | Yes Date of Vaccination: U/A | Yes Date of Vaccination: U/A | No | No | ||||||||||||||||
| BBS0000-CF900107990052919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 53 Y | Female | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L; ALT: 47 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Thyroid disease | Aspirin, Famotidine, Levothyroxine | No | No | |||||||||||||||||
| BBS0000-CF900111828053019DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 13.00 | $150.00 | 46 Y | Female | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 177 U/L; AST: 74 U/L; ALT: 126 U/L:Test Date 30-May-2019 | $150.00 | Unknown | Anxiety, Arthritis, Cataract, Diabetes mellitus, Gastroesophageal reflux disease, Gout, Hypertension, Myositis of left upper extremity, Obesity unspecified, Obstructive sleep apnea, Other chronic nonalcoholic liver disease, Post-operative nausea and vomiting, Allergies | Solu-Medrol, Trulicity, Pepcid, Ibuprofen, Basaglar KwikPen, Claritin, Metformin, Toprol XL, Pyridium, Prednisone, Rituxan, Januvia, Ultram, Triamcinolone | No | No | |||||||||||||||
| BBS0000-CF900111839062619DD | Suspect Hepatitis C (HCV) | USA | Serum | 1.00 | 15.00 | $150.00 | 48 Y | Male | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 (1987) | Suspect HCV:Adult | Primary Signs and Symptoms | Enlarged liver | $150.00 | Unknown | Iron deficieny anemia, Splenomegaly, Hepatomegaly, NASH cirrhosis, Diabetes mellitus, Esophageal varices, Morbid obesity, Myocardial infarction, GI bleed | Lactulose, Loratadine, Metformin, Multivitamin, Propranolol, Sitagliptin, Zinc | U/A | U/A | No | Yes | ||||||||||||||
| BBS0000-CF900352672112019DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 16.00 | $75.00 | Y | Male | Hispanic | <-70C | 20-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 5265 U/L; ALT: 4113 U/L 19-Nov-2019 | $75.00 | Unknown | 2019-11-20 | No | No | No | No | U/A | |||||||||||||||
| BBS0000-CF900352673112619DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 23.00 | $75.00 | Y | Female | Hispanic | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 229 U/L 25-Nov-2019 | $75.00 | Unknown | Diabetes mellitus, Hypertension, End stage renal disease on hemodialysis | 2019-11-26 | Amlodipine, Carvedilol, Ergocalciferol, Furosemide, Insulin glargine, Insulin lispro, Sodium bicarbonate, Topiramate | No | No | No | No | No | |||||||||||||
| BBS0000-CF900352674112619DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 20.00 | $75.00 | Y | Male | Unknown | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L 25-Nov-2019 | $75.00 | Unknown | Diabetes mellitus, Hypertension, Coronary artery disease, Myocardial infarction x2 | 2019-11-26 | Allopurinol, Aspirin, Calcium carbonate, Canagliflozin, Carvedilol, Cholecalcirerol, Clopidogrel, Dasatinib, DHA, Doxycycline, Fluticasone, Hydrocodone-acetaminophen, Ibuprofen, Insulin detemir, Ipratropium, Nitroglycerin, Novolog flexpen, Phentermine, Rosuvastatin, Triamcinolone, Salmeterol | No | No | No | No | Multivitamin, Gummies | |||||||||||||
| BBS0000-CF900352675112619DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.80 | 18.00 | $75.00 | Y | Female | Unknown | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 373 U/L; ALT: 420 U/L; ALP: 275 U/L 25-Nov-2019 | $75.00 | Unknown | 2019-11-26 | Alprazolam, Sertraline HCl | No | No | No | No | No | ||||||||||||||
| BBS0000-CF900352676112619DD | Suspect Hepatitis C (HCV) | USA | Serum | 2.00 | 8.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 26-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Aortic regurgitation, Atrial fibrillation, Dyslipidemia | 2019-11-26 | Apixaban, Ascorbic acid, Atorvastatin, Carvedilol, Docusate Polyethylene glycol, Torsemide | No | No | No | No | Theragran | |||||||||||||
| BBS0000-CF900352677111919DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 16.00 | $75.00 | Y | Male | Unknown | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 139 U/L 19-Nov-2019 | $75.00 | Unknown | Diabetes mellitus, Hypertension, COPD, T6-T11 fusion of spine / epidural abcess, Fibromyalgia, Chronic pain disorder, Lumbar disc disease | 2019-11-19 | Atorvastatin, Baclofen, Benazepril, Finasteride, Heparin, Hydrocodone-acetaminophen, Hydroxyzine, Insulin glargine, Lidocaine, Morphine, Naloxone HCl, Pantoprazole, Senna, Tamalosin, Zinc sulfate | No | No | No | No | Theragran | |||||||||||||
| BBS0000-CF900355510111919DD | Suspect Hepatitis C (HCV) | USA | Serum | 3.80 | 15.00 | $75.00 | Y | Male | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | ALT: 55 U/L 19-Nov-2019 | $75.00 | Unknown | Chronic pancreatitis, Diabetes mellitus, Hypertension, Gastroparesis | 2019-11-19 | Acetaminophen, Aspirin, Atenolol, Dextran, Hypromellose, Dicyclomine, Docusate sodium, Enalapril, Hydrocortisone, Ibuprofen, Insulin glargine, Insulin lispro, Levetiracetam, Metformin, Ondansetron, Furosemide, Lactulose, Metoprolol succinate, Ondansetron, Pantoprazole, Tamulosin | U/A | U/A | Yes | No | No | |||||||||||||
| BBS0000-CF900355514111919DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 21.00 | $75.00 | Y | Female | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Angina pectoris, Arthritis, Asthma, Bronchitis, Cerebrovascular accident, Chronic kidney disease, Diabetes mellitus, Gunshot wound, Herniated disc, Hypertension, Hypertriglyceridemia, Pancreatitis, Sciatica, Sleep apnea, Stroke (cerebrum) | 2019-11-19 | Albuterol HFA, Acetaminophen, Alogliptin, Aluminum-maghydroxide-simethicone, Aspirin, Atorvastatin, Benzonatate, Carvedilol, Cetirizine, Clopidogrel, Dicyclomine, Duloxetine, Ertugliflozin, Fluticasone, Gabapentin, Gemfibrozil, Hydrocodone-acetaminophen, Hydroxyzine, Insulin lispro, Lantus SoloStar, Lidocaine, Lisinopril, Methocarbamol, Narcan, Ranitidine, Senna, Trazodone | No | Yes 26-Feb-18 | Yes | No | No | |||||||||||||
| BBS0000-CF900355515111919DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 15.00 | $75.00 | Y | Male | Unknown | <-70C | 19-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain | $75.00 | Unknown | Multiple sclerosis, Pancreatitis | 2019-11-19 | Acyclovir, Ascorbic acid, Bifidobacterium infantis, Calcium carbonate, Copper, oral, Cyanocobalamin, Dalfampridine, Folic acid, Hydrocodone-acetaminophen, Immunoglobulin, Iodine, Lidocaine, Manganese, Mirabegron, Modafinil, Nystatin, Omega 3, Panzyga, Potassium animobenzoate, Seleium, Taurine, Testosterone, Turmeric, Zinc | U/A | Yes 23-Sep-2019 | 6-Nov-2019 | No | No | Vitamin A, C and E-Lutein-Minerals, Vitamin A, Vitamin B complex, Cholecalciferol | |||||||||||||
| BBS0000-CF900355516111919DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 17.00 | $75.00 | Y | Female | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 180 U/L; ALT: 90 U/L; ALP: 590 U/L19-Nov-2019 | $75.00 | Unknown | Anxiety, Hypertension | 2019-11-19 | Lorazepam | No | No | No | No | No | |||||||||||||
| BBS0000-CF900355517111919DD | Suspect Hepatitis C (HCV) | USA | Serum | 3.80 | 11.00 | $75.00 | Y | Female | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 104 U/L; ALT: 56 U/L; ALP: 139 U/L 18-Nov-2019 | $75.00 | Unknown | Juvenile rheumatoid arthritis | 2019-11-19 | Epinephrine, Famotidine, Folic acid, Hydrocodone-acetaminophen, Ibuprofen, Leucovorin, Naproxen, Prednisone, Tramadol | No | No | Yes | No | Yes | U/A | |||||||||||||
| BBS0000-CF900355518111919DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.40 | 17.00 | $75.00 | Y | Male | Hispanic | <-70C | 19-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Coronary artery bypass graft, Hypertension, Diabetes mellitus, Partial colectomy | 2019-11-19 | Acetaminophen, Aspirin, Atorvastatin, Benazepril, Fluocinonide, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Lidocaine, Metoprolol tartrate, Omeprazole | No | No | No | No | No | |||||||||||||
| BBS0000-CF900358438120319DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Male | Hispanic | <-70C | 03-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Myocardial infarction, Status post stent placement 2 years ago, Diabetes mellitus, High cholesterol, Hypertension, End stage renal disease on hemodialysis | 2019-12-03 | Aspirin, Atorvastatin, B Complex vitamin, Folic acid, Clopidogrel, Decara, Diphenhydramine, Furosemide, Gabapentin, Hydrocodone-acetaminophen, Insulin aspart, Insulin lispro, Lisinopril, Metoprolol tartrate, Sevelamer carbonate, Sevelamer hydrochloride, Stool softener | No | No | No | No | No | |||||||||||||
| BBS0000-CF900358439120919DD | Suspect Hepatitis C (HCV) | USA | Serum | 3.00 | 2.00 | $75.00 | Y | Female | Unknown | <-70C | 09-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Pulmonary embolisms on Eliquis, Breast cancer not on current treatment, Cervical cancer in remission, Appendectomy, Total hysterectomy | 2019-12-09 | Albuterol HFA, Anastrozole, Apixaban, Atorvastatin, Bupropion, Cholecalciferol Vitamin D3, Cyclobenzaprine, Diclofenac sodium, Fluticasone-propionate-salmeterol, Gabapentin, Hydroxazine, Ketoconazole, Morphine, Naloxone, Omeprazole, Oxycodone | Yes | Yes | Yes | No | Centrum OTC | Promethazine, Quetiapine, Zolpidem | ||||||||||||
| BBS0000-CF900358440120219DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 02-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | AST: 31 U/L; ALP: 285 U/L | 2-Dec-19 | $75.00 | Unknown | Lupus, End stage renal disease on hemodialysis | 2019-12-02 | Albuterol HFA, Atorvastatin, Calcium carbonate, Calcium, Carvedilol, Clonidine HCl, Escitalopram oxalate, Furosemide, Hydralazine, Hydromorphone, Losartan, Morphine, Nifedipine, Pantoprazole, Quetiapine, Sevelamer carbonate, Zolpidem | Yes | Yes | Yes | Yes | No | ||||||||||||
| BBS0000-CF900358441120919DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.90 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 09-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Hypertension, COPD | 2019-12-09 | Acetaminophen, Allopurinol, Apixaban, Gabapentin, Lidocaine, Morphine, Pregabalin, Tramadol, Trazodone | Yes 1975 | No | No | No | B Complex with vitamin C | |||||||||||||
| BBS0000-CF900358442120319DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.20 | 2.00 | $75.00 | Y | Female | Unknown | <-70C | 03-Dec-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 (1984); Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 157 U/L | 2-Dec-19 | $75.00 | Unknown | End stage renal disease secondary to diabetic neuropathy, Status post kidney transplant Jul-2019, Status post colectomy with ileostomy 1984, Left below knee amputation 2017 | 2019-12-03 | Ciprofloxacin HCl, Epoetin alfa, Ferrous sulfate, Fluoxetine, Hydrocodone-acetaminophen, Insulin aspart, Mycophenolate, Ondansetron, Oxybutynin, Pantoprazole, Patiromer calcium sorbitex, Prednisone, Pregabalin, Sodium bicarbonate, Tacrolimus | No | No | No | No | No | ||||||||||||
| BBS0000-CF900358443120219DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 02-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 43 U/L | 30-Nov-19 | $75.00 | Unknown | Aspergillus on voriconazole, COPD, Rheumatoid arthritis, Hypertension, Diastolic heart function | 2019-12-02 | Acetaminophen, Aspirin, Atorvastatin, Budesonide-formoterol, Dextromethorphan guaifenesin, Epinephrine, Finasteride, Folic acid, Gabapentin, Hydralazine, Hydromorphone, Ipratropium-albuterol, Losartan, Metformin, Naloxone, Nifedipine, Omalizumab | No | No | No | No | Centrum OTC, Theragran-M | Prednisone, Pregabalin, Senna, Silver sulfadiazine, Ventolin HFA, Voriconazole | |||||||||||
| BBS0000-CF900358444120919DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 09-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Lung cancer status post left lobectomy, COPD | 2019-12-09 | Acetaminophen, Albuterol HFA, Amlodipine, Cyclobenzaprine, Finasteride, Gabapentin, Hydrocodone acetaminophen, Levothyroxine, Mirtazapine, Naloxone, Quetiapine, Tamsulosin | U/A | U/A | Yes | No | No | |||||||||||||
| BBS0000-CF900358474120319DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 03-Dec-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 44 U/L | 3-Dec-19 | $75.00 | Unknown | None | 2019-12-03 | Ibuprofen, Ondansetron | No | No | No | No | No | ||||||||||||
| BBS0000-CF900358482121619DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 16-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Arthritis, Chronic back pain, Chronic pain of right knee | 2019-12-16 | Albuterol HFA, Benzonatate, Diclofenac, Hydrocodone-acetaminophen, Hysingla ER, Polyethylene glycol, Prednisone, Suflamethoxazole, Voltaren | No | No | No | No | No | |||||||||||||
| BBS0000-CF900358483121019DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Male | Hispanic | <-70C | 10-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Diabetes mellitus, Hypertension | 2019-12-10 | Amlodipine, Carvedilol, Clonidine, Hydrochlorothiazide, Metformin, Lisinopril | No | No | No | No | No | |||||||||||||
| BBS0000-CF900359161102819DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-10-28 | Docusate sodium, Gabapentin, Hydrocodone-acetaminophen, Methocarbamol, Phenytoin | Yes U/A | Yes | Yes | No | No | |||||||||||||
| BBS0000-CF900359162102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 50 U/L | 2019-10-28 | $75.00 | Unknown | Dermatomyositis | 2019-10-29 | Gabapentin Levothyroxine, Prednisione | No | No | No | No | No | ||||||||||||
| BBS0000-CF900359163102419DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 24-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 67 U/L | ALP: 189 U/L | 2019-10-23 | $75.00 | Unknown | Liver cirrhosis, End stage renal disease on dialysis, Diabetes mellitus, Thrombocytopenia | 2019-10-24 | Calcium carbonate, Carbamide peroxide, Cyclobenzaprine, Lactulose, Levemir FlexTouch insulin, NovoFine, Hydrocodone-acetaminophen | No | Yes | Yes | Yes | B Complex with vitamin C | ||||||||||||
| BBS0000-CF900359164102819DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 173 U/L | 2019-10-28 | $75.00 | Unknown | None | 2019-10-28 | Cephalexin | Yes U/A | Yes | No | No | Yes Unknown name and brand | ||||||||||||
| BBS0000-CF900359170111319DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Male | Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Atrial fibrillation, Hypertension | 2019-11-13 | Aspirin, Carvedilol, Diltiazem, Lisinopril, Oseltamivir, Tramadol | No | No | No | No | No | |||||||||||||
| BBS0000-CF900359171111319DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 13-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Kidney transplant and failed transplant, Small-bowel obstruction, Anemia, Chronic kidney disease on peritoneal dialysis, Hypertension, Hernia repair | 2019-11-13 | Amlodipine, Aspirin, Carvedilol, Furosemide, Hydralazine, Levothyroxine, Minoxidil, Pantoprazole, Prednisone, Procrit, Tacrolimus | No | No | No | No | No | |||||||||||||
| BBS0000-CF900359172111419DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | None | 2019-11-14 | Albuterol HFA, Denosumab, Ferric carboxymaltose, Ferrous sulfate, Lidocaine, Paroxetine, Triamcinolone | No | No | No | Yes | ||||||||||||||
| BBS0000-CF900359173111419DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes | AST: 91 U/L | ALT: 80 U/L | ALP: 161 U/L | 2019-11-14 | $75.00 | Unknown | Liver transplant on immunosuppression, Recurrent hepatic epithelioid hemangioendothelioma with metastasis to lung, liver, spine | 2019-11-14 | Acetaminophen, Aspirin, Docusate sodium, Furosemide, Lactulose, Metoprolol succinate, Ondansetron, Oxycodone, Senna, Tacrolimus, Tramadol | Yes 2017 | Yes 2014 | Yes | No | |||||||||||||
| BBS0000-CF900359174110519DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 05-Nov-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 184 U/L | 2019-11-04 | $75.00 | Unknown | Multiple myeloma status post marrow transplant, Chronic kidney disease on dialysis | 2019-11-05 | Acyclovir, Bortezomib, Bumetanide, Calcium acetate, Cyclophosphamide, Dexamethasone, Hydrocortisone, Indapamide, Lidocaine, Metoprolol succinate, Midodrine, Pantoprazole, Senna, Sensipar, Sodium chloride with meropenem | Yes U/A | Yes | Yes | No | |||||||||||||
| BBS0000-CF900359175120319DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 03-Dec-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $75.00 | Unknown | Hypertension | 2019-12-03 | Albuterol HFA, Atenolol, Atorvastatin, Fluticasone / Salmeterol, Gabapentin, Magnesium oxide, Naloxone, Omeprazole, Oxycodone, Oxycodone-acetaminophen, Polyvinyl alcohol, Prochlorperazine, Sertraline, Tizanidine, Topiramate, Trazadone, Verapamil | Yes | Yes | No | No | No | |||||||||||||
| BBS0000-CF900359176102219DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 22-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Diabetes mellitus type 2, Seizure, Hypertension, Prior hemorrhage CVA (stroke) status post stent placement with subsequent fungal infection status post removal | 2019-10-22 | Acetaminophen, Amitriptyline, Amlodipine, Ascorbic acid, Atorvastatin, Enoxaparin, Fluconazole, Gabapentin, Levetiracetam, Metoprolol tartrate, Polyethylene glycol, Potassium chloride, Propranolol, Psyllium, Sumatriptan | Yes U/A | Yes | Yes | No | Theragran | |||||||||||||
| BBS0000-CF900359177102819DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain | Elevated liver enzymes | ALT: 39 U/L | ALP: 186 U/L | 2019-10-27 | $75.00 | Unknown | Stage 4 Cholangiocarcinoma with metastasis to liver status post partial hepatectomy | 2019-10-28 | Docusate sodium, Famotidine, Gabapentin, Loratadine, Magnesium hydroxide, Ondansetron, Potassium chloride, Senna, Triamcinolone, Zolpidem | Yes U/A | Yes | Yes | No | No | ||||||||||||
| BBS0000-CF900359178110519DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 05-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 34 U/L | 2019-11-04 | $75.00 | Unknown | Hypertension, Diabetes mellitus type 2 | 2019-11-05 | Albuterol HFA, Alprazolam, Aspirin, Aspirin-acetaminophen-caffeine, Butalbital-acetaminophen-caffeine, Cyclobenzaprine, Fluticasone, Hydrocodone-acetaminophen, Losartan, Metoprolol tartrate, Naloxone, Naproxen sodium, Pantoprazole, Rosuvastatin, Senna, Sumatriptan | No | No | No | No | No | ||||||||||||
| BBS0000-CF900359179110519DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 05-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Diabetes mellitus type 1, Hypothyroidism, Chronic kidney disease | 2019-11-05 | Ascorbic acid, Aspirin, Atorvastatin, Carvedilol, Duloxetine, Epoetin, Ferrous sulfate, Iron, Glucagon, Hydralazine, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Levothyroxine, Mirtazapine, Naloxegol, Naloxone, Simethicone, Sodium bicarbonate, Tamsulosin, Testosterone cypionate, Tramadol, Vitamin D2, Zinc sulfate | No | No | Yes | No | ||||||||||||||
| BBS0000-CF900359180111419DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 38 U/L; ALT: 39 U/L | 2019-11-14 | $75.00 | Unknown | None | 2019-11-14 | Ferrous sulfate, Ibuprofen | No | No | No | No | |||||||||||||
| BBS0000-CF900359181120919DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Male | Hispanic | <-70C | 09-Dec-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 162 U/L 9-Dec-2019 | $75.00 | Unknown | Hypertension, Deep vein thrombosis on coumadin | 2019-12-09 | Warfarin | Yes 2016 | Yes 2016 | No | No | No | |||||||||||||
| BBS0000-CF900359182110519DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 05-Nov-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 32 U/L | 2019-11-04 | $75.00 | Unknown | Sickle cell disease, Previous acute chest syndrome | 2019-11-05 | Docusate sodium, Folic acid, Gabapentin, Glutamine, Hydroxyurea, Lidocaine, Morphine, Naloxone, Omeprazole, Oxycodone-acetaminophen, Polyethylene glycol, Senna, Tramadol | No | No | No | No | |||||||||||||
| BBS0000-CF900359183102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Back pain, Congestive heart failure, Chronic kidney disease stage 3, COPD, Diabetes mellitus type 2, Blood transfusion, Fibromyalgia, Heart failure unspecified, Mixed hyperlipidemia, Obesity unspecified, Obstructive sleep apnea, Osteopenia, Asthma, Essential hypertension, Glaucoma | 2019-10-29 | Albuterol HFA, Amlodipine, Carvedilol, Cholecalciferol, Clonidine, Docusate sodium, Fluoxetine, Fluticasone, Gabapentin, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Nitroglycerin, Omeprazole, Piperacillin sodium tazobactam, Polyethylene glycol, Quetiapine, Senna, Simvastatin | Yes U/A | Yes | Yes | No | Yes | |||||||||||||
| BBS0000-CF900359184102819DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 28-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzyme | AST: 79 U/L | ALT: 104 U/L | 2019-10-27 | $75.00 | Unknown | Alcohol abuse (ETOH) | 2019-10-28 | None | U/A | U/A | No | No | No | ||||||||||||
| BBS0000-CF900359185102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 3.50 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Esophageal cancer on Keytruda | 2019-10-29 | Acetaminophen, Amlodipine, Methocarbamol, Keytruda, Metoprolol tartrate, Omeprazole, Ondansetron, Prochlorperazine | U/A | U/A | Yes | No | No | |||||||||||||
| BBS0000-CF900359186110419DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 04-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Hypertension, Diabetes mellitus type 2, Focal segmental glomerulosclerosis status post renal transplant | 2019-11-04 | Aspirin, Cholecalciferol, Docusate sodium, Ezetimibe, Ferrous sulfate, Furosemide, Insulin lispro, Insulin NPH, Mycophenolate, Nitrofurantoin, Prednisone, Simvastatin, Tacrolimus, Tamsulosin | Yes U/A | Yes | Yes | No | No | |||||||||||||
| BBS0000-CF900359187102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Gastritis, Diverticulitis, Osteoarthritis | 2019-10-29 | Albuterol HFA, Aspirin, Calcium, Cetirizine, Cholecalciferol, Flovent HFA, Hydrocortisione, Ibandronate, Omeprazole | No | No | Yes | No | No | |||||||||||||
| BBS0000-CF900359188102419DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.00 | 4.00 | $75.00 | Y | Male | Hispanic | <-70C | 24-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 127 U/L | ALT: 104 U/L | 2019-10-24 | $75.00 | Unknown | Alcoholic dilated cardiomyopathy, Hypertension | 2019-10-24 | Famotidine | U/A | U/A | No | No | No | ||||||||||||
| BBS0000-CF900359189102319DD | Suspect Hepatitis C (HCV) | USA | Serum | 7.00 | 5.00 | $75.00 | Y | Male | Hispanic | <-70C | 23-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 295 U/L | ALT: 68 U/L | 2019-10-24 | $75.00 | Unknown | Osteomyelitis of right hip status post gun shot would 7 years ago, Paraplegic, Opioid use, Ostomy bag placement 4 years ago | 2019-10-23 | Amitriptyline, Ascorbic acid, Baclofen, Docusate sodium, Duloxetine, Fentanyl, Lidocaine, Magnesium hydroxide, Methocarbamol, Naloxone, Polyethylene glycol, Pregabalin, Quetiapine, Senna, Simethicone, Valproic acid | U/A | U/A | No | No | Theragran | ||||||||||||
| BBS0000-CF900359190102419DD | Suspect Hepatitis C (HCV) | USA | Serum | 3.00 | 4.00 | $75.00 | Y | Male | Unknown | <-70C | 24-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Hypertension, Dyslipidemia, Prostate cancer status post surgery and chemo 15 years ago | 2019-10-24 | Amlodipine, Benazepril, Bisoprolol, Chlorthalidone, Hydrocodone-acetaminophen, TriLyte, Sildenafil, Valsartan | No | No | No | No | No | |||||||||||||
| BBS0000-CF900359191102219DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 22-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L | 2019-10-21 | $75.00 | Unknown | Diabetes mellitus, Hypertension, Hypersensitivity lung disease, Chronic kidney disease secondary to DM not on dialysis, Coronary artery disease with right sided stents, Coronary artery bypass graft (quadruple bypass), Bilateral coronary stents | 2019-10-22 | Amiodarone HCl, Aspirin, Ergocalciferol, Furosemide, Levothyroxine, Metformin, Metoprolol tartrate, Spironolactone | U/A | U/A | No | Yes | Unknown name and brand | ||||||||||||
| BBS0000-CF900359192102319DD | Suspect Hepatitis C (HCV) | USA | Serum | 3.50 | 4.00 | $75.00 | Y | Female | Unknown | <-70C | 23-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 248 U/L | 2019-10-22 | $75.00 | Unknown | Congestive heart failure with an ejection fraction of 45%, Anorexia nervosa currently refeeding | 2019-10-23 | Alprazolam, Furosemide, Levothyroxine, Zolpidem | U/A | U/A | No | Yes | Alive! Max for women | ||||||||||||
| BBS0000-CF900359193102219DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 22-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 213 U/L | 2019-10-22 | $75.00 | Unknown | Acute kidney injury, End stage renal disease on dialysis | 2019-10-22 | Albuterol HFA, Amlodipine, Atorvastatin, Cyanocobalamin, Cyclosporine, Fluorometholone, Hydrocodone-acetaminophen, Loteprednol etabonate, Melatonin, Ondansetron, Pantoprazole, Risperidone, Senna docusate, Sucralfate, Zolpidem | No | No | No | No | Multivitamin with iron and folate | ||||||||||||
| BBS0000-CF900359194111419DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 14-Nov-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | Metastatic breast cancer | 2019-11-14 | Acetaminophen | No | No | No | No | No | |||||||||||||
| BBS0000-FH900358406101619DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Long term hemodialysis patient; HIV infected individual | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Anorexia, Diabetes mellitus type 2, Other disorders of plasma-protein metabolism (older co-morbidities listed in chart) | 2019-10-16 | Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Calcium acetate, Carvedilol, Eliquis, Lactulose, Senna, Levothyroxine, Sevelamer, Linzess, Simvastatin, Losartan, Terazosine, MiraLax, Tramadol, Norco | No | No | Yes | No | No | |||||||||||||
| BBS0000-FH900358407102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Atorvastatin, Omega 3, Ferrous sulfate, Veltassa, Gabapentin, PhosLo, Midodrine, Sertraline, Nateglinide, Metoprolol succinate | No | No | Yes 21-Sep-19 | No | Vitamin B complex, Men's multivitamin, Vitamins E,C & D | |||||||||||||
| BBS0000-FH900358408102819DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient; Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-28 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Ferrous sulfate, Nexium, Gabapentin, Januvia, Metoprolol, Renvela, Midodrine | No | No | Yes 18-Sep-19 | No | No | |||||||||||||
| BBS0000-FH900358409110119DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 01-Nov-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus types 1 & 2, Other disorders of plasma-protein metabolism (older co-morbidities listed in chart) | 2019-11-01 | Hectorol, Liquacel, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Lantus, Aspirin, Atorvastatin, NovoLog, Carvedilol, Renvela, Clopidogrel, Warfarin, Fluticasone, Zetia | No | No | Yes 8-Oct-19 | No | Calcitriol | |||||||||||||
| BBS0000-FH900358410103119DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Acute kidney failure, Anemia in chronic kidney disease, Secondary hyperparathyroidism of renal origin | 2019-10-31 | Engerix, Epogen, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Promethazine, Aspirin, Isosorbide mononitrate, Azelastine, Omeprazole, Bumetanide, Restasis, Uloric, Hydralazine | No | Yes 15-Oct-19 | Yes 21-Sep-19 | No | Dialybite | |||||||||||||
| BBS0000-FH900358411101119DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 11-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hyperkalemia, Other disorders of calcium metabolism (older co-morbidities listed in chart) | 2019-10-11 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Lantus, Levothyroxine, Losartan, Lovenox, Meclizine, Norco, Famotidine, NovoLog, Simvastatin | No | No | Yes 18-Sep-19 | No | Cyanocobalamin, Vitamin B12, Cholecalciferol, Vitamin D | |||||||||||||
| BBS0000-FH900358412102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Recipient of clotting factor concentrates produced before 1987, Long term hemodialysis patient, Blood, blood component or organ transplant recipient prior to 1992 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Hyperkalemia, Hypokalemia, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Acetaminophen, Eliquis, Warfarin, Bengay, DuoNeb, Febuxostat, Meloxicam, Midodrine, Senna, Sensipar, Levothyroxine | No | No | Yes 21-Sep-19 | No | No | |||||||||||||
| BBS0000-FH900358413101419DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Hispanic | <-70C | 14-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Hyperkalemia, Iron deficiency anemia, Unspecified protein-calorie malnutrion, Hypkalemia, Secondary hyperparathyroidism | 2019-10-14 | Engerix, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Asprin, Atorvastatin, Insulin detemir, Bisoprolol, Lactulose, MiraLax, EMLA, Nifedipine, Famotidine, Sevelamer, Ferrous sulfate, Sodium bicarbonate | No | Yes 17-Jul-19 | No | No | Folbee Plus | |||||||||||||
| BBS0000-FH900358414101619DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2019-10-16 | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Losartan, Norvasc, Renvela, Lasix, Sucroferric oxyhydroxide velphoro | No | No | Yes 21-Oct-19 | No | Dialyvite tablet / Ultra D | |||||||||||||
| BBS0000-FH900358415103119DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient, Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-31 | Epogen, Hectorol, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Amiodarone, Atorvastatin, Metoprolol, Eliquis, Auryxia, Plavix, Bumetanide, Renvela, Ferrous sulfate, Sertraline, Irbesartan, Tramadol, Medroxyprogesterone | No | No | No | No | No | |||||||||||||
| BBS0000-FH900358416103119DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Cellulitus of left finger and left upper limb, Hypokalemia, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-31 | Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Calcium acetate, Eliquis, Latanoprost, Losartan, Simvastatin | No | No | Yes 19-Sep-19 | No | Dialyvite, Vitamin B complex, Vitamin D | |||||||||||||
| BBS0000-FH900358417103119DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 31-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Recipient of clotting factor concentrates produced before 1987 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Secondary hyperparathyroidism, Hypokalemia, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-31 | Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Atorvastatin, Bumetanide, Eliquis, Januvia, Clopidogrel | No | Yes 26-Sep-19 | No | No | Dialyvite, Vitamin D | |||||||||||||
| BBS0000-FH900358418102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperlipidemia, Vitamin D deficiency, Hypocalcemia, Renal osteodystrophy (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amiodarone, Calcium acetate, Omeprazole, Tums, Warfarin | No | No | Yes 19-Sep-19 | No | Dialyvite | |||||||||||||
| BBS0000-FH900358419102819DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 28-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Hyperkalemia (older co-morbidities listed in chart) | 2019-10-28 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Azathioprine, Hydrocodone-acetaminophen, Calcium acetate, Xtampza, Carvedilol, Sensipar, Gabapentin, Zolpidem, Levothyroxine | No | No | Yes 21-Oct-19 | No | No | |||||||||||||
| BBS0000-FH900358420101119DD | Suspect Hepatitis C (HCV) | USA | Serum | 5.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 11-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; HIV infected individual; Healthcare, emergency medical and public health worker after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | Right upper side abdominal pain | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Chronic kidney disease stage 4, Vitamin D deficiency, Anemia, Iron deficiency anemia, Unspecified protein-calorie malnutrition, Secondary Hyperparathyroidism of renal origin | 2019-10-11 | Epogen, Venofer, Amlodipine, Lopinavir, Mometasone furoate, Clonidine, Fexofenadine, Sevelamer, Hydralazine, Tylenol, Imodium, Xanax, Carvedilol, Kelletra, Benadryl | No | No | Yes 18-Sep-19 | No | Centrum chewables; Omega | |||||||||||||
| BBS0000-FH900359165102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2, Other disorders of electrolyte and fluid balance (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Hectorol, Liquacel, Parsabiv, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Aspirin, Atorvastatin, Midodrine, Azathioprine, Prednisone, Calcium acetate | No | No | Yes 19-Sep-19 | No | Dialybite | |||||||||||||
| BBS0000-FH900359166101619DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-16 | Epogen, Hectorol, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Levothyroxine, Carvedilol, Metolazone, Januvia, Clopidogrel, Crestor, Magnesium, Diclofenac, Renvela, Tamsulosin, Lantus, Zolpidem | No | No | Yes 18-Sep-19 | No | Vitamin D2; Centrum silver | |||||||||||||
| BBS0000-FH900359167103019DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.00 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 30-Oct-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965; Healthcare, emergency medical and public health workers after needle stick, sharps or mucosal exposure to HCV positive blood. | Primary Signs and Symptoms | Right upper side abdominal pain | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-10-30 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Albuterol, Loperamide, Meclizine, Clopidogrel, Nifedipine, Fluticasone, Furosemide,Pantoprazole, Isosorbide dinitrate | No | No | No | No | Vitamin D2 | |||||||||||||
| BBS0000-FH900359168121319DD | Suspect Hepatitis C (HCV) | USA | Serum | 4.50 | 4.00 | $75.00 | Y | Male | Non-Hispanic | <-70C | 13-Dec-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | N/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypocalcemia, Hypotension, Diabetes mellitus types 1 & 2, Hypothyroidism (older co-morbidities listed in chart) | 2019-12-09 | Epogen, Hectoral, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Mirtazapine, Levothyroxine, Omeprazole, Metoclopramide, Renvela, Midodrine | No | No | Yes 2019-11-11 | No | Dialyvite | |||||||||||||
| BBS0000-FH900359169102919DD | Suspect Hepatitis C (HCV) | USA | Serum | 6.50 | 4.00 | $75.00 | Y | Female | Non-Hispanic | <-70C | 29-Oct-19 | Subject Risk Information | Long term hemodialysis patient | Primary Signs and Symptoms | U/A | $75.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hypotension of hemodialysis, Calcinosis cutis, Other disorders of calcium metabolism (older co-morbidities listed in chart) | 2019-10-29 | Epogen, Liquacel, Venofer, Acetaminophen, Clonidine, Diphenhydramine, Amitriptyline, Aspirin, Lyrica, Dulcolax, Eliquis, Fludrocortisone, Ropinirole, Midodrine, Nexium, Tramadol, Tums | No | No | Yes 24-Oct-19 | No | Vitamin D | |||||||||||||
| BBS0000-FH900359196121319DD | Suspect Hepatitis C (HCV) | Serum | 5.00 | 4.00 | $450.00 | Y | Male | Non-Hispanic | <-70C | 13-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease (older co-morbidities listed in chart) | 2019-12-09 | Epogen, Hectoral, Venofer, Acetaminophen, Clonidine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Advair, Losartan, Aspirin, Metoprolol, Atorvastatin, Ventolin HFA, Combivent | No | No | No | No | No | ||||||||||||||
| BBS0000-FH900359197121219DD | Suspect Hepatitis C (HCV) | Serum | 6.00 | 4.00 | $450.00 | Y | Female | Hispanic | <-70C | 12-Dec-19 | Subject Risk Information | Current or former user of IV drugs; Long term hemodialysis patient | Primary Signs and Symptoms | Upper right side abdominal pain | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Hyperkalemia, Disorders of electrolyte and fluid balance, Disorders of phosphorus metabolism, Renal osteodystrophy (older co-morbidities listed in chart) | 2019-12-10 | Epogen, Venofer, Acetaminophen, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Fentanyl, Aspirin, Pregabalin, Atorvastatin, Sevelamer, Buspirone, Tizanidine, Sodium bicarbonate | No | No | Yes 2019-11-12 | No | Vitamin B complex, Vitamin B1 | ||||||||||||||
| BBS0000-FH900359198121219DD | Suspect Hepatitis C (HCV) | Serum | 5.00 | 4.00 | $450.00 | Y | Female | Non-Hispanic | <-70C | 12-Dec-19 | Subject Risk Information | Long term hemodialysis patient; Healthcare, emergency medical and public health worker after needle stick, sharps or mucosal exposure to HCV positive blood | Primary Signs and Symptoms | N/A | $450.00 | Unknown | End stage renal disease, Anemia in chronic kidney disease, Diabetes mellitus type 2 (older co-morbidities listed in chart) | 2019-12-10 | Epogen, Hectorol, Clonidine, Diphenhdramine, Lidocaine, Maalox, Nitroglycerin, Promethazine, Amlodipine, Atorvastatin, Cinacalcet, Megestrol, Pantoprazole, Pregabalin, Methocarbamol, Sevelamer, Neosporin, Synthroid, Albuterol sulfate, Tramadol | No | No | Yes 2019-09-19 | No | Dialyvite | ||||||||||||||
| BBS0000-FI900105625070919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 57 Y | Male | <-70C | 09-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||||
| BBS0000-FI900105626070919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 12.00 | $150.00 | 54 Y | Female | <-70C | 09-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Yes U/A | Yes U/A | |||||||||||||||||||
| BBS0005-AC900057148051312DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 24 Y | Male | Unknown | <-70C | 13-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 53 U/L | 14 U/L | 7 U/L ALP | AST | ALT 6.4 g/dL | 3.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||||
| BBS0005-AC900057149041012DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 10-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Fever / chills; Elevated LFTs | Positive | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 107 U/L | 173 U/L | 25 U/L ALP | AST | ALT 5.1 g/dL | 1.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||||
| BBS0005-AC900064076091512DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 49 Y | Female | Unknown | <-70C | 15-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Jaundice; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 35 U/L | 7 U/L ALP | AST | ALT 6.9 g/dL | 2.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Sex worker | |||||||||||||||
| BBS0005-AC900065317050613DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 35 Y | Female | Unknown | <-70C | 06-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Elevated LFTs | Positive | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 97 U/L | 27 U/L | 20 U/L ALP | AST | ALT 5.2 g/dL | 2.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners | |||||||||||||||
| BBS0005-AC900065318032913DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 22 Y | Male | Unknown | <-70C | 29-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.4 mg/dL TBIL | DBIL 265 U/L | 31 U/L | 8 U/L ALP | AST | ALT 4.8 g/dL | 1.8 g/dL Protein | Albumin | Institutionalized population | |||||||||||||||
| BBS0005-AC900069462100512DD | Suspect Hepatitis C (HCV) | Mexico | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 19 Y | Male | Unknown | <-70C | 05-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.6 mg/dL TBIL | DBIL 442 U/L | 42 U/L | 9 U/L ALP | AST | ALT 5.3 g/dL | 1.7 g/dL Protein | Albumin | Homosexual M | |||||||||||||||
| BBS0005-AC900074789081912DD | Suspect Hepatitis C (HCV) | Mexico | 1.00 | 4.00 | $150.00 | 29 Y | Female | <-70C | 19-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Jaundice; Fatigue; Nausea; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 3.6 mg/dL | 2.3 mg/dL TBIL | DBIL 132 U/L | 32 U/L | 6 U/L ALP | AST | ALT 3.8 g/dL | 1.6 g/dL Protein | Albumin | Institutionalized population | |||||||||||||||||
| BBS0005-BD900023627092519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||
| BBS0005-BD900026637092019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 30 Y | Male | <-70C | 20-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Dovato | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026638091019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 27 Y | Male | <-70C | 10-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Triumeq | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026639090919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 17.00 | $150.00 | 44 Y | Male | <-70C | 09-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026640091619DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 45 Y | Female | <-70C | 16-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Chronic kidney disease | Rilpivirine, Tivicay, Seroquel | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026641091219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 9.00 | $150.00 | 21 Y | Male | <-70C | 12-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900026642090319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 17.00 | $150.00 | 27 Y | Male | <-70C | 03-Sep-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027871082619DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 17.00 | $150.00 | 29 Y | Male | <-70C | 26-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027872080519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 59 Y | Male | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Prezista, Norvir, Isentress | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027873082619DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 57 Y | Male | <-70C | 26-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027874080619DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 17.00 | $150.00 | 54 Y | Female | <-70C | 06-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Complera | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027875072919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 17.00 | $150.00 | 49 Y | Male | <-70C | 29-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027876080519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 18.00 | $150.00 | 40 Y | Female | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Genvoya | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027877071919DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 35 Y | Male | <-70C | 19-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Evotaz, Descovy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027878070119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 16.00 | $150.00 | 33 Y | Male | <-70C | 01-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Odefsey, Descovy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027879072219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 54 Y | Female | <-70C | 22-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Kidney disease | Biktarvy | No | No | No | No | |||||||||||||||||
| BBS0005-BD900027880070219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 18.00 | $150.00 | 46 Y | Male | <-70C | 02-Jul-19 | Subject Risk Information | HIV infected individual | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Genvoya, Klonopin | No | No | No | No | |||||||||||||||||
| BBS0005-BU900032895101812DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 39 Y | Male | Hispanic | <-70C | 18-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Chills;Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 47 U/L | 15 U/L | 12 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Body punctures (Tattooing); Haemodialysis patient | |||||||||||||||
| BBS0005-BU900032896080212DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 23 Y | Male | Non-Hispanic | <-70C | 02-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 54 U/L | 58 U/L | 41 U/L ALP | AST | ALT 8.3 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M; Multiple sex partners | |||||||||||||||
| BBS0005-BU900032903010713DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 07-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 33 U/L | 17 U/L | 11 U/L ALP | AST | ALT 8 g/dL | 4.1 g/dL Protein | Albumin | Hemolized | |||||||||||||||
| BBS0005-BU900032906020413DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 04-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.6 mg/dL TBIL | DBIL 47 U/L | 19 U/L | 12 U/L ALP | AST | ALT 6.8 g/dL | 44 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||||
| BBS0005-BU900032907021413DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 14-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 62 U/L | 24 U/L | 26 U/L ALP | AST | ALT 7.4 g/dL | 4.5 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||||
| BBS0005-BU900036004013014DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 30-Jan-14 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia) | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 132 U/L | 28 U/L | 17 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | |||||||||||||||
| BBS0005-BU900036005092513DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 25-Sep-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | N/A | 1 mg/dL | 0.4 mg/dL TBIL | DBIL 116 U/L | 119 U/L | 52 U/L ALP | AST | ALT 9.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||||
| BBS0005-BU900036007121113DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 11-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Chills | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 32 U/L | 19 U/L ALP | AST | ALT 7.7 g/dL | 4.3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| BBS0005-BU900036888031213DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 12-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | Positive | 11.3 mg/dL | 0.6 mg/dL TBIL | DBIL 54 U/L | 13 U/L | 12 U/L ALP | AST | ALT 6.5 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmited diseases (STD); Multiple sex partners | |||||||||||||||
| BBS0005-BU900036889111512DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 0.6 mg/dL | 0.4 mg/dL TBIL | DBIL 58 U/L | 19 U/L | 9 U/L ALP | AST | ALT 4.6 g/dL | 2.8 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||||
| BBS0005-BU900036891112312DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 23-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Elevated LFTs | N/A | 1.6 mg/dL | 1.1 mg/dL TBIL | DBIL 812 U/L | 71 U/L | 40 U/L ALP | AST | ALT 6.6 g/dL | 3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| BBS0005-BU900036900110512DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 43 Y | Male | Non-Hispanic | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 49 U/L | 15 U/L | 11 U/L ALP | AST | ALT 6.1 g/dL | 3.8 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||||
| BBS0005-BU900042698120512DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 21 Y | Male | Non-Hispanic | <-70C | 05-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 41 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||||
| BBS0005-BU900042703120712DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 07-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Jaundice; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine; Elevated LFTs | N/A | 0.8 mg/dL | 0.5 mg/dL TBIL | DBIL 66 U/L | 3245 U/L | 316 U/L ALP | AST | ALT 8.1 g/dL | 3.9 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Occupational contact with blood (Trained as medical assistant); Body punctures (Piercing, human bite); Household contacts of HBV or HCV infected person | |||||||||||||||
| BBS0005-BU900050689122712DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 27-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 71 U/L | 28 U/L | 15 U/L ALP | AST | ALT 8.7 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures (Piercing, human bite); Household contacts of HBVor HCV infected person | |||||||||||||||
| BBS0005-BU900050690111612DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Fever / chills; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 84 U/L | 61 U/L | 9 U/L ALP | AST | ALT 9.1 g/dL | 5.5 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures (Piercing) | |||||||||||||||
| BBS0005-BU900050691012813DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 28-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 17 U/L | 14 U/L ALP | AST | ALT 6.2 g/dL | 3.6 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Occupational contact (Medical or dental workers); Body punctures (Tattooing, piercing, human bite); Institutionalized population (Prisoners) | |||||||||||||||
| BBS0005-BU900052406022812DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 28-Feb-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.8 mg/dL | 0.4 mg/dL TBIL | DBIL 166 U/L | 194 U/L | 24 U/L ALP | AST | ALT 7.2 g/dL | 3.9 g/dL Protein | Albumin | Haemodialysis patient | |||||||||||||||
| BBS0005-BU900052417061412DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 14-Jun-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 276 U/L | 50 U/L | 19 U/L ALP | AST | ALT 7.6 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| BBS0005-BU900057146031912DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 19-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.1 mg/dL | 0.4 mg/dL TBIL | DBIL 27 U/L | 11 U/L | 14 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| BBS0005-BU900057147032012DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 22 Y | Male | Non-Hispanic | <-70C | 20-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 1.3 mg/dL | 0.4 mg/dL TBIL | DBIL 49 U/L | 10 U/L | <6 U/L ALP | AST | ALT 8.2 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| BBS0005-BU900057174043013DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 42 Y | Female | Non-Hispanic | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 63 U/L | 10 U/L | 17 U/L ALP | AST | ALT 6.1 g/dL | 4.2 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Acupuncture, piercing) | |||||||||||||||
| BBS0005-BU900057176061013DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 32 Y | Male | Non-Hispanic | <-70C | 10-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.5 mg/dL TBIL | DBIL 65 U/L | 9 U/L | 8 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| BBS0005-BU900057177041713DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 17-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Chills; Elevated LFTs | N/A | 1.8 mg/dL | 0.9 mg/dL TBIL | DBIL 59 U/L | 86 U/L | 48 U/L ALP | AST | ALT 6.6 g/dL | 4.1 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures (Tattooing, piercing) | |||||||||||||||
| BBS0005-BU900064064041212DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 12-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 15 U/L | 8 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing) | |||||||||||||||
| BBS0005-BU900066340112513DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 25-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 87 U/L | 37 U/L | 22 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Intravenous drug user; Body punctures (Tattooing, piercing); Institutionalized population (Prisoners) | |||||||||||||||
| BBS0005-BU900074796091012DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 4.00 | $150.00 | 58 Y | Female | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 47 U/L | 20 U/L | 15 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Acupuncture, Pierciing) | |||||||||||||||||
| BBS0005-BU900074797091412DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 6.00 | $150.00 | 46 Y | Female | <-70C | 14-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills;Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 66 U/L | 28 U/L | 13 U/L ALP | AST | ALT 7.8 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Dental workers); Body punctures (Acupuncture, tattooing) | |||||||||||||||||
| BBS0005-BU900079066090512DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 05-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 83 U/L | 33 U/L | 12 U/L ALP | AST | ALT 8.8 g/dL | 5.1 g/dL Protein | Albumin | Haemodialysis patient; Household contacts of HBV or HCV infected person | |||||||||||||||
| BBS0005-BU900079077100812DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 36 Y | Female | Hispanic | <-70C | 08-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.4 mg/dL | 0.7 mg/dL TBIL | DBIL 138 U/L | 1323 U/L | 688 U/L ALP | AST | ALT 8.7 g/dL | 5.4 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing); | |||||||||||||||
| BBS0005-BU900079079102212DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 28 Y | Female | Non-Hispanic | <-70C | 22-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Abdominal pains; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 14 U/L | 9 U/L ALP | AST | ALT 7.6 g/dL | 4.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| BBS0005-BU900079080091712DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 31 Y | Male | Non-Hispanic | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains;Dark color urine; Elevated LFTs | N/A | 0.7 mg/dL | 0.5 mg/dL TBIL | DBIL 63 U/L | 276 U/L | 42 U/L ALP | AST | ALT 6.4 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| BBS0005-BV900066338083013DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 29 Y | Male | Non-Hispanic | <-70C | 30-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Diarrhea;Elevated LFTs | Positive | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 67 U/L | 16 U/L | 10 U/L ALP | AST | ALT 8.2 g/dL | 4.9 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures | |||||||||||||||
| BBS0005-BV900069486052113DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 41 Y | Male | Non-Hispanic | <-70C | 21-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Elevated LFTs | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 41 U/L | 15 U/L | <6 U/L ALP | AST | ALT 5.1 g/dL | 3.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Homosexual M; Body punctures | |||||||||||||||
| BBS0005-CC900022537061019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L: Test Date 10-Jun-2019 | $150.00 | Unknown | Congestive heart failure, Cerebrovascular accident, Cardiomyopathy 2�� to substance abuse, Atrial fibrillaiton | Aspirin, Atorvastatin, Enoxaprin, Fluoxetine, Furosemide, Metoprolol tartrate, Warfarin | No | No | |||||||||||||||
| BBS0005-CC900022542060419DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 17.00 | $150.00 | 27 Y | Male | Non-Hispanic | <-70C | 04-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 80 U/L; ALT: 108 U/L; ALP: 802 U/L: Test Date 4-Jun-2019 | $150.00 | Unknown | Billary atresia, Encounter for blood transfusion, Hypokalemia, Renal papillary necrosis, Sickle cell anemia, | Folvite, Gabapentin, Glutamine powder, Hydromorphone, Hydrea, Eucerin, Naloxone, Miralax, Senna | No | U/A | |||||||||||||||
| BBS0005-CC900022690050619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 06-May-19 | Subject Risk Information | Current or former user of IV drugs; HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | Unknown | Endocarditis, Syphilis, HSV-2 | Buspar, Ferrous sulfate, Prozac, Gabapentin, Lactobacillus, Zofron, Seroquel, Buprenorphine | No | No | No | No | ||||||||||||
| BBS0005-CC900024128061219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L; ALP: 364 U/L Test Date: 11-Jun-2019 | $150.00 | Unknown | Atrial fibrillation, Valve replacement, Pneumonia, Atrial septal defect, Cardiomyopathy, Congestive heart failure, Encounter for blood transfusion, Essential hypertension, Secondary biliary cirrhosis, Severe tricuspid valve insufficiency, Hypothyroidism | Amoxicillin, Aspirin, Bumetanide, Famotidine, Ferrous sulfate, Gabapentin, Levothyroxine, Magnesium chloride, Potassium chloride, Senna docusate, Spironolactone, Warfarin | U/A | U/A | |||||||||||||||
| BBS0005-CC900024131061219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 84 Y | Female | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 33 U/L: Test Date 11-Jun-2019 | $150.00 | Unknown | Diabetic ketoacidosis, Chronic kidney disease, Hypertensive heart and kidney disease, Anemia, Diabetes mellitus, Atrial fibrillation, Congestive heart failure, Coronary artery diseae, Cystocele, Hypertension, Hypothyroidism, Myocardial infarction, Obstructive sleep apnea, Osteoarthritis | Tylenol, Amiodarone, Eliquis, Atorvastatin, Benazepril, Colace, Robitussin, Lantus, Insulin lispro, Bidil, Levothyroxine, Melatonin, Metoprolol succinate, Miralax, Polyvinyl alcohol, Potassium chloride, Senna, Torsemide, Tramadol, Triamcinolone | No | No | |||||||||||||||
| BBS0005-CC900024277051319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 13-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $150.00 | Unknown | Sickle Cell | Biktarvy, Cleocin, Ferrous sulfate, Ibuprofen, Claritin, Naprosyn, Multivitamins with minerals | No | No | No | No | ||||||||||||
| BBS0005-CC900024278051319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 13-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $150.00 | Unknown | AIDS | Atovaquone, Genvoya, Ibuprofen, Phenergan | No | No | No | No | ||||||||||||
| BBS0005-CC900024279070119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 29 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Bendryl, Docusate sodium, Ferrous sulfate, Diflucan, Genvoya, Mycostatin, PNV-DHA-Docusate, Terbinafine cream | No | No | No | No | |||||||||||||||
| BBS0005-CC900024282062519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 25-Jun-19 | Subject Risk Information | HIV infected individuals | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Bictegravir-Emtricitab-Tenofov AF | No | No | No | No | |||||||||||||||
| BBS0005-CC900024283043019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 25 Y | Female | Non-Hispanic | <-70C | 30-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | Unknown | None | Complera, Ferrous sulfate, Prenatal Multi DHA | No | No | ||||||||||||||
| BBS0005-CC900024284050219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 02-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | Unknown | AIDS | Atazanvir, Prenatal Vitamin Plus low Iron | No | No | No | No | ||||||||||||
| BBS0005-CC900024285041119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 11-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | Unknown | None | Truvada, Isentress | No | No | ||||||||||||||
| BBS0005-CC900024286042519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 25 Y | Female | Non-Hispanic | <-70C | 25-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | Unknown | None | Triumeq, Fioricet, Zofran, Prenatal vitamin | No | No | ||||||||||||||
| BBS0005-CC900024287042519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 25-Apr-19 | Subject Risk Information | Current or former user of IV drugs | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | Unknown | Asthma, Migraines, Anemia, Thrombocytopenia | Aspirin, Fioricet, Flexeril, Ferrous sulfate, Prenatal multivitamin, Proair HFA, Zoloft, Magnesium oxide | Alzheimers | No | No | |||||||||||||
| BBS0005-CC900024288041119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 11-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | Unknown | None | Fioricet, Zofran | Alzheimers | No | No | |||||||||||||
| BBS0005-CC900024289031819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 29 Y | Female | Non-Hispanic | <-70C | 18-Mar-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | Unknown | HPV, Acute cystitis, Syphilis, Asthma, Candidiasis of skin, BV | Atazanavir, Benadryl, Truvada, Flagyl, Prenatal multivitamin, Ritonavir | Alzheimers | No | No | |||||||||||||
| BBS0005-CC900027863061319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 14.00 | $150.00 | 64 Y | Male | <-70C | 13-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 160 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | Diabetes Mellitus | None | U/A | U/A | |||||||||||||||||
| BBS0005-CC900027865061319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 7.00 | $150.00 | 19 Y | Male | <-70C | 13-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Pediatric | Primary Signs and Symptoms | Elevated liver enzymes | AST: 85 U/L: Test Date 13-Jun-2019 | $150.00 | Unknown | None | Acetaminophen, Ibuprofen | U/A | U/A | |||||||||||||||||
| BBS0005-CC900027866061119DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 4.00 | $150.00 | 62 Y | Female | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Small bowel obstruction, Arachnoiditis, Arthritis, Fracture of L1 vertebra, Herniation of intervertebral disc between L5 and S1, Retinal detachment, Urinary tract infection unresolved with antibiotics | Amitriptyline, Cyclobenzaprine, Hydrocodone acetaminophen, Ibuprofen, Levothyroxine, Mirabegron, Multivitamin, Omeprazole, Zonisamide | No | No | ||||||||||||||||||
| BBS0005-CC900028029022619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 32 Y | Female | Non-Hispanic | <-70C | 26-Feb-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $150.00 | Unknown | Osteoarthritis lower leg, Rheumatoid arthritis | Epzicom, Isentress, Astelin, Zyrtec, Flonase, Ferrous sulfate, Prednisone, Tylenol, Naproxen, Prilosec | Alzheimers | No | Yes | 3-Jan-2017 | |||||||||||||
| BBS0005-CC900028030042319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 19 Y | Female | Non-Hispanic | <-70C | 23-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | Unknown | Syphilis, Hypertension, Herpes simplex virus | Acyclovir, Keflex, Colace, Zofran, Prenatal vitamins, Zantac | Alzheimers | No | No | |||||||||||||
| BBS0005-CC900028031042319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 23-Apr-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | Unknown | Hypothyroid | Flexeril, Ferrous sulfate, Zofran, Zanta, Levothyroxine | Alzheimers | No | No | |||||||||||||
| BBS0005-CC900028032060619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 28 Y | Female | Non-Hispanic | <-70C | 06-Jun-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 2nd | $150.00 | Unknown | AIDS | Acyclovir, Cyproheptadine, Darunavir-Cobicstat-Emtricitabine-Tenofovir, Alafenamide, Dolutegravir, Diflucan, Prednisone, Prenatal multivitamins ultra | Alzheimers | No | No | No | No | |||||||||||
| BBS0005-CC900028033052819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 30 Y | Female | Non-Hispanic | <-70C | 28-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | Unknown | Asthma | Prezcobix, Descovy, Ferrous sulfate, Ibuprofen, Zofran, Prenatal vitamin, Proair HFA, Phenergan, Bactrim DS | Alzheimers | No | No | No | No | |||||||||||
| BBS0005-CC900028034060619DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 21 Y | Female | <-70C | 06-Jun-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | Unknown | Hypothyroidism | Descovy, Synthroid, Prenatal multivitamin with FA-DHA, Vitamin D | No | No | No | No | ||||||||||||||
| BBS0005-CC900028042052019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 13.00 | $150.00 | 35 Y | Female | <-70C | 20-May-19 | Subject Risk Information | HIV infected individuals, Previous laparoscopic sleeve gastrectomy in the past | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 3rd | $150.00 | Unknown | Anemia | Prenatal multivitamin with FA-DHA | No | No | No | No | ||||||||||||||
| BBS0005-CC900028043052019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 9.00 | $150.00 | 33 Y | Female | <-70C | 20-May-19 | Subject Risk Information | HIV infected individuals | Suspect HCV:Pregnant | Primary Signs and Symptoms | U/A | Trimester | 1st | $150.00 | Unknown | History of depression, Chronic fatigue | Prenatal multivitamin with Fe-Fumerate-FA, Zoloft, Zantac, Acetaminophen, Dextromethorphan-Guaifenesin, Genvoya, Norco, Imodium, Claritin, Nasonex, Kenalog, Zofran | No | No | No | No | ||||||||||||||
| BBS0005-CC900031093061219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 57 Y | Male | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Diabetes Mellitus, Osteomyelitis, Chronic right foot wound | Aspirin, Atorvastatin, Furosemide, Gabapentin, Glimepiride, Humalog, Tramadol, Insulin glargine, Ketorolac, Losartan, Omeprazole, Steglatro, Sulfamethoxazole trimethoprim, Tamsulosin | U/A | No | ||||||||||||||||
| BBS0005-CC900031096060519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 54 Y | Male | Hispanic | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L; ALT: 65 U/L: Test Date 5-Jun-2019 | $150.00 | Unknown | None | Ondansetron | No | No | |||||||||||||||
| BBS0005-CC900032897080712DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 07-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Fatigue; Nausea; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing) | |||||||||||||||
| BBS0005-CC900037605061219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Ascites; Elevated liver enzymes | AST: 97 U/L; ALT: 65 U/L:Test Date 12-Jun-2019 | $150.00 | Unknown | Chronic kidney disease, Diabetes mellitus, Hypertension, Malignant neoplasm liver cancer | Ciproflxacin, Furosemide, Lactulose, Metformin, Xifaxan, Spironolactone | U/A | U/A | |||||||||||||||
| BBS0005-CC900037606061219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 25 Y | Female | Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Long term hemodialysis patients | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Lupus, Congestive heart failure, Renal transplant, End-stage renal disease on dialysis, Cardiomyopathy Hypertension, Lupus nephritis | Amlodipine, Beclomethasone, Calcium acetate, Carvedilol, Clonidine, Sevelamer carbonate, Senna docusate, Hydrocodone acetaminophen, Levofloxacin, Lisinopril, Loratadine, Prednisone, Tacrolimus, Warfarin | YES | U/A | Yes | 2017 | ||||||||||||||||
| BBS0005-CC900037607061019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 102 U/L; ALP: 1697 U/L: Test Date 10-Jun-2019 | $150.00 | Unknown | Arthritis, Bilateral lower extremity edema, Coronary artery disease, Cirrhosis, Diabetes mellitus, Encounter for blood transfusion, Gastrointestinal hemorrhage with hematemesis, Glaucoma, Hypertension, Myocardial infarction, Neuromyopathy | Maalox plus, Aspirin, Atorvastatin, Clotrimazole lotrimin, Diclofenac sodium, Ergocalciferol, Flonase, Lasix, Gabapentin, Robitussin, Atarax, Insulin glargine, Lactulose, Multivitamin, Mycostatin, Prilosec, Xifaxan, Gas-X, Spironolactone, Timoptic, Trazodone | U/A | Yes | 27-Feb-2018 | |||||||||||||||
| BBS0005-CC900041238060519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 05-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 196 U/L; ALT: 52 U/L; ALP: 830 U/L: Test Date 4-Jun-2019 | $150.00 | Unknown | Colon cancer metastasized to liver | Docusate sodium, Hydromorphone, Spironolactone, Trazodone | No | No | |||||||||||||||
| BBS0005-CC900041244061219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 12-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Dark colored urine; Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 65 U/L; ALT: 155 U/L; ALP: 140 U/L:Test Date 11-Jun-2019 | $150.00 | Unknown | History of hepatitis B virus infection, Laryngopharyngeal reflux, Myocardial infarction | Aspirin, Ranitidine | U/A | U/A | |||||||||||||||
| BBS0005-CC900041246061119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 56 Y | Male | Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Hypertension, GERD, Pneumonia, Seizure | Albuterol, Carvedilol, Famotidine, Fluoxetine, Hydralazine, Hydrocortisone, Hydroxyzine, Omeprazole, Quetiapine fumarate | YES | U/A | YES | U/A | ||||||||||||||||
| BBS0005-CC900046340061019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 59 Y | Female | Hispanic | <-70C | 10-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Right upper side abdominal pain; Elevated liver enzymes | AST: 93 U/L; ALT: 187 U/L; ALP: 247 U/L: Test Date 8-Jun-2019 | $150.00 | Unknown | Arthritis, Carpal tunnel syndrome, Disc degeneration, lumbar | None | No | No | |||||||||||||||
| BBS0005-CC900069459051812DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 18-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chlls; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 1 U/L | 6 U/L ALP | AST | ALT 6.1 g/dL | 3.9 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures | |||||||||||||||
| BBS0005-CC900069460052912DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 29-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Liver cirrhosis; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chills; Dark color urine / light color feces; Elevated LFTs | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 52 U/L | 13 U/L | 10 U/L ALP | AST | ALT 7.6 g/dL | 4.2 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures | |||||||||||||||
| BBS0005-CC900069835061119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 11-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Kidney transplant, Cataract, Congestive heart failure, Chronic renal insufficiency, Diabetic neuropathy, Diabetes mellitus, End-stage renal disease, Fibromyalgia, Hyperlipidemia, Hypertension, Rheumatoid arthritis | Acetaminophen, Albuterol, Ascorbic acid, Carvedilol, Cholecalciferol, Insulin aspart, Insulin glargine, Mycophenolate, Lorazepam, Pantoprazole, Prednisone, Simethicone, Sulfamethoxazole trimethoprim, Tacrolimus, Olopatadine | No | No | ||||||||||||||||
| BBS0005-CD900064062011513DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 20 Y | Female | Non-Hispanic | <-70C | 15-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 68 U/L | 75 U/L | 29 U/L ALP | AST | ALT 8.6 g/dL | 4.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person (Mom) | |||||||||||||||
| BBS0005-CF900022538062519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 307 U/L; ALT: 132 U/L | 25-Jun-19 | $150.00 | Unknown | Congestive heart failure, COPD, Hypertension, Cholangitis, Disorder of thyroid, Kidney disorder, Transient ischemic attack | Dicyclomine, Docusate sodium, Gabapentin, Levothyroxine, Lisinopril, Pantoprazole, Promethazine | No | U/A | No | No | |||||||||||||
| BBS0005-CF900022539071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 21 Y | Female | Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L; ALT: 73 | 9-Jul-19 | $150.00 | Unknown | Cardiac transplant, Diabetes mellitus, Hypertension | Aluminum hydroxide, Magnesium hydroxide, Simethicone, Amoxicillin, Aspirin, Budesonide-Formoterol, Calcium carb & citrate, Vitamin D3, Cetirizine, Cyproheptadine, Hydrocortisone, Ipratropium, Levalbuterol, Magnesium oxide, Metoprolol succinate, Mometasone, Montelukast, Pantoprazole, Sirolimus, Tacrolimus | Yes Date of Vaccination: 6-Jun-2002 | Yes Date of Vaccination: 5/20/1998 | No | No | |||||||||||||
| BBS0005-CF900022540052919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 54 Y | Female | Hispanic | <-70C | 29-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Acute gastric ulcer, Anxiety, Complex care coordination, Diabetes Mellitus, Hypertension, Major depressive disorder without psychotic features, Malignant neoplasm breast cancer left breast | Acetaminophen, Atorvastatin, Benzocaine-Menthol, Cholecalciferol, Cyclobenzaprine, Gabapentin, Guaifenesin, Metformin, Midodrine, Naproxen, Polyethylene glycol, Senna | U/A | U/A | ||||||||||||||||
| BBS0005-CF900022541072219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 59 Y | Male | Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 51 U/L; ALP: 216 U/L | 21-Jul-19 | $150.00 | Unknown | Coronary artery disease s/p PCI, Congestive heart failure, Diabetes mellitus type 2, Hypersensitivity lung disease | Aspirin, Atorvastatin, Carvedilol, Diphenhydramine, Furosemide, Hydralazine, Insulin glargine | No | No | No | No | |||||||||||||
| BBS0005-CF900022543072219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 17.00 | $150.00 | 25 Y | Female | Non-Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 89 U/L | 21-Jul-19 | $150.00 | Unknown | Lupus, Acute encephalopathy, Ascites, Hypertension, Ileus, Nephrotic syndrome, Pancreatitis, Tachycardia | Acetaminophen, Amlodipine, Antovaquone, Calcium carbonate, Cholecalciferol, Vitamin D3, Dextromethorphan guaifenesin, Dronabinol, Hydroxychloroquine, Magnesium oxide, Melatonin, Ondansetron, Pantoprazole, Senna | Yes Date of Vaccination: 2001 & 2007 | Yes Date of Vaccination: 1994, 1997 & 1998 | No | No | |||||||||||||
| BBS0005-CF900022544071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 70 Y | Female | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 34 U/L; ALP: 245 U/L | 18-Jul-19 | $150.00 | Unknown | Hypertension, Asthma | Lisinopril-Hydrochlorothiazide, Risedronate | No | No | No | No | |||||||||||||
| BBS0005-CF900022545070219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 66 Y | Male | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus type 2, Dyslipidemia, End-stage renal failure on dialysis, Hypertension, Renal transplant (2017) | Aspirin, Chlorthalidone, Lisinopril, Metoprolol tartrate, Insulin aspart, Insulin glargine, Latanoprost, Mycophenolate, Prednisone, Simvastatin, Tacrolimus | Yes Date of Vaccination: U/A | Yes Date of Vaccination: 1-Oct-2015 and 1-Jan-2016 | No | No | ||||||||||||||
| BBS0005-CF900022546070919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 76 Y | Female | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 64 U/L; ALT: 61 U/L | 9-Jul-19 | $150.00 | Unknown | Hypertension | None | No | No | No | No | |||||||||||||
| BBS0005-CF900023452071119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 11-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 10-Jul-19 | $150.00 | Unknown | Diabetes mellitus, Coronary stents, Myocardial infarction (twice) | Amitriptyline, Aspirin, Atorvastatin, Benazepril, Carvedilol, Insulin glargine, Multivitamin | U/A | Yes Date of Vaccination: 10/6/2016 | No | Yes | |||||||||||||
| BBS0005-CF900023453091019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 23 Y | Female | Hispanic | <-70C | 10-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Abnormal menstrual periods | Aluminum-magnesium-hydroxide-simethicone, Hydrocodone-acetaminophen, Ondansetron, Pantoprazole | Yes U/A | Yes U/A | No | Yes | |||||||||||||||
| BBS0005-CF900023454090519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 05-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | AST: 42 U/L | ALT: 83 U/L | 4-Sep-2019 | $150.00 | Unknown | Stents in brachial cephalic vein, Cardiac stents, Hyperlipidemia, GERD, End stage renal disease, Heart failure, COPD, Epilepsy, On oxygen nasal cannula | Allopurinol, Aspirin, Atorvastatin, Budesonide, Calcium acetate, Citalopram, Clonidine, Diphenhydramine, Fluticasone Furoate-vilanterol, Gabapentin, Hydrocodone-acetaminophen, Lactulose, Levothyroxine, Loperamide, Metoclopramide, Metoprolol succinate, Metoprolol tartrate, Nifedipine, Olanzapine, Pantoprazole, Patiromer calcium sorbitex, Promethazine, Sevelamer carbonate, Simvastatin, Vitamin B complex, Zolpidem | No | No | No | No | ||||||||||||||
| BBS0005-CF900023455072319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 37 Y | Male | Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L; ALT: 59 | 23-Jul-19 | $150.00 | Unknown | Heart transplant | Escitalopram, Losartan, Metformin, Omeprazole, Ondansetron, Sirolimus, Tacrolimus, Trazodone | Yes Date of Vaccination: 8-Apr-12 | Yes Date of Vaccination: 9-Apr-12 | No | No | |||||||||||||
| BBS0005-CF900023456100919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 24 Y | Female | Hispanic | <-70C | 09-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 95 U/L | ALT: 66 U/L | 8-Oct-19 | $150.00 | Unknown | Cholecystectomy | None | Yes 26-Jan-01 | Yes U/A | No | No | ||||||||||||||
| BBS0005-CF900023457100119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 34 Y | Female | Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L | 30-Sep-19 | $150.00 | Unknown | Lupus, Seizures, Hyperthyroidism, Bipolar disorder | Albuterol, Azithromycin, Alprazalam, Baclofen, Bethomethasone, Benzonatate, Cholecalciferol, Diclofenac sodium, Divalproex, Epinephrine, Ferrous sulfate, Iron, Fluticasone, Folic acid, Hydrocodone-acetaminophen, Hydroxychloroquine, Ipratropium-albuterol, Levothyroxine, Lisinopril, Lurasidone, Multivitamin with iron and minerals, Mycophenolate, Omeprazole, Prednisone, Senna, Sertraline, Zolpidem | No | No | No | No | ||||||||||||||
| BBS0005-CF900023458101519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 70 Y | Female | Non-Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Chronic lymphocytic leukemia (no treatment) | Albuterol, Allopurinol, Aspirin, Carvedilol, Cholecalciferol, Clobetasol, Colchicine, Flucinonide, Furosemide, Gabapentin, Ibuprofen, Ipratropium-albuterol, Mupirocin ointment, Potassium chloride, Secukinumab, Sertraline, Triamcinolone | No | No | No | No | |||||||||||||||
| BBS0005-CF900023459100219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 72 Y | Male | Non-Hispanic | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes AST: 184 U/L; ALT: 126 U/L | 1-Oct-19 | $150.00 | Unknown | Hiatal hernia; Hypertension | Amlodipine, Aspirin, Docusate sodium, Hydrocodone-acetaminophen | No | No | No | No | ||||||||||||||
| BBS0005-CF900024129060319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 57 Y | Female | Non-Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Long term hemodialysis patients; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 218 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Absolute anemia, Chronic obstructive pulmonary disease, Congestive heart failure, Diabetes mellitus, Dialysis patient (non-compliant), End stage renal disease, GERD, Hypertension, Hypotension, Non-ST elevation myocardial infarction, Paroxysmal atrial fibrillation, Pulmonary hypertension, Umbilical hernia | Albuterol, Albuterol HFA, Aspirin, Atorvastatin, Dulcolax, Cetirizine, Cholecalciferol, Vitamin D3, Flexeril, Dicyclomine, Fluconazole, Folic acid, Combivent, Synthroid, Lidocaine, Lopressor, Proamatine, Protonix, Veltassa, Miralax, Lyrica, Senna, Renvela | No | No | |||||||||||||||
| BBS0005-CF900024130071119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 43 Y | Male | Hispanic | <-70C | 11-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 40 U/L; ALT: 58 U/L | 10-Jul-19 | $150.00 | Unknown | HLP, GERD | Ciclopirox, Omeprazole, Polyethylene glycol | Yes Date of Vaccination: 3-Jun-2013 | U/A | No | No | |||||||||||||
| BBS0005-CF900024132072919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 29 Y | Female | Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 42 U/L | 29-Jul-2019 | $150.00 | Unknown | Central nervous system lymphoma | Acyclovir, Docusate sodium, Levofloxacin, Ondansetron, Polyethylene glycol, Prochlorperazine, Sulfamethoxazole | Yes Date of Vaccination: 12-Jun-09 | U/A | No | No | |||||||||||||
| BBS0005-CF900024133100819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 58 Y | Female | Hispanic | <-70C | 08-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Osteoporosis | Unknown | No | No | No | No | |||||||||||||||
| BBS0005-CF900024134091819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 55 Y | Male | Hispanic | <-70C | 18-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus, Cerebrovascular accident, COPD, Coronary artery disease, Benign prostatic hyperplasia, Hypertension | Atorvastatin, Hydrocodone-acetaminophen, Insulin glargine, Insulin lispro, Losartan, Metformin, Tamulosin, Tramadol | Yes 2017 | Yes U/A | Yes | No | |||||||||||||||
| BBS0005-CF900024135101519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 68 Y | Male | Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 60 U/L | ALT: 65 U/ | ALP: 150 U/L | 14-Oct-19 | $150.00 | Unknown | None | Amoxicillin / potassium clav | No | No | Yes | No | ||||||||||||||
| BBS0005-CF900024136100719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 67 Y | Male | Non-Hispanic | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Hypersensitivity lung disease, Hypertension, Neuroendocrine tumor status post resection of pancreatic mesentery mass en bloc with distal pancreas, spleen, Fourth portion of duodenum, Duodenoileostomy, Gastrostomy and Jejunostomy tube placement | Ascorbic acid, Aspirin, Atorvastatin, Hydrochlorothiazide, Insulin lispro, Insulin NPH, Lidocaine, Losartan, Metrocarbamol, Metronidazole, Oxycodone, Pancrelipase, Vitamin D3 | Yes 9-Jul-05 | Yes 9-Jul-05 | Yes | No | |||||||||||||||
| BBS0005-CF900026482100219DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 72 Y | Male | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Metastatic bladder cancer status post radical cystoprostatectomy with urostomy; Pulmonary embolism | Acetaminophen, Diphenoxylate-atropine, Methadone, Ondansetron, Oxycodone-acetaminophen, Polyethylene glycol, Prednisone, Rivaroxaban, Senna | U/A | U/A | No | No | |||||||||||||||||
| BBS0005-CF900027862062719DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 10.00 | $150.00 | 73 Y | Female | <-70C | 27-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 39 U/L; ALP: 60 U/L | 27-Jun-19 | $150.00 | Unknown | Diabetes mellitus, Thyroid disorder, Dyslipidemia, Hypertension | Aspirin, Atenolol, Atorvastatin, Chlorhexidine, Glipizide, Hydrochlorothiazide, Ibuprofen, Insulin glargine, Insulin lispro, Liraglutide, Losartan, Metformin, Methimazole, Mupirocin ointment | U/A | U/A | U/A | U/A | |||||||||||||||
| BBS0005-CF900027864070319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 1.00 | $150.00 | 75 Y | Male | <-70C | 03-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 46 U/L | 2-Jul-19 | $150.00 | Unknown | Congestive heart failure, Arterial fibrillation, Multiple myeloma, Recent UTI | Acetaminophen, Acyclovir, Alfuzosin, Allopurinol, Apixaban, Benazepril, Cephalexin, Cholecalciferol, Vitamin D3, Cyanocobalamin, Finasteride, Insulin glargine, Insulin lispro, Magnesium oxide, Melatonin, Metoprolol succinate, Morphine, Pantoprazole, Polyethylene glycol, Senna, Sodium chloride, Sulfamethoxazole trimethoprim, Tamsulosin, Tramadol, Zinc sulfate | U/A | U/A | No | No | |||||||||||||||
| BBS0005-CF900027867053019DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 7.00 | $150.00 | 35 Y | Male | <-70C | 30-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L; ALT: 52 U/L: Test Date 30-May-2019 | $150.00 | Unknown | Hypertension, Wolf parkinson white syndrome | Lorazepam | No | No | |||||||||||||||||
| BBS0005-CF900027868060319DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 7.00 | $150.00 | 51 Y | Male | <-70C | 03-Jun-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | ALT: 59 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Arthritis, Uncontrolled Diabetes Type 2 | Remeron, Nicoderm CQ | No | No | |||||||||||||||||
| BBS0005-CF900027869062619DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 15.00 | $150.00 | 69 Y | Male | <-70C | 26-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 64 U/L; ALT: 79 U/L; ALP: 634 U/L | 26-Jun-19 | $150.00 | Unknown | Pancreatic adenocarcinoma, Duodenal stricture, Obstructive jaundice | Acetaminophen, Dexamethasone, Ferrous sulfate, Ibuprofen, Insulin glargine, Ondansetron, Polyethylene, Potassium chloride, Prochlorperazine, Sertraline | No | No | No | No | |||||||||||||||
| BBS0005-CF900027870062519DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 16.00 | $150.00 | 66 Y | Female | <-70C | 25-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 171 U/L | 24-Jun-19 | $150.00 | Unknown | Hypertension, Diabetes mellitus, Anemia | Acetaminophen, Albuterol, Aprdra Solostar insulin, Baclofen, Carvediol, Docusate sodium, Omeprazole, Feburostat, Ferrous sulfate, Furosemide, Hydralazine, Hydrocodone-acetaminophen, Insuin aspart, Metoclopramide, Simvastatin, Spironolactone, Tramadol | U/A | U/A | No | No | |||||||||||||||
| BBS0005-CF900031091073019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 77 Y | Male | Hispanic | <-70C | 30-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 558 U/L; ALT: 355 U/L; ALP: 177 U/L | 29-Jul-2019 | $150.00 | Unknown | Diabetes mellitus, Hypersensitivity lung disease, Non-Hodgkin's Lymphoma after chemo, Mandible squamous cell cancer | Albuterol, Aspirin, Ibuprofen, Clonazepam, Finasteride, Fluoxetine | No | No | No | Yes | |||||||||||||
| BBS0005-CF900031092071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 70 Y | Male | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 56 U/L | 18-Jul-19 | $150.00 | Unknown | Hypertension, Gout, Anxiety | Allopurinol, Aspirin, Atorvastatin, Fluoxetine, Lisinopril, Terazosin | No | No | No | No | |||||||||||||
| BBS0005-CF900031094072419DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 24-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 151 U/L | 24-Jul-19 | $150.00 | Unknown | Heart transplant, Lymphoma | Acyclovir, Allopurinol, Docusate sodium, Etoposide, Fluconazole, Gabapentin, Hydrocodone-acetaminophen, Insulin aspart, Levofloxacin, Loperamide, Magnesium oxide, Metoclopramide, Metoprolol succinate, Mirtazapine, Omeprazole, Ondansetron, Polyethylene glycol, Prednisone, Prochlorperazine, Senna, Sulfamethoxazole-trimethoprim, Tachrolimus | Yes Date of Vaccination: 14-May-15 | Yes U/A | No | No | |||||||||||||
| BBS0005-CF900031095070219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 0.60 | 1.00 | $150.00 | 22 Y | Female | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 1-Jul-19 | $150.00 | Unknown | Spina bifida, Obesity, Steatosis of liver, Arthritis, Tonsillar hypertrophy, Paraplegia, Obstructive sleep apnea, Atopic dermatitis, Urinary retention, Juvenile plantar dermatosis, Cellulitis, Recurrent urinary tract infections / pyelonephritis, Chiari malformation type II, Adjustment disorder with depressed mood, Hydrocephalus, Myelomeningocele, Asthma | Acetaminophen, Epinephrine, Albuterol, Escitalopram oxalate, Fluticasone, Gabapentin, Lidocaine, Loperamide, Morphine, Naloxone, Nystatin, Ondansetron, Oxybutynin, Polyethylene glycol, Trazodone | No | No | No | No | |||||||||||||
| BBS0005-CF900031097062619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 83 Y | Female | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 46 U/L; ALT: 58 U/L | 26-Jun-19 | $150.00 | Unknown | Multiple myeloma on chemo, Recent c.diff infection, Arthritis, Cholelithiasis, Breast cancer, Cataract, Diabetes mellitus, Fatty liver, Hypertension, Hyperlipidemia, Osteoarthritis, Obesity, Tinea pedis | Acyclovir, Aspirin, Atovaquone, Cyanocobalamin, Dexamethasone, Fidaxomicin, Gabapentin, Glucosamine sulfate, Ixazomib, Lenalidomide, Levothyroxine, Oxybutynin, Potassium chloride | No | No | U/A | No | |||||||||||||
| BBS0005-CF900031098071719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 31 Y | Female | Non-Hispanic | <-70C | 17-Jul-19 | Subject Risk Information | Blood, blood component or organ recipient prior to 1992 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 287 U/L; ALT: 69 U/L; ALP: 455 U/L | 17-Jul-19 | $150.00 | Unknown | Liver cirrhosis after liver transplant | Sirolimus, Tacrolimus | Yes U/A | Yes U/A | No | U/A | |||||||||||||
| BBS0005-CF900037603052819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 58 Y | Female | Non-Hispanic | <-70C | 28-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | BMI 36.0-36.9, Cerebrovascular accident, Coronary artery calcification seen on CAT scan, Thyroid disorder, Hypertension | Amlodipine, Atorvastatin, Aspirin, Isosorbide mononitrate, Levothyroxine, Topiramate | U/A | U/A | ||||||||||||||||
| BBS0005-CF900037604070119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 48 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 59 U/L | 30-Jun-19 | $150.00 | Unknown | Diabetes mellitus type 1, Asthma, Gastroesophageal reflux without esophagitis, Hypertension, Kidney disease, Myocardial infarction | Acetaminophen, Albuterol, Amlodipine, Aspirin, Cyclobenzaprine, Diphenhydramine, Docusate sodium, Ferrous sulfate, Fluticasone, Glucagon, Glucose, Insulin aspart, Insulin Glargine, Lisinopril, Loratadine, Magnesium oxide, Metoclopramide, Metoprolol succinate, Nitroglycerin, Omeprazole, Ondansetron, Tiopropium bromide, Tolterodine, Vitamin B complex | No | No | No | No | |||||||||||||
| BBS0005-CF900037608052919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Diabetes Mellitus, Vertigo, Hypertension, Arthritis, Asthma, Carpal tunnel syndrome, Diverticulitis, Fatigue, Fibromyalgia, Glaucoma, Hiatal hernia, Migraines, Obstructive sleep apnea, Patent foramen ovale, Premature ventricular contractions, Transient ischemic attack | Alprazolam, Budesonide, Clopidogrel, Fluoxetine, Insulin Glargine, Insulin Lispro, Magnesium oxide, Metoprolol, Semaglutide, Pravastatin, Zolpidem | U/A | U/A | ||||||||||||||||
| BBS0005-CF900037609052919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice, Elevated liver enzymes | AST: 94 U/L; ALT: 85 U/L; ALP: 445 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Dysphonia, Dysphagia, Muscle tension dysphonia, Edema of larynx, Globus sensation, Laryngopharyngeal reflux, Reinke's edema of vocal folds, Tinnitus | Amlodipine, Aspirin, Benazepril, Omeprazole, Hydrochlorothiazide | Yes | Yes | |||||||||||||||
| BBS0005-CF900037610053019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 50 Y | Male | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Umbilical hernia | None | Yes | 2009 | Yes | 2009 | ||||||||||||||||
| BBS0005-CF900041239060319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 63 Y | Female | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Anxiety, Depression, Diabetes Mellitus type 2, Essential hypertension, Hyperlipidemia, Subclinical hypothyroidism | Aspirin, Cholecalciferol, Vitamin D3, Glipizide, Lisinopril, Metformin | U/A | Yes | 24-Apr-2014 | ||||||||||||||||
| BBS0005-CF900041240052819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 28-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 45 U/L; ALT: 70 U/L: Test Date 28-May-2019 | $150.00 | Unknown | None | None | Yes | Yes | |||||||||||||||
| BBS0005-CF900041241052819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 42 Y | Female | Hispanic | <-70C | 28-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 395 U/L; ALT: 182 U/L: Test Date 28-May-2019 | $150.00 | Unknown | Anemia, Depression, Endometriosis, Gallstones, Gastritis, Malignant melanoma of skin of left lower extremity, Uterine polyp | Albuterol, Clobetasol, Ibuprofen, Macrobid, Zofran ODT, Percocet, Miralax | No | Yes | 1997 & 1998 | |||||||||||||||
| BBS0005-CF900041242060319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 48 Y | Male | Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Long term hemodialysis patients; HIV infected individuals | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 286 U/L: Test Date 3-Jun-2019 | $150.00 | Unknown | Asthma, Congestive heart failure, Cirrhosis, Diabetes mellitur, Dialysis patient, End stage renal disease, HIV, Hypertension, Legally blind, Liver disease, Myocardial infarction, Neuropathy, Renal disorder, Renal failure | Ziagen, Tylenol, Reyataz, Atorvastatin, B complex vitamin, Zyrtec, Sensipar, Plavix, Colace, Tivicay, Dorzolamide, Pepcid, Gabapentin, Norco, Insulin, Xalatan, Keppra, Lopressor, Zoloft, Norvir, Sevelamer, Dulcolax, Sodium chloride | Yes | Yes | |||||||||||||||
| BBS0005-CF900041243060319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 67 Y | Male | Non-Hispanic | <-70C | 03-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Recurrent pleural effusion; Mass of upper lobe of right lung | None | No | No | ||||||||||||||||
| BBS0005-CF900041245052919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 29-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Dark colored urine; Elevated liver enzymes | AST: 381 U/L; ALT: 326 U/L; ALP: 422 U/L: Test Date 29-May-2019 | $150.00 | Unknown | Abscess left vulvar, Amputated great right toe, Anemia, Anxiety, Asthma, COPD, PTSD, Seizure, Septic shock, Suspicion of cervical cancer, Depression, Diabetes Mellitus, Head trauma, High cholesterol, Hypertension, Hypotension, Low potassium, MRSA, Necrotizing fasciitis, Neuropathy, Osteomyelitis, Postpartum depression | Ferrous sulfate, Gabapentin, Ibuprofen, Insulin Glargine, Insulin Lispro, Levofloxacin, Metformin, Nicotine, Nystatin, Phenytoin, Tramadol | Yes | Yes | |||||||||||||||
| BBS0005-CF900041397101519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 71 Y | Female | Non-Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Congestive heart failure with an ejection fraction of 25%, AICD placement, Coronary artery disease status post Coronary artery bypass graft, Arterial fibrillation on Eliquis, Myocardial infarction, Cerebrovascular accident (stroke) | Amiodarone, Aspirin, Atorvastatin, Benazepril, Carvedilol, Eliquis, Ferrous sulfate, Iron, Furosemide, Insulin glargine, Insulin lispro, Mexiletine, Pantoprazole | No | No | Yes | No | |||||||||||||||
| BBS0005-CF900041398100719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 327 U/L | 7-Oct-19 | $150.00 | Unknown | Hypertension, Diabetes mellitus, Multiple femoral deep vein thrombosis on Eliquis, Ulcerative colitis, Liver transplant | Alenronate, Apixaban, Atenolol, Azathioprine, Calcium carbonate, Cholecalciferol, Diphenoxylate atropine, Famotidine, Ferrous fumorate, Hydrochlorothiazide, Lisinopril, Prednisone, Tacrolimus, Tramadol, Verapamil | Yes 2017 | Yes 2017 | No | No | ||||||||||||||
| BBS0005-CF900041399101519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 65 Y | Female | Non-Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Cerebrovascular accident (stroke) with left sided hemiplegia | Alpraolam, Baclofen, Cyanocobalamin, Fluticasone, Hydrocodone-acetaminophen, Insulin glargine, Ketoconazole, Lidocaine, Losartan, Metoprolol succinate, Nifedipine, Oxybutynin, Pantoprazole, Triamcinolone | Yes U/A | Yes U/A | No | Yes | |||||||||||||||
| BBS0005-CF900045241053019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 60 Y | Male | Hispanic | <-70C | 30-May-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Obstructive sleep apnea, Heart failure with improved ejection fraction, ST-Elevation Myocardia Infarction, Anxiety, Arthritis, Obesity | Acetaminophen, Aspirin, Atorvastatin, Astelin, Coreg, Dextromethorphan, Zetia, Flonase, Ibuprofen, Zaditor, Eucerin, Lidocaine, Artificial Tears, Sodium chloride, Coenzyme Q10, Vitamins D2 & D3 | No | No | ||||||||||||||||
| BBS0005-CF900046339053019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 82 Y | Female | Non-Hispanic | <-70C | 30-May-19 | Subject Risk Information | N/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 58 U/L; ALP: 404 U/L: Test Date 30-May-2019 | $150.00 | Unknown | Aortic stenosis, Arthritis, Bilateral sensorineural hearing loss, Cardiac arrhythmia, Congestive heart failure, Essential hypertension, Hypothyroidism, Macular degeneration | Amiodarone, Amlodipine, Apixaban, Aspirin, Escitalopram oxalate, Furosemide, Levothyroxine, Melatonin, Metoprolol succinate, Pantoprazole, Potassium chloride, Valsartan | No | No | |||||||||||||||
| BBS0005-CF900046341062619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 26-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Chiari malformation, Cholelithiasis | None | U/A | U/A | No | No | ||||||||||||||
| BBS0005-CF900046342072919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 33 Y | Male | Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 305 U/L | 29-Jul-2019 | $150.00 | Unknown | Diabetes mellitus, End stage renal disease on dialysis, Ischemic bowel disease | Albuterol, Ascorbic acid, Aspirin, Bismuth subsalicylate, Buspirone, Calcium carbonate, Carvedilol, Cholecalciferol, Cinacalcet, Epoetin alfa-epbx, Gabapentin, Heparin, Hydrocortisone, Hydromorphone, Hydroxyzine, Insulin glargine, Insulin lispro, Levothyroxine, Lidocaine, Methocarbamol, Midodrine, Mirtazapine, Ondansetron, Oxycodone-acetaminophen, Pantoprazole, Piperacillin-Tazobactum, Polyethylene glycol, Prednisone, Sensipar, Sertraline, Sevelamer carbonate, Sodium chloride, Sulfamethoxazole, | U/A | Yes U/A | No | Yes | |||||||||||||
| BBS0005-CF900046343062719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 66 Y | Male | Non-Hispanic | <-70C | 27-Jun-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 47 U/L; ALT: 61 U/L | 27-Jun-19 | $150.00 | Unknown | Hypertension, Heart murmur, A-fib, Measles, Mumps | Aspirin, Diltiazem, Rivaroxaban | U/A | U/A | No | Yes | |||||||||||||
| BBS0005-CF900046344072919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 80 Y | Male | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 279 U/L; ALT: 149 U/L; ALP: 248 U/L | 9-Jul-19 | $150.00 | Unknown | Diabetes Mellitus type 2, Stomach cancer with metastasis to liver | None | No | No | No | No | |||||||||||||
| BBS0005-CF900046345070319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 56 Y | Female | Hispanic | <-70C | 03-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 43 U/L | 2-Jul-19 | $150.00 | Unknown | Diabetes mellitus, Hypertension, High cholesterol | Amlodipine, Aspirin, Atorvastatin, Gabapentin, Metformin, Naproxen, Tramadol | Yes Date of Vaccination: U/A | No | No | No | |||||||||||||
| BBS0005-CF900046508092419DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 24-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 65 U/L | | 24-Sep-19 | $150.00 | Unknown | Asthma, Hypertension | Albuterol, Lisinopril | U/A | U/A | No | No | ||||||||||||||
| BBS0005-CF900046509101519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 15-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 77 U/L; ALP: 138 U/L | 15-Oct-19 | $150.00 | Unknown | Diabetes mellitus, Hypertension, Coronary artery disease status post stent placement | Amlodipine, Atorvastatin, Clopidogrel, Ferrous sulfate, Iron, Folic acid, Glucagon, Insulin glargine, Insulin lispro, Lamotrigine, Lorazepam, Phenytoin, Potassium chloride, Prednisolone acetate, Opthalmic suspension, Sertraline, Thiamine | No | No | No | No | ||||||||||||||
| BBS0005-CF900046510101719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 17-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Hypertension, GERD, PUD (peptic ulcer) with bleeding ulcer | Amlodipine, Diclofenac sodium, Lidocaine, Pantoprazole | No | No | No | No | |||||||||||||||
| BBS0005-CF900046511091819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 53 Y | Female | Hispanic | <-70C | 18-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 47 U/L | ALT: 42 U/L | 17-Sep-19 | $150.00 | Unknown | Malignant neoplasm of jaw | Atorvastatin, Clindamycin, Docusate sodium, Hydrochlorothiazide, Hydrocodone-acetaminophen, Ibuprofen, Insulin lispro, Morphine, Ondansetron, Sertraline, Tramadol | No | No | No | No | ||||||||||||||
| BBS0005-CF900046512091819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 57 Y | Female | Hispanic | <-70C | 18-Sep-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 157 U/L | 17-Sep-19 | $150.00 | Unknown | Diabetes mellitus, End stage renal disease on hemodiaylysis, Hypertension, Big toe amputation | Albuterol, Amlodipine, Aspirin, Furosemide, Hydralazine, Insulin glargine, Metoprolol succinate, Sevelamer, Terazosin | Yes U/A | Yes U/A | Yes | No | ||||||||||||||
| BBS0005-CF900046513100819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 74 Y | Female | Non-Hispanic | <-70C | 08-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | Albuterol HFA, Azithromycin | Yes U/A | Yes U/A | No | No | |||||||||||||||
| BBS0005-CF900046514092519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 25-Sep-19 | Subject Risk Information | N/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 36 U/L | ALT: 40 U/L | 25-Sep-19 | $150.00 | Unknown | Hypertension, Brohchitis, Hypothyroidism, Asthma | Albuterol, Amlodipine, Fluticasone, Methimazole, Methocarbamol, Prednisone, Propranolol, Ranitidine | No | No | No | No | ||||||||||||||
| BBS0005-CF900055629071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 72 Y | Male | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 49 U/L; ALT: 50 U/L | 9-Jul-19 | $150.00 | Unknown | COPD, Myocardial infarction in 2011 & 2012, Pacemaker placement | Acetaminophen, Amlodipine, Albuterol HFA, Aspirin, Atorvastatin, Budesonide-Formoterol, Losartan, Montelukast, Nitroglycerin, Omeprazole, Pramipexole, Rivaroxaban, Tamsulosin, Tiotropium | Yes Date of Vaccination: U/A | Yes Date of Vaccination: U/A | No | No | |||||||||||||
| BBS0005-CF900055630070219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L | 1-Jul-19 | $150.00 | Unknown | Lupus, Hypertension, Nephrotic syndrome, Tachycardia | Antacids, Azithromycin | No | No | No | Yes | |||||||||||||
| BBS0005-CF900055631071719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 17-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Enlarged liver; Elevated liver enzymes | ALP: 144 U/L | 17-Jul-19 | $150.00 | Unknown | Lupus, Breast cancer, Hypothyroidism, Fibromyalgia | Albuterol, Amitriptyline, Armour thyroid, Budesonide, Cetirizine, Cyclobenzaprine, Diclofenac, Diltiazem, Epinephrine, Escitalopram, Famotidine, Fluocinonide, Fluticasone, Gabapentin, Hydrochlorothiazide, Hydrocodone-acetaminophen, Hydroxychloroquine, Ibuprofen, Levothyroxine, Mirabegron, Multivitamin, Naloxone, Polyethylene glycol, Pyridoxine, Topiramate | U/A | U/A | No | No | |||||||||||||
| BBS0005-CF900055632073119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 39 Y | Female | Non-Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 299 U/L | 31-Jul-19 | $150.00 | Unknown | Hypertension, Diabetes mellitus, Heart failure with reduced ejection fraction (HFrEF) after meth abuse | Aspirin, Atorvastatin, Brimonidine, Carvedilol, Docusate sodium, Dorzolamide-timolol, Latanoprost, Lisinopril, Metformin, Nicotine, Nitroglycerin, Spironolactone, Tramadol | U/A | U/A | No | No | |||||||||||||
| BBS0005-CF900055633072319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 42 Y | Male | Non-Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | Current or former user of IV drugs | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Chronic fracture, IV drug abuse,Migraine | Methadone HCl | U/A | U/A | No | No | ||||||||||||||
| BBS0005-CF900055634070219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 58 Y | Female | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 35 U/L; ALT: 63 | 2-Jul-19 | $150.00 | Unknown | Diabetes mellitus, Hyperlipidemia, Menopause | Cyanocobalamin, Docusate sodium, Hydrocodone-acetaminophen, Nitrofurantoin, Phenazopyridine | U/A | U/A | No | Yes | |||||||||||||
| BBS0005-CF900055635072419DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 63 Y | Female | Non-Hispanic | <-70C | 24-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 344 U/L | 24-Jul-2019 | $150.00 | Unknown | Hypertension, Diastolic congestive heart failure, End stage renal disease on dialysis, Pulmonary hypertension, Angina | Atorvastatin, Carvedilol, Cinacalcet, Dexlansoprazole, Docusate sodium, Furosemide, Hydrocodone-acetaminophen, Insulin aspart, Insulin gargine, Latanoprost, Ophthalmic solution, Levalbuterol, Senna, Sevelamer carbonate | Yes U/A | Yes U/A | No | No | |||||||||||||
| BBS0005-CF900055636073119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 64 Y | Male | Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 37 U/L; ALT: 69 U/L; ALP: 285 U/L | 31-Jul-2019 | $150.00 | Unknown | Asthma, Hypertension | None | No | No | No | No | |||||||||||||
| BBS0005-CF900057233091719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 17-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992 (1986); Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Spinal effusion | Ascorbic acid, Docusate sodium, Methocarbamol, Naloxone, Oxycodone-acetaminophen, Polyethylene glycol | No | No | No | No | |||||||||||||||
| BBS0005-CF900057234100119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 01-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Hypertension, UTI, GERD, Gastric bypass | Albuterol, Albuterol HFA, Aspirin, Azelastine, Cetirizine, Conjugated estrogens vaginal cream, Cyclobenzaprine, Desloratadine, Diclofenac sodium, Omeprazole, Fluticasone, Fluticasone salmeterol, Lisinopril, Lotemax, Montelukast, Olopatadine, Opthalmic solution, Restasis, Opthalmic emulsifier, Venlafaxine | Yes U/A | Yes U/A | No | Yes | |||||||||||||||
| BBS0005-CF900057235101019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 10-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Ascites | $150.00 | Unknown | Ovarian cancer with metastasis | Docusate sodium, Ondansetron | No | No | No | Yes | |||||||||||||||
| BBS0005-CF900057236101619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 6.00 | $150.00 | 47 Y | Male | Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Umbilical hernia, GERD | Omeprazole | No | No | No | No | |||||||||||||||
| BBS0005-CF900057237102119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 73 Y | Male | Non-Hispanic | <-70C | 21-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 240 U/L; ALT: 133 U/L | ALP: 532 U/L | 20-Oct-19 | $150.00 | Unknown | Recent diagnosis of cancer | Aspirin, Docusate sodium, Gabapentin, Metoclopramide, Ondansetron, Oxycodone, Polyethylene glycol, Senna docusate, Tramadol | No | No | No | No | ||||||||||||||
| BBS0005-CF900057238092619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 26-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Hypersensivity lung disease, Diabetes mellitus, Hypertension | Aspirin, Atorvastatin, Azithromycin, Clopidogrel, Gabapentin, Levothyroxine, Metoprolol succinate, Metoprolol tartrate, Promethazine codeine, Triamcinolone | Yes 2018 | Yes 2018 | No | No | |||||||||||||||
| BBS0005-CF900057241092619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 26-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Congestive heart failure, Aortic root dilation status post aortic root repair | Aspirin, Furosemide, Sildenafil, Warfarin | U/A | U/A | No | No | |||||||||||||||
| BBS0005-CF900060369070219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.25 | 2.00 | $150.00 | 51 Y | Female | Hispanic | <-70C | 02-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Right upper side abdominal pain | $150.00 | Unknown | Diabetes mellitus, Gastroparesis, Alcoholism, Essential hypertension, Pancreatitis, Seizure | Cyclobenzaprine, Hydrocodone-acetaminophen, Hydromorphone, Insulin glargine, Lisinopril, Lorazepam, Metoclopramide, Ondansetron, Pantoprazole, Promethazine, Sulfamethoxazole, Tramadol | Yes | Yes | Yes | No | ||||||||||||||
| BBS0005-CF900060370072319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 79 Y | Female | Non-Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | End stage renal disease on dialysis, Osteomyelitis right foot and ankle, Congestive heart failure, COPD, Diabetes mellitus type 2 | Acetaminophen, Diphenhydramine, Ferrous sulfate, Ascorbic acid, Vitamin C, Furosemide, Insulin lispro, Aspirin, Ipratropium albuterol, Isosorbide mononitrate, B-complex vitamin, Metoprolol succinate, Ondansetron, Budesonide, Pantoprazole, ProAir HFA, Calcium-vitamin D, Sevelamer hydrochloride, Clopidogrel, Zinc sulfate | No | No | No | Yes | ||||||||||||||
| BBS0005-CF900060371072919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 78 Y | Female | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 32 U/L | 29-Jul-19 | $150.00 | Unknown | Asthma, Hypertension, Anxiety | Baclofen, Hydrocodone-acetaminophen, Ibuprofen | No | No | No | No | |||||||||||||
| BBS0005-CF900060372070919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 67 Y | Male | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 54 U/L; ALT: 65 U/L; ALP: 400 U/L | 8-Jul-19 | $150.00 | Unknown | Metastatic prostate cancer, Anemia of chronic kidney disease, Diabetes mellitus, Gout, Hypertension | Amlodipine, Atorvastatin, Bicalutamide, Clopidogrel, Mirtazapine, Naloxone, Polyethylene glycol, Senna-docusate, Sertraline | Yes Date of Vaccination: 7-Apr-14 | No | No | No | |||||||||||||
| BBS0005-CF900060373070119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 48 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 134 U/L | 30-Jun-19 | $150.00 | Unknown | Hashimoto's thyroiditis, Hypertension | Biotin, Calcium-Vitamin D, Hydrochlorothiazide, Hydrocodone-acetaminophen, Levothyroxine, Multivitamin, Quetiapine | No | No | No | Yes | |||||||||||||
| BBS0005-CF900060374072219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 43 Y | Female | Non-Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 69 U/L; ALT: 72 U/L; ALP: 221 U/L | 22-Jul-19 | $150.00 | Unknown | Coronary artery disease, Chronic kidney disease, Congestive heart failure, Cerebrovascular accident, Pulmonary embolism on coumadin, Implanted AICD | Albuterol HFA, Amiodarone, Atorvastatin, Bumetanide, Bupropion, Combivent respimat, Famotidine, Gabapentin, Hydrocodone-acetaminophen, Melatonin, Metoprolol, Nicotine gum, Ondansetron, Tramadol, Warfarin | No | No | No | No | |||||||||||||
| BBS0005-CF900060375062719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 18 Y | Male | Hispanic | <-70C | 27-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Pediatric | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 381 U/L | 26-Jun-19 | $150.00 | Unknown | None | None | No | No | No | No | |||||||||||||
| BBS0005-CF900060376070119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 79 Y | Female | Non-Hispanic | <-70C | 01-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 68 U/L; ALT: 71 U/L; ALP: 734 U/L | 30-Jun-19 | $150.00 | Unknown | Hypertension, Anemia, Anxiety, Depression, Dyslipidemia, Encounter for blood transfusion, Hypothyroidism, Paroxysmal A-fib | Albuterol, Atorvastatin, Cholecalciferol, Citalopram, Levothyroxine, Multivitamin, Tolterodine | No | No | No | No | |||||||||||||
| BBS0005-CF900062531101619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 71 Y | Male | Hispanic | <-70C | 16-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | N/A | $150.00 | Unknown | Abdominal surgeries and Small bowel obstruction | Albuterol HFA, Aspirin, Ciclopirox, Esomeprazole, Fluticasone propionate, Levothyroxine, Loratadine, Mirabegron, Ondansetron, Sildenafil, Tamsulosin, Trazodone, Triamcinolone | No | Yes 1999 | 2000 | Yes | No | |||||||||||||||
| BBS0005-CF900062532101719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 17-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 45 U/L | 16-Oct-19 | $150.00 | Unknown | Bronchiectasis | Advair diskus, Albuterol HFA, Amlodipine besylate, Escitalopram oxalate, Levofloxacin, Lorazepram | Yes U/A | Yes U/A | Yes | No | ||||||||||||||
| BBS0005-CF900062533102119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 67 Y | Male | Non-Hispanic | <-70C | 21-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Recent diagnosis of optic neuropathy | Albuterol HFA, Atorvastatin, Bromocriptine, Clopidogrel, Coenzyme, Dupilumab, Empagliflozin, Immun glob, Losartan, Magnesium chloride, Theragran, Nebivolol, Omeprazole, Prednisone | No | Yes U/A | No | No | |||||||||||||||
| BBS0005-CF900062534100719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 68 Y | Male | Non-Hispanic | <-70C | 07-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Hypertension, Valve replacements, Palpitations | Atorvastatin, Fluticasone propionate, Lisinopril, Metoprolol tartrate, Tamulosin, Warfarin | Yes U/A | Yes U/A | No | No | |||||||||||||||
| BBS0005-CF900069836073019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 24 Y | Male | Hispanic | <-70C | 30-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 36 U/L; ALT: 61 U/L | 30-Jul-19 | $150.00 | Unknown | Anxiety, Bi-polar disorder, Hypertension | Albuterol, Cyclobenzaprine, Diltiazem, Ibuprofen, Lorazepam, Quetiapine, Sertraline | U/A | U/A | No | No | |||||||||||||
| BBS0005-CF900069837062719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 50 Y | Male | Hispanic | <-70C | 27-Jun-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 113 U/L; ALT: 93 | 27-Jun-19 | $150.00 | Unknown | Gunshot wound to face, Tracheostomy | Lansoprazole, Ondansetron | U/A | No | No | No | |||||||||||||
| BBS0005-CF900069838073119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 33 U/L; ALP: 529 U/L | 31-Jul-2019 | $150.00 | Unknown | Irritable bowel syndrome, Primary biliary cholangitis with liver cirrhosis | Albuterol, Bupropion, Clonidine, Cyclobenzaprine, Dicyclomine, Hydromorphone, Hydroxyzine, Levothyroxine, Levofloxacin, Lisinopril, Methocarbamol, Metoprolol succinate, Multivitamin, Naproxen, Narcan, Ondansetron, Oxycontin, Pantoprazole, Ropinirole, Sertraline, Ursodiol, Vitamin D2 | No | No | No | No | |||||||||||||
| BBS0005-CF900069839071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 76 Y | Female | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 51 U/L | 9-Jul-19 | $150.00 | Unknown | Congestive heart failure, Diabetes mellitus, Hypertension, Tachy-Brady Syndrome with pacemaker, A-Fib | Albuterol, Albuterol HFA, Atorvastatin, Cyclosporine, Ferrous sulfate, Fluticasone, Furosemide, Gabapentin, Hydralazine, Losartan, Metformin, Metoprolol, Pantoprazole, Rivaroxaban, Senna-docusate, Sodium chloride, Sucralfate | Yes Date of Vaccination: U/A | Yes Date of Vaccination: U/A | No | No | |||||||||||||
| BBS0005-CF900069840072919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 17.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 29-Jul-19 | Subject Risk Information | Long term hemodialysis patient; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus, Chonic kidney disease, End stage renal disease on hemodialysis, Peripheral artery disease, Congestive heart failure EF 25% after AICD | Aspirin, Atorvastatin, B-complex vitamin C - Folic acid, Calcium carbonate, Clopidogrel, Docusate sodium, Epoetin alfa, Fenofibrate, Gabapentin, Insulin lispro, Midodrine, Omeprazole, Polyethylene glycol, Sertraline, Sevelamer carbonate | No | No | U/A | U/A | ||||||||||||||
| BBS0005-CF900069841071119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 11-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 45 U/L | 11-Jul-19 | $150.00 | Unknown | Hypertension, Asthma | Albuterol HFA, Aspirin, Diphenhydramine, Famotidine, Fluticasone propionate, Guaifenesin, Losartan, Nifedipine, Prednisone, Salmeterol, Ziprasidone | No | No | No | No | |||||||||||||
| BBS0005-CF900069842071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 25 Y | Female | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | Current or former user of IV drugs | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 41 U/L; ALT: 53 U/L; ALP: 182 U/L | 18-Jul-19 | $150.00 | Unknown | MSSA endocarditis (tricuspid and pulmonary valve) | None | Yes U/A | Yes U/A | Yes | No | |||||||||||||
| BBS0005-CF900069990090519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 19.00 | $150.00 | 71 Y | Female | Hispanic | <-70C | 05-Sep-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Adult born from 1945 through 1965; Long term hemodialysis patient | Primary Signs and Symptoms | Elevated liver enzymes | AST: 73 U/L | ALT: 40 U/L | ALP: 408 U/L | 5-Sep-19 | $150.00 | Unknown | Coronary artery bypass grafting, End stage renal disease on dialysis | Aspirin, Atenolol, Fexofenadine, Fluticasone propionate, Glyburide, Ketorolac, Losartan potassium, Prednisolone | Yes 2018 | Yes 2018 | No | No | ||||||||||||||
| BBS0005-CF900069991091919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 61 Y | Female | Non-Hispanic | <-70C | 19-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Right upper side abdominal pain; Elevated liver enzymes | AST: 45 U/L | 19-Sep-19 | $150.00 | Unknown | Cirrhosis, Left sided breast cancer, Status post knee replacement | Diclofenac sodium gel, Furosemide, Multivitamin calcium-iron-min, Propanolol, Spironolactone | No | Yes 2016 | No | No | ||||||||||||||
| BBS0005-CF900069992102119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 19.00 | $150.00 | 26 Y | Male | Hispanic | <-70C | 21-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Elevated liver enzymes | AST: 61 U/L | ALT: 78 U/L | 20-Oct-19 | $150.00 | Unknown | Lupus, Sjogren's syndrome | Acetaminophen, Calcium citrate, Cholecalciferol, Gabapentin, Glycopyrrolate, Guaifenesin, Hydroxychloroquine, Metoprolol, Pantoprazole, Prednisone, Propranolol, Sulfamethoxazole | Yes 2005 | 2006 | U/A | No | No | ||||||||||||||
| BBS0005-CF900069993091719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 17-Sep-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | Elevated liver enzymes | AST: 32 U/L | 16-Sep-19 | $150.00 | Unknown | Myocardial infarction, Hypersensitivity lung disease, NSTEMI, Cardiomyopathy with kidney disease | Aspirin, Atorvastatin, Carvedilol, Cholecalciferol, COQ10, Ticagrelor | No | No | No | No | ||||||||||||||
| BBS0005-CF900069994100219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 68 Y | Female | Hispanic | <-70C | 02-Oct-19 | Subject Risk Information | Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes mellitus, Hypertension, Recent retinal detachment of right eye status post repair | Amlodipine, Candesartan, Glimepiride, Nitrofurantoin, Phenazopyridine, Tobramycin dexamethasone opthalmic solution | No | No | No | Yes | |||||||||||||||
| BBS0005-CF900069995101019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 18.00 | $150.00 | 49 Y | Male | Hispanic | <-70C | 10-Oct-19 | Subject Risk Information | U/A | Primary Signs and Symptoms | Ascites; Enlarged liver; Elevated liver enzymes | AST: 59 U/L | ALT: 62 U/L | ALP: 151 U/L | 9-Oct-19 | $150.00 | Unknown | Alcoholic cirrhosis, Diabetes mellitus, Hypertension | Ferrous sulfate, Furosemide, Ondansetron, Pantoprazole, Spironolactone | Yes U/A | Yes U/A | Yes | No | ||||||||||||||
| BBS0005-CF900073335071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 49 Y | Male | Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Jaundice; Elevated liver enzymes | AST: 52 U/L; ALT: 61 U/L; ALP: 309 U/L | 18-Jul-19 | $150.00 | Unknown | Biliary stent placement, Obstructive jaundice, Duodenal cancer, Peritoneal carcinomatosis, Primary sclerosing cholangitis | Cholecalciferol vitamin D3, Fluconazole, Fluorouracil, Gabapentin, Hydrocodone-acetaminophen, Loratadine, Ondansetron, Potassium chloride | No | No | No | No | |||||||||||||
| BBS0005-CF900073336070819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 66 Y | Male | Non-Hispanic | <-70C | 08-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 70 U/L; ALT: 59 | 8-Jul-19 | $150.00 | Unknown | Congestive heart failure, Cerebrovascular accident on coumadin, Hypertension, Premature ventricular contractions, Arthritis, Basal cell carcinoma, Embolism & Thrombosis, Hyperlipidemia, Neuromuscular disease, Premature atrial contraction, Polycolona gammopathy | Albuterol, Aspirin, Hydrochlorothiazide, Jantoven, Losartan, Warfarin, Zolpidem | No | No | No | No | |||||||||||||
| BBS0005-CF900073337071719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 77 Y | Female | Non-Hispanic | <-70C | 17-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 82 U/L; ALT: 122 U/L; ALP: 183 U/L | 17-Jul-19 | $150.00 | Unknown | Hypothyroid, Adrenal adenoma, Anemia, Benign secondary hypertension due to primary aldonenonium, Cancer, Chronic kidney disease, Magnesium deficiency, Multiple myeloma | Acyclovir, Albuterol, Allopurinol, Calcitriol, Dexamethasone, Fluticasone, Hydralazine, Ipratropium-albuterol, Multivitamin, Nifedipine, Ondansetron, Pantoprazole, Potassium chloride, Ursodiol | No | No | No | No | |||||||||||||
| BBS0005-CF900073338071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 69 Y | Male | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 37 U/L; ALT: 49 | 9-Jul-19 | $150.00 | Unknown | Myocardial infarction with cardiac stents, Calculus of gallbladder, GERD, Hemorrhoids, Hypertension Leg fracture, Rectal prolapse, Tobacco use disorder | None | No | No | No | No | |||||||||||||
| BBS0005-CF900073339072219DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 22-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 51 U/L; ALP: 151 U/L | 21-Jul-19 | $150.00 | Unknown | Sickle cell disease, Hypertension, Enlarged heart, Leaky heart valve | Hydroxyurea, Losartan, Oxycodone-acetaminophen, Trazodone | No | No | No | No | |||||||||||||
| BBS0005-CF900073340073119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 28 Y | Female | Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 55 U/L; ALT: 69 U/L | 31-Jul-19 | $150.00 | Unknown | None | Ondansetron | Yes U/A | Yes U/A | No | No | |||||||||||||
| BBS0005-CF900073341072319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 38 Y | Male | Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALP: 133 U/L | 23-Jul-2019 | $150.00 | Unknown | Multiple drug resistant epilepsy, Diabetes mellitus, Bipolar 1 disorder | Acarbose, Amlodipine, Diazepam, Lithium, Losartan, Quetiapine | No | No | No | No | |||||||||||||
| BBS0005-CF900073887102119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 64 Y | Male | Non-Hispanic | <-70C | 21-Oct-19 | Subject Risk Information | Blood, blood component or organ transplant recipient prior to 1992; Adult born from 1945 through 1965 | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Neobladder status post bladder rupture from trauma 1980's | Amlodipine, Aspirin, Clindamycin, Hydralazine, Hydrocodone-acetaminophen, Losartan, Metoprolol tartrate, Minoxidil, Morphine, Nitrofurantoin, Omeprazole | No | No | No | No | |||||||||||||||
| BBS0005-CF900073888081319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 75 Y | Male | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | U/A | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L | 12-Aug-19 | $150.00 | Unknown | Atrial fibrillation | Acyclovir, Aspirin, Atorvastatin, Baclofen, Edoxaban, Gabapentin, Ibuprofen, Ipratropium, Lisinopril, Magnesium chloride, Metformin, Metoprolol tartrate, Oxybutynin chloride, Proair HFA, Trazodone, Voltaren | No | Yes Date of Vaccination: 2015 | No | No | |||||||||||||
| BBS0005-CF900073889081319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 28 Y | Male | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Sickle cell anemia, End stage renal disease on dialysis | Acetaminophen, Albuterol HFA, Allopurinol, Calcitriol, Calcium carbonate, Carvedilol, Docusate sodium, Epoetin alfa, Famotidine, Folic acid, Gentamicin, Glutamine, Hydrocodone-acetaminophen, Hydromorphone, Hydroxyurea, Metoclopramide, Mirtazapine, Naloxone, Ondansetron, Senna, Sevelamer carbonate, Sodium bicarbonate, Sumatriptan | Yes U/A | Yes Date of Vaccination: 19-Apr-17 | No | No | ||||||||||||||
| BBS0005-DI900036168112613DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 26-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 87 U/L | 13 U/L | 8 U/L ALP | AST | ALT 7.2 g/dL | 4.7 g/dL Protein | Albumin | Multiple sex partners; Household contacts of HBV or HCV infected person | |||||||||||||||
| BBS0005-DI900036169112013DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 20-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 54 U/L | 15 U/L | 6 U/L ALP | AST | ALT 5.9 g/dL | 3.4 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person | |||||||||||||||
| BBS0005-DI900036170111313DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 115 U/L | 13 U/L | <6 U/L ALP | AST | ALT 6 g/dL | 3.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person; Confirmed HCV 1a | |||||||||||||||
| BBS0005-DI900036177111913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 19-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Fever / chills | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 59 U/L | 28 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures | |||||||||||||||
| BBS0005-DI900054746071513DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 66 U/L | 9 U/L | <6 U/L ALP | AST | ALT 7.4 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Piercing); Institutionalized population | |||||||||||||||
| BBS0005-DI900054754071513DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 4.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 49 U/L | 21 U/L | 8 U/L ALP | AST | ALT 7.1 g/dL | 4 g/dL Protein | Albumin | Multiple sex partners; Institutionalized population | |||||||||||||||
| BBS0005-DI900061420071913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 27 Y | Male | Non-Hispanic | <-70C | 19-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 37 U/L | 21 U/L | 12 U/L ALP | AST | ALT 7.6 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Institutionalized population | |||||||||||||||
| BBS0005-DI900061421072613DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 26-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 99 U/L | 85 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Sex worker; Body punctures; Institutionalized population | |||||||||||||||
| BBS0005-DI900061422073013DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 74 Y | Female | Non-Hispanic | <-70C | 30-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 69 U/L | 66 U/L | 38 U/L ALP | AST | ALT 8 g/dL | 4.2 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing); Transplant / transfusion of unscreened blood or blood products (Prior to 1992) | |||||||||||||||
| BBS0005-DI900061431073113DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 42 U/L | 15 U/L | 12 U/L ALP | AST | ALT 7.4 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Doctor in Cuba); Transfusion of unscreened blood or blood products (In 1993 in Cuba) | |||||||||||||||
| BBS0005-DI900066901073113DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 53 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Elevated LFTs | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 51 U/L | 43 U/L | 25 U/L ALP | AST | ALT 7.9 g/dL | 4.2 g/dL Protein | Albumin | Intravenous drug user (used reusable needles); Occutpational contact with blood (Medical or dental worker - needlestick in 1992); Household contact with HBV infected person | |||||||||||||||
| BBS0005-DI900066904080813DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 08-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 63 U/L | 14 U/L | 6 U/L ALP | AST | ALT 7.5 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Institutionalized population | |||||||||||||||
| BBS0005-DI900066905080913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 77 Y | Female | Non-Hispanic | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 80 U/L | 22 U/L | 23 U/L ALP | AST | ALT 7.9 g/dL | 4.7 g/dL Protein | Albumin | Occupational contact with blood (Retired nurse); Transplant / transfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||||
| BBS0005-DI900066906080913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 3.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 19 U/L | 6 U/L ALP | AST | ALT 7.4 g/dL | 4.2 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | |||||||||||||||
| BBS0005-FC900041697102413DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 28 Y | Male | Non-Hispanic | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 77 U/L | 18 U/L | 10 U/L ALP | AST | ALT 6.9 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||||
| BBS0005-FC900041698102913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 41 Y | Female | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 86 U/L | 9 U/L | 6 U/L ALP | AST | ALT 7.2 g/dL | 3.7 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||||
| BBS0005-FC900041699102913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Nausea; Abdominal pain | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 97 U/L | 14 U/L | 8 U/L ALP | AST | ALT 7.8 g/dL | 4.2 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||||
| BBS0005-FI900031803072319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 53 Y | Male | Non-Hispanic | <-70C | 23-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ASLT: 42 U/L | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900031804072419DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 24-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | U/A | |||||||||||||||||
| BBS0005-FI900031805072419DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 24-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV; High blood pressure | U/A | U/A | |||||||||||||||||
| BBS0005-FI900032899091012DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 5.00 | $150.00 | 51 Y | Female | Unknown | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 96 U/L | 120 U/L | 117 U/L ALP | AST | ALT 7.1 g/dL | 4.2 g/dL Protein | Albumin | Body punctures; Transplant / tranfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||||
| BBS0005-FI900034882072419DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 24-Jul-19 | Subject Risk Information | Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | None | No | No | |||||||||||||||||
| BBS0005-FI900034883072519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | U/A | U/A | |||||||||||||||||
| BBS0005-FI900034884072519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes 19-Jun | Yes in Jan-2018 18-Jan | |||||||||||||||||
| BBS0005-FI900034885072519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | AST: 46 U/L; ALT: 39 U/L | $150.00 | Unknown | HIV | Yes 1999 | Yes in 1999 1999 | |||||||||||||||||
| BBS0005-FI900034886072519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 49 Y | Male | Non-Hispanic | <-70C | 25-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900034887073119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, Diabetes type 2 | U/A | U/A | |||||||||||||||||
| BBS0005-FI900034888073119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 29 Y | Male | Non-Hispanic | <-70C | 31-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900038353080119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 63 Y | Male | Non-Hispanic | <-70C | 01-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900038354080519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 50 Y | Male | Non-Hispanic | <-70C | 05-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | Yes U/A | |||||||||||||||||
| BBS0005-FI900038355080619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 06-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, Diabetes type 2 | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900038356080819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 08-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes 1997 | Yes in 1997 1997 | |||||||||||||||||
| BBS0005-FI900038357080819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 23 Y | Female | Non-Hispanic | <-70C | 08-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900038363081319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 8.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965; Long term hemodialysis patient | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes, HIV, High blood pressure, Kidney disease | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900038364081319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 17.00 | $150.00 | 62 Y | Male | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | High blood pressure, HIV | Yes 18-Jun-2009 | 21-May-19 | Yes on 18-Dec-2008, 18-Jun-2009 & 20-Nov-2010 18-Dec-2008 | 18-Jun-09 | 20-Nov-10 | |||||||||||||||||
| BBS0005-FI900038365081319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 12.00 | $150.00 | 47 Y | Male | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | High blood pressure, HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900038366081319DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 21 Y | Male | Non-Hispanic | <-70C | 13-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900038367081519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 46 Y | Male | Non-Hispanic | <-70C | 15-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900046698081919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 19-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900046699081919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 9.00 | $150.00 | 24 Y | Female | Non-Hispanic | <-70C | 19-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900046708082019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 47 Y | Female | Non-Hispanic | <-70C | 20-Aug-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Seizures, HIV | No | No | |||||||||||||||||
| BBS0005-FI900046709082019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 7.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 20-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900046710082119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 60 Y | Male | Non-Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900046711082119DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 62 Y | Male | Non-Hispanic | <-70C | 21-Aug-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | Diabetes, HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900054745112012DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 2.00 | $150.00 | 22 Y | Female | Non-Hispanic | <-70C | 20-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 1.3 mg/dL | 0.3 mg/dL TBIL | DBIL 48 U/L | 13 U/L | <6 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| BBS0005-FI900057910070919DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 23 Y | Female | Non-Hispanic | <-70C | 09-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | U/A | U/A | |||||||||||||||||
| BBS0005-FI900057911071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 63 Y | Female | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, High blood pressure | U/A | U/A | |||||||||||||||||
| BBS0005-FI900057912071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, Depression | No | No | |||||||||||||||||
| BBS0005-FI900057913071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 11.00 | $150.00 | 26 Y | Male | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | U/A | U/A | |||||||||||||||||
| BBS0005-FI900057914071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900057915071019DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 42 Y | Male | Non-Hispanic | <-70C | 10-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 48 U/L | $150.00 | Unknown | HIV, High cholesterol, Diabetes, Anxiety | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900057916071519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 40 Y | Female | Non-Hispanic | <-70C | 15-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, Diabetes, Depression | No | Yes U/A | |||||||||||||||||
| BBS0005-FI900064428071519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 39 Y | Female | Non-Hispanic | <-70C | 15-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | U/A | |||||||||||||||||
| BBS0005-FI900064429071519DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 13.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 15-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, Hepatitis B | No | No | |||||||||||||||||
| BBS0005-FI900064430071619DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 14.00 | $150.00 | 20 Y | Female | Non-Hispanic | <-70C | 16-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900064431071719DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 60 Y | Male | Non-Hispanic | <-70C | 17-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900064432071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 16.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, Diabetes, Hepatitis B | Yes U/A | No | |||||||||||||||||
| BBS0005-FI900064433071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 18.00 | $150.00 | 68 Y | Male | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | U/A | U/A | |||||||||||||||||
| BBS0005-FI900064434071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 44 Y | Female | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV, Hyperthyroidism | U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900064435071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 10.00 | $150.00 | 51 Y | Male | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | Yes U/A | Yes U/A | |||||||||||||||||
| BBS0005-FI900064436071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 55 Y | Male | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | U/A | $150.00 | Unknown | HIV | No | No | |||||||||||||||||
| BBS0005-FI900064437071819DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 15.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 18-Jul-19 | Subject Risk Information | HIV infected individual; Adult born from 1945 through 1965 | Suspect HCV:Adult | Primary Signs and Symptoms | Elevated liver enzymes | ALT: 37 U/L; ALP: 235 U/L | $150.00 | Unknown | HIV | U/A | U/A | |||||||||||||||||
| BBS0005-FI900066336052913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 37 Y | Male | Non-Hispanic | <-70C | 29-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Nausea;Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 45 U/L | 31 U/L | 11 U/L ALP | AST | ALT 7.9 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Homosexual M | |||||||||||||||
| BBS0005-FI900069490061913DD | Suspect Hepatitis C (HCV) | USA | 0.5 mL Serum | 1.00 | 1.00 | $150.00 | 40 Y | Female | Non-Hispanic | <-70C | 19-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 44 U/L | 20 U/L | 8 U/L ALP | AST | ALT 7.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures; Transplant / transfusion of blood or blood products (prior to 1992) | |||||||||||||||
| DSP3800-AC900057148051312DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 24 Y | Male | Unknown | <-70C | 13-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 53 U/L | 14 U/L | 7 U/L ALP | AST | ALT 6.4 g/dL | 3.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||||
| DSP3800-AC900057149041012DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 29 Y | Female | Unknown | <-70C | 10-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Fever / chills; Elevated LFTs | Positive | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 107 U/L | 173 U/L | 25 U/L ALP | AST | ALT 5.1 g/dL | 1.7 g/dL Protein | Albumin | Multiple sex partners; Body punctures | |||||||||||||||
| DSP3800-AC900064076091512DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 49 Y | Female | Unknown | <-70C | 15-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Jaundice; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 35 U/L | 7 U/L ALP | AST | ALT 6.9 g/dL | 2.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Sex worker | |||||||||||||||
| DSP3800-AC900064077051913DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 20 Y | Female | Unknown | <-70C | 19-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 3.8 mg/dL | 2.6 mg/dL TBIL | DBIL 188 U/L | 186 U/L | 72 U/L ALP | AST | ALT 5.3 g/dL | 2.3 g/dL Protein | Albumin | Multiple sex partners | |||||||||||||||
| DSP3800-AC900065316032613DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 50 Y | Male | Unknown | <-70C | 26-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Dark color urine / light color feces; Elevated LFTs | N/A | 1.9 mg/dL | 1.3 mg/dL TBIL | DBIL 257 U/L | 68 U/L | <6 U/L ALP | AST | ALT 4.6 g/dL | 1.4 g/dL Protein | Albumin | Transplant / transfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||||
| DSP3800-AC900065317050613DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 35 Y | Female | Unknown | <-70C | 06-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Elevated LFTs | Positive | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 97 U/L | 27 U/L | 20 U/L ALP | AST | ALT 5.2 g/dL | 2.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners | |||||||||||||||
| DSP3800-AC900065318032913DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 22 Y | Male | Unknown | <-70C | 29-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.4 mg/dL TBIL | DBIL 265 U/L | 31 U/L | 8 U/L ALP | AST | ALT 4.8 g/dL | 1.8 g/dL Protein | Albumin | Institutionalized population | |||||||||||||||
| DSP3800-AC900069458092512DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 38 Y | Male | Unknown | <-70C | 25-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Jaundice; Weight loss; Fatigue; Dark color urine / light color feces; Elevated LFTs | N/A | 8.2 mg/dL | 5.7 mg/dL TBIL | DBIL 87 U/L | 102 U/L | 44 U/L ALP | AST | ALT 5.4 g/dL | 1.3 g/dL Protein | Albumin | Multiple sex partners | |||||||||||||||
| DSP3800-AC900069462100512DD | Suspect Hepatitis C (HCV) | Mexico | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 19 Y | Male | Unknown | <-70C | 05-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.6 mg/dL TBIL | DBIL 442 U/L | 42 U/L | 9 U/L ALP | AST | ALT 5.3 g/dL | 1.7 g/dL Protein | Albumin | Homosexual M | |||||||||||||||
| DSP3800-AC900074789081912DD | Suspect Hepatitis C (HCV) | Mexico | 1.00 | 8.00 | $150.00 | 29 Y | Female | <-70C | 19-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Jaundice; Fatigue; Nausea; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 3.6 mg/dL | 2.3 mg/dL TBIL | DBIL 132 U/L | 32 U/L | 6 U/L ALP | AST | ALT 3.8 g/dL | 1.6 g/dL Protein | Albumin | Institutionalized population | |||||||||||||||||
| DSP3800-BU900032895101812DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 39 Y | Male | Hispanic | <-70C | 18-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Abdominal pains; Chills;Elevated LFTs | N/A | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 47 U/L | 15 U/L | 12 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Body punctures (Tattooing); Haemodialysis patient | |||||||||||||||
| DSP3800-BU900032896080212DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 23 Y | Male | Non-Hispanic | <-70C | 02-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 54 U/L | 58 U/L | 41 U/L ALP | AST | ALT 8.3 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M; Multiple sex partners | |||||||||||||||
| DSP3800-BU900032903010713DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 27 Y | Female | Non-Hispanic | <-70C | 07-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.1 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 33 U/L | 17 U/L | 11 U/L ALP | AST | ALT 8 g/dL | 4.1 g/dL Protein | Albumin | Hemolized | |||||||||||||||
| DSP3800-BU900032906020413DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 36 Y | Male | Non-Hispanic | <-70C | 04-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.6 mg/dL TBIL | DBIL 47 U/L | 19 U/L | 12 U/L ALP | AST | ALT 6.8 g/dL | 44 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||||
| DSP3800-BU900032907021413DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 59 Y | Male | Non-Hispanic | <-70C | 14-Feb-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 62 U/L | 24 U/L | 26 U/L ALP | AST | ALT 7.4 g/dL | 4.5 g/dL Protein | Albumin | Body punctures (Acupuncture) | |||||||||||||||
| DSP3800-BU900036004013014DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 60 Y | Female | Non-Hispanic | <-70C | 30-Jan-14 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia) | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 132 U/L | 28 U/L | 17 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | |||||||||||||||
| DSP3800-BU900036005092513DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 25-Sep-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | N/A | 1 mg/dL | 0.4 mg/dL TBIL | DBIL 116 U/L | 119 U/L | 52 U/L ALP | AST | ALT 9.2 g/dL | 4.4 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||||
| DSP3800-BU900036006111313DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia) | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 68 U/L | 11 U/L | 6 U/L ALP | AST | ALT 7 g/dL | 4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M | |||||||||||||||
| DSP3800-BU900036007121113DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 37 Y | Female | Non-Hispanic | <-70C | 11-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Vomiting; Abdominal pains; Chills | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 32 U/L | 19 U/L ALP | AST | ALT 7.7 g/dL | 4.3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| DSP3800-BU900036008122313DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 30 Y | Male | Non-Hispanic | <-70C | 23-Dec-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 66 U/L | 21 U/L | 15 U/L ALP | AST | ALT 8.7 g/dL | 5 g/dL Protein | Albumin | Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BU900036888031213DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 12-Mar-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | Positive | 11.3 mg/dL | 0.6 mg/dL TBIL | DBIL 54 U/L | 13 U/L | 12 U/L ALP | AST | ALT 6.5 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmited diseases (STD); Multiple sex partners | |||||||||||||||
| DSP3800-BU900036889111512DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 0.6 mg/dL | 0.4 mg/dL TBIL | DBIL 58 U/L | 19 U/L | 9 U/L ALP | AST | ALT 4.6 g/dL | 2.8 g/dL Protein | Albumin | Body punctures (Piercing) | |||||||||||||||
| DSP3800-BU900036890102512DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 23 Y | Female | Non-Hispanic | <-70C | 25-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Jaundice; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 5.8 mg/dL | 3.9 mg/dL TBIL | DBIL 126 U/L | 414 U/L | 144 U/L ALP | AST | ALT 9.2 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| DSP3800-BU900036891112312DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 23-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Elevated LFTs | N/A | 1.6 mg/dL | 1.1 mg/dL TBIL | DBIL 812 U/L | 71 U/L | 40 U/L ALP | AST | ALT 6.6 g/dL | 3 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| DSP3800-BU900036900110512DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 43 Y | Male | Non-Hispanic | <-70C | 05-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains; Dark color urine / light color feces; Elevated LFTs | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 49 U/L | 15 U/L | 11 U/L ALP | AST | ALT 6.1 g/dL | 3.8 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BU900042698120512DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 21 Y | Male | Non-Hispanic | <-70C | 05-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 41 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BU900042703120712DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 55 Y | Female | Non-Hispanic | <-70C | 07-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Jaundice; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine; Elevated LFTs | N/A | 0.8 mg/dL | 0.5 mg/dL TBIL | DBIL 66 U/L | 3245 U/L | 316 U/L ALP | AST | ALT 8.1 g/dL | 3.9 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Occupational contact with blood (Trained as medical assistant); Body punctures (Piercing, human bite); Household contacts of HBV or HCV infected person | |||||||||||||||
| DSP3800-BU900050689122712DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 27-Dec-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 71 U/L | 28 U/L | 15 U/L ALP | AST | ALT 8.7 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures (Piercing, human bite); Household contacts of HBVor HCV infected person | |||||||||||||||
| DSP3800-BU900050690111612DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 16-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Fever / chills; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 84 U/L | 61 U/L | 9 U/L ALP | AST | ALT 9.1 g/dL | 5.5 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures (Piercing) | |||||||||||||||
| DSP3800-BU900050691012813DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 28-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 17 U/L | 14 U/L ALP | AST | ALT 6.2 g/dL | 3.6 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Occupational contact (Medical or dental workers); Body punctures (Tattooing, piercing, human bite); Institutionalized population (Prisoners) | |||||||||||||||
| DSP3800-BU900052406022812DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 45 Y | Female | Non-Hispanic | <-70C | 28-Feb-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Elevated LFTs | N/A | 0.8 mg/dL | 0.4 mg/dL TBIL | DBIL 166 U/L | 194 U/L | 24 U/L ALP | AST | ALT 7.2 g/dL | 3.9 g/dL Protein | Albumin | Haemodialysis patient | |||||||||||||||
| DSP3800-BU900052417061412DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 26 Y | Female | Non-Hispanic | <-70C | 14-Jun-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 276 U/L | 50 U/L | 19 U/L ALP | AST | ALT 7.6 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BU900054744110612DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 06-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.7 mg/dL | 0.8 mg/dL TBIL | DBIL 52 U/L | 70 U/L | 19 U/L ALP | AST | ALT 6.8 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Piercing); Haemodialysis patient | |||||||||||||||
| DSP3800-BU900057146031912DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 19-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.1 mg/dL | 0.4 mg/dL TBIL | DBIL 27 U/L | 11 U/L | 14 U/L ALP | AST | ALT 6.3 g/dL | 3.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BU900057147032012DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 22 Y | Male | Non-Hispanic | <-70C | 20-Mar-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 1.3 mg/dL | 0.4 mg/dL TBIL | DBIL 49 U/L | 10 U/L | <6 U/L ALP | AST | ALT 8.2 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BU900057174043013DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 42 Y | Female | Non-Hispanic | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 63 U/L | 10 U/L | 17 U/L ALP | AST | ALT 6.1 g/dL | 4.2 g/dL Protein | Albumin | Multiple sex partners; Body punctures (Acupuncture, piercing) | |||||||||||||||
| DSP3800-BU900057176061013DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 32 Y | Male | Non-Hispanic | <-70C | 10-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Dark color urine; Elevated LFTs | N/A | 1.6 mg/dL | 0.5 mg/dL TBIL | DBIL 65 U/L | 9 U/L | 8 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| DSP3800-BU900057177041713DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 25 Y | Male | Non-Hispanic | <-70C | 17-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Chills; Elevated LFTs | N/A | 1.8 mg/dL | 0.9 mg/dL TBIL | DBIL 59 U/L | 86 U/L | 48 U/L ALP | AST | ALT 6.6 g/dL | 4.1 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures (Tattooing, piercing) | |||||||||||||||
| DSP3800-BU900064064041212DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 38 Y | Male | Non-Hispanic | <-70C | 12-Apr-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Fatigue; Abdominal pains; Fever / chills; Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 15 U/L | 8 U/L ALP | AST | ALT 7.7 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BU900066340112513DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 25-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Chills; Elevated LFTs | N/A | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 87 U/L | 37 U/L | 22 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Intravenous drug user; Body punctures (Tattooing, piercing); Institutionalized population (Prisoners) | |||||||||||||||
| DSP3800-BU900074796091012DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 7.00 | $150.00 | 58 Y | Female | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 47 U/L | 20 U/L | 15 U/L ALP | AST | ALT 6.2 g/dL | 3.8 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Acupuncture, Pierciing) | |||||||||||||||||
| DSP3800-BU900074797091412DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 8.00 | $150.00 | 46 Y | Female | <-70C | 14-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills;Dark color urine; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 66 U/L | 28 U/L | 13 U/L ALP | AST | ALT 7.8 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Dental workers); Body punctures (Acupuncture, tattooing) | |||||||||||||||||
| DSP3800-BU900074799090612DD | Suspect Hepatitis C (HCV) | USA | 1.00 | 5.00 | $150.00 | 23 Y | Male | <-70C | 06-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Abdominal pains; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 2.9 mg/dL | 0.9 mg/dL TBIL | DBIL 85 U/L | 121 U/L | 40 U/L ALP | AST | ALT 8.6 g/dL | 50 g/dL Protein | Albumin | Homosexual M | |||||||||||||||||
| DSP3800-BU900079066090512DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 50 Y | Female | Non-Hispanic | <-70C | 05-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 83 U/L | 33 U/L | 12 U/L ALP | AST | ALT 8.8 g/dL | 5.1 g/dL Protein | Albumin | Haemodialysis patient; Household contacts of HBV or HCV infected person | |||||||||||||||
| DSP3800-BU900079077100812DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 36 Y | Female | Hispanic | <-70C | 08-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains; Fever / chills; Elevated LFTs | N/A | 1.4 mg/dL | 0.7 mg/dL TBIL | DBIL 138 U/L | 1323 U/L | 688 U/L ALP | AST | ALT 8.7 g/dL | 5.4 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing); | |||||||||||||||
| DSP3800-BU900079079102212DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 28 Y | Female | Non-Hispanic | <-70C | 22-Oct-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Abdominal pains; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 14 U/L | 9 U/L ALP | AST | ALT 7.6 g/dL | 4.8 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| DSP3800-BU900079080091712DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 31 Y | Male | Non-Hispanic | <-70C | 17-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains;Dark color urine; Elevated LFTs | N/A | 0.7 mg/dL | 0.5 mg/dL TBIL | DBIL 63 U/L | 276 U/L | 42 U/L ALP | AST | ALT 6.4 g/dL | 3.8 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Tattooing) | |||||||||||||||
| DSP3800-BV900065319043013DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 29 Y | Male | Non-Hispanic | <-70C | 30-Apr-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Abdominal pains; Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 77 U/L | 26 U/L | 21 U/L ALP | AST | ALT 9.1 g/dL | 5.4 g/dL Protein | Albumin | Homosexual M | |||||||||||||||
| DSP3800-BV900066337062513DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 35 Y | Male | Non-Hispanic | <-70C | 25-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Elevated LFTs | Positive | 0.9 mg/dL | 0.4 mg/dL TBIL | DBIL 70 U/L | 43 U/L | 65 U/L ALP | AST | ALT 9.5 g/dL | 5.6 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Body punctures; Homosexual M | |||||||||||||||
| DSP3800-BV900066338083013DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 29 Y | Male | Non-Hispanic | <-70C | 30-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Diarrhea;Elevated LFTs | Positive | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 67 U/L | 16 U/L | 10 U/L ALP | AST | ALT 8.2 g/dL | 4.9 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Body punctures | |||||||||||||||
| DSP3800-BV900069484050813DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 2.00 | $150.00 | 43 Y | Male | Non-Hispanic | <-70C | 08-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Weight loss; Abdominal pain; Muscle or joint aches (Myalgia); Elevated LFTs | Positive | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 53 U/L | 13 U/L | <6 U/L ALP | AST | ALT 7.8 g/dL | 4.5 g/dL Protein | Albumin | Homosexual M | |||||||||||||||
| DSP3800-BV900069485050913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 40 Y | Male | Non-Hispanic | <-70C | 09-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Elevated LFTs | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 84 U/L | 29 U/L | 42 U/L ALP | AST | ALT 7.9 g/dL | 4.5 g/dL Protein | Albumin | Body punctures; Homosexual M | |||||||||||||||
| DSP3800-BV900069486052113DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 41 Y | Male | Non-Hispanic | <-70C | 21-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Elevated LFTs | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 41 U/L | 15 U/L | <6 U/L ALP | AST | ALT 5.1 g/dL | 3.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Homosexual M; Body punctures | |||||||||||||||
| DSP3800-CC900032897080712DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 51 Y | Female | Non-Hispanic | <-70C | 07-Aug-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Fatigue; Nausea; Abdominal pains; Fever / chills; Dark color urine / light color feces; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 50 U/L | 21 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures (Piercing) | |||||||||||||||
| DSP3800-CC900069459051812DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 18-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chlls; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 38 U/L | 1 U/L | 6 U/L ALP | AST | ALT 6.1 g/dL | 3.9 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures | |||||||||||||||
| DSP3800-CC900069460052912DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 33 Y | Female | Non-Hispanic | <-70C | 29-May-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Jaundice; Liver cirrhosis; Weight loss; Fatigue; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever/chills; Dark color urine / light color feces; Elevated LFTs | Positive | 0.7 mg/dL | 0.3 mg/dL TBIL | DBIL 52 U/L | 13 U/L | 10 U/L ALP | AST | ALT 7.6 g/dL | 4.2 g/dL Protein | Albumin | Sexual contacts of HBV or HCV infected person; Body punctures | |||||||||||||||
| DSP3800-CD900064062011513DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 20 Y | Female | Non-Hispanic | <-70C | 15-Jan-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.3 mg/dL TBIL | DBIL 68 U/L | 75 U/L | 29 U/L ALP | AST | ALT 8.6 g/dL | 4.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person (Mom) | |||||||||||||||
| DSP3800-DI900036168112613DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 52 Y | Female | Non-Hispanic | <-70C | 26-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Abdominal pains | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 87 U/L | 13 U/L | 8 U/L ALP | AST | ALT 7.2 g/dL | 4.7 g/dL Protein | Albumin | Multiple sex partners; Household contacts of HBV or HCV infected person | |||||||||||||||
| DSP3800-DI900036169112013DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 20-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 54 U/L | 15 U/L | 6 U/L ALP | AST | ALT 5.9 g/dL | 3.4 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person | |||||||||||||||
| DSP3800-DI900036170111313DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 62 Y | Female | Non-Hispanic | <-70C | 13-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Nausea; Vomiting; Abdominal pains | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 115 U/L | 13 U/L | <6 U/L ALP | AST | ALT 6 g/dL | 3.8 g/dL Protein | Albumin | Household contacts of HBV or HCV infected person; Confirmed HCV 1a | |||||||||||||||
| DSP3800-DI900036177111913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 34 Y | Female | Non-Hispanic | <-70C | 19-Nov-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Muscle or joint aches (Myalgia); Fever / chills | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 59 U/L | 28 U/L | 15 U/L ALP | AST | ALT 7.6 g/dL | 4.3 g/dL Protein | Albumin | Occupational contact with blood (Medical or dental workers); Body punctures | |||||||||||||||
| DSP3800-DI900054746071513DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 54 Y | Female | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 66 U/L | 9 U/L | <6 U/L ALP | AST | ALT 7.4 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures (Piercing); Institutionalized population | |||||||||||||||
| DSP3800-DI900054754071513DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 57 Y | Male | Non-Hispanic | <-70C | 15-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 49 U/L | 21 U/L | 8 U/L ALP | AST | ALT 7.1 g/dL | 4 g/dL Protein | Albumin | Multiple sex partners; Institutionalized population | |||||||||||||||
| DSP3800-DI900061420071913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 27 Y | Male | Non-Hispanic | <-70C | 19-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 37 U/L | 21 U/L | 12 U/L ALP | AST | ALT 7.6 g/dL | 5.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Institutionalized population | |||||||||||||||
| DSP3800-DI900061421072613DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 26-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Weight loss; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Fever / chills; Elevated LFTs | N/A | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 85 U/L | 99 U/L | 85 U/L ALP | AST | ALT 7.7 g/dL | 4.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Intravenous drug user; Multiple sex partners; Sex worker; Body punctures; Institutionalized population | |||||||||||||||
| DSP3800-DI900061422073013DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 74 Y | Female | Non-Hispanic | <-70C | 30-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Abdominal pains | N/A | 0.6 mg/dL | 0.2 mg/dL TBIL | DBIL 69 U/L | 66 U/L | 38 U/L ALP | AST | ALT 8 g/dL | 4.2 g/dL Protein | Albumin | Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing); Transplant / transfusion of unscreened blood or blood products (Prior to 1992) | |||||||||||||||
| DSP3800-DI900061431073113DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 38 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue | N/A | 0.3 mg/dL | 0.1 mg/dL TBIL | DBIL 42 U/L | 15 U/L | 12 U/L ALP | AST | ALT 7.4 g/dL | 4.6 g/dL Protein | Albumin | Occupational contact with blood (Doctor in Cuba); Transfusion of unscreened blood or blood products (In 1993 in Cuba) | |||||||||||||||
| DSP3800-DI900066901073113DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 5.00 | $150.00 | 53 Y | Female | Non-Hispanic | <-70C | 31-Jul-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Elevated LFTs | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 51 U/L | 43 U/L | 25 U/L ALP | AST | ALT 7.9 g/dL | 4.2 g/dL Protein | Albumin | Intravenous drug user (used reusable needles); Occutpational contact with blood (Medical or dental worker - needlestick in 1992); Household contact with HBV infected person | |||||||||||||||
| DSP3800-DI900066904080813DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 58 Y | Male | Non-Hispanic | <-70C | 08-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 63 U/L | 14 U/L | 6 U/L ALP | AST | ALT 7.5 g/dL | 4.9 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Institutionalized population | |||||||||||||||
| DSP3800-DI900066905080913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 7.00 | $150.00 | 77 Y | Female | Non-Hispanic | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 80 U/L | 22 U/L | 23 U/L ALP | AST | ALT 7.9 g/dL | 4.7 g/dL Protein | Albumin | Occupational contact with blood (Retired nurse); Transplant / transfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||||
| DSP3800-DI900066906080913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 56 Y | Male | Non-Hispanic | <-70C | 09-Aug-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Elevated LFTs | N/A | 0.2 mg/dL | 0.1 mg/dL TBIL | DBIL 76 U/L | 19 U/L | 6 U/L ALP | AST | ALT 7.4 g/dL | 4.2 g/dL Protein | Albumin | Homosexual M; Multiple sex partners; Occupational contact with blood (Laboratory or support personnel); Body punctures (Piercing) | |||||||||||||||
| DSP3800-FC900041696102413DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 49 Y | Male | Non-Hispanic | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Weight loss; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 65 U/L | 15 U/L | 11 U/L ALP | AST | ALT 6.9 g/dL | 4.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M | |||||||||||||||
| DSP3800-FC900041697102413DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 3.00 | $150.00 | 28 Y | Male | Non-Hispanic | <-70C | 24-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting | Positive | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 77 U/L | 18 U/L | 10 U/L ALP | AST | ALT 6.9 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||||
| DSP3800-FC900041698102913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 41 Y | Female | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Fatigue; Nausea; Vomiting | N/A | 0.2 mg/dL | 0.2 mg/dL TBIL | DBIL 86 U/L | 9 U/L | 6 U/L ALP | AST | ALT 7.2 g/dL | 3.7 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||||
| DSP3800-FC900041699102913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 52 Y | Male | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Nausea; Abdominal pain | Positive | 0.1 mg/dL | 0.1 mg/dL TBIL | DBIL 97 U/L | 14 U/L | 8 U/L ALP | AST | ALT 7.8 g/dL | 4.2 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Body punctures; Institutionalized population | |||||||||||||||
| DSP3800-FC900041700102913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 54 Y | Male | Non-Hispanic | <-70C | 29-Oct-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Loss of appetite; Weight loss; Fatigue; Nausea; Vomiting; Muscle or joint aches (Myalgia); Fever / chills; Dark color urine / light color feces | Positive | 0.3 mg/dL | 0.2 mg/dL TBIL | DBIL 96 U/L | 17 U/L | 22 U/L ALP | AST | ALT 7.5 g/dL | 4.4 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Homosexual M; Multiple sex partners; Body punctures | |||||||||||||||
| DSP3800-FI900032899091012DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 9.00 | $150.00 | 51 Y | Female | Unknown | <-70C | 10-Sep-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Muscle or joint aches (Myalgia); Elevated LFTs | N/A | 0.5 mg/dL | 0.2 mg/dL TBIL | DBIL 96 U/L | 120 U/L | 117 U/L ALP | AST | ALT 7.1 g/dL | 4.2 g/dL Protein | Albumin | Body punctures; Transplant / tranfusion of unscreened blood or blood products (prior to 1992) | |||||||||||||||
| DSP3800-FI900054745112012DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 8.00 | $150.00 | 22 Y | Female | Non-Hispanic | <-70C | 20-Nov-12 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Loss of appetite; Nausea; Vomiting; Abdominal pains; Muscle or joint aches (Myalgia); Dark color urine / light color feces; Elevated LFTs | N/A | 1.3 mg/dL | 0.3 mg/dL TBIL | DBIL 48 U/L | 13 U/L | <6 U/L ALP | AST | ALT 7.2 g/dL | 4.1 g/dL Protein | Albumin | Body punctures (Tattooing, piercing) | |||||||||||||||
| DSP3800-FI900066336052913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 4.00 | $150.00 | 37 Y | Male | Non-Hispanic | <-70C | 29-May-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Positive | $150.00 | Unknown | Fatigue; Nausea;Abdominal pains; Elevated LFTs | Positive | 0.4 mg/dL | 0.2 mg/dL TBIL | DBIL 45 U/L | 31 U/L | 11 U/L ALP | AST | ALT 7.9 g/dL | 4.1 g/dL Protein | Albumin | Sexually transmitted diseases (STD); Multiple sex partners; Homosexual M | |||||||||||||||
| DSP3800-FI900069490061913DD | Suspect Hepatitis C (HCV) | USA | Double Spun Plasma | 1.00 | 6.00 | $150.00 | 40 Y | Female | Non-Hispanic | <-70C | 19-Jun-13 | Ortho HCV 3.0 ELISA | Negative | Bio-Rad GS HBsAg EIA 3.0 | Negative | HIV Status | Negative | $150.00 | Unknown | Fatigue; Nausea; Muscle or join |